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t Is de lucht achter Oethoezen,
t Is t torentje van Spiek,
t Is de weg van Lains noar Klooster,
En deur Westpolder langs de diek.
t Binnen de meulens en de moaren,
t Binnen de kerken en de börgen,
t Is t laand woar ik as kind
Nog niks begreep van pien of zörgen:
Dat is mien laand, mien Hogelaand... 
t Is n doevetil, n dörpsstroat,
t Is n olle bakkerij,
t Binnen de grode boerenploatsen,
Van Waarvum, Oskerd, zo noar Mij.
t Is de waait, t is de hoaver,
t Is t koolzoad in de blui,
t Is de horizon bie Roanum,
Vlak noa n dunderbui:
Dat is mien laand, mien Hogelaand...
t Is n mooie oavend in maai,
n Kou houst doeknekt in t gruinlaand,
Ik heb veur d’eerste moal verkeren,
En vuil de vonken van dien haand.
De wilde plannen dij ik haar,
Komt sikkom niks meer van terecht,
Totdat de nacht van t Hogelaand,
n Donker klaid over ons legt:
Dat is mien laand, mien Hogelaand...
Nederlandse vertaling
Het Hogeland
Het is de lucht achter Uithuizen,
Het is het torentje van Spijk,
Het is de weg van Leens naar Kloosterburen,
En door Westpolder langs de dijk.
Het zijn de molens en de maren,
Het zijn de kerken en de borgen,
Het is het land waar ik als kind
Nog niets begreep van pijn en zorgen:
Dat is mijn land, mijn Hogeland…
Het is een duiventil, een dorpsstraat, 
Het is een oude bakkerij,
Het zijn de grote boerenplaatsen,
Van Warffum, Usquert, zo naar Uithuizermeeden.
Het is de tarwe, het is de haver,
Het is het koolzaad in de bloei,
Het is de horizon bij Ranum, 
Vlak na een donderbui:
Dat is mijn land, mijn Hogeland…
Het is een mooie avond in mei, 
Een koe hoest voorover gebogen in het weiland,
Ik heb voor de eerste keer verkering, 
En voel de vonken van jouw hand.
De wilde plannen die ik had, 
Daar komt bijna niets meer van terecht,
Totdat de nacht van het Hogeland,
Een donker kleed over ons legt:
Dat is mijn land, mijn Hogeland…
Ter nagedachtenis aan mijn moeder
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Obstructive Sleep Apnoea Syndrome
Sleep disorders commonly occur in the general population and may give rise to serious repercus-
sions on general health, social life and daily functioning. The obstructive sleep apnoea syndrome 
(OSAS) is a sleep-related breathing disorder, which is characterized by intense snoring and recur-
rent obstructions of the upper airway during sleep (1, 2). These airway obstructions can either be 
complete (apnoeas) or partial (hypopnoeas) and can cause (possibly severe) oxygen desaturation 
of the blood. In order to restore airway patency, patients experience arousals from sleep as the 
sympathetic nervous system is activated (3). These arousals result in sleep fragmentation and 
therefore, restorative sleep stages are rarely reached. As a consequence of this deprived sleep, 
patients may suffer from excessive daytime sleepiness (EDS), impaired cognitive function and an 
increased risk of (traffic) accidents (4-6). Furthermore, the disorder is associated with various car-
diovascular complications and an increased mortality when untreated (7). 
The severity of OSAS is usually expressed as the apnoea-hypopnoea index (AHI), defined as the 
average number of apnoeas and hypopnoeas per hour sleep and is assessed through a sleep 
registration (e.g., polysomnography). During polysomnography, oronasal airflow, respiratory ef-
fort, oxyhemoglobin saturation, the level of snoring, sleeping position, limb movements, cardiac 
function (electrocardiography) and brain activity (electroencephalography) are registered. Based 
on the outcome of this polysomnographic study, OSAS is classified as mild (AHI 5-15), moderate 
(AHI 15-30) or severe (AHI> 30) (8). 
During the mid-sixties of the 20th century it was discovered that sleepy obese individuals, suf-
fered from obstructions of the upper airway during sleep and had repetitive awakenings during 
sleep (9). Since then the relationship between obesity and OSAS, particularly in midlife and old 
age, has been clearly established. Nowadays, the condition requires global attention and is the 
subject of intense scientific research. The disorder affects 4% of male and 2% of female adults in 
the North American population (10). Despite these rates it is estimated that 93% of the female 
and 82% of the male population with moderate to severe OSAS is still undiagnosed (11). In the 
Netherlands, the prevalence of clinically significant sleep apnoea syndrome in men, aged 35 years 
and older, is suggested to be at least 0.45% (12). Given the demographic shift in age and the 
predicted increase in body weight over the next years, the prevalence of OSAS is expected to rise 
furthermore.
Treatment of OSAS
When treating OSAS, clinicians may consider various non-invasive, surgical or pharmacological 
treatment modalities (13, 14). When conservative treatment is not applicable or effective, con-
tinuous positive airway pressure (CPAP) used to be the preferred intervention in OSAS patients. 





administration is related to a mechanical splinting effect (15). Obstructions of the upper airway 
are avoided in this way or at least significantly reduced (16). Positive airway pressure is generated 
through a flow generator and is administered through an (oro)nasal mask. Although very effec-
tive, the obtrusive nature of the flow generator and (oro)nasal mask, may cause patients to cease 
or adhere poorly to CPAP therapy. (17, 18). Furthermore, CPAP therapy is associated with side-
effects such as sneezing, nasal congestion and dryness of the airway mucosa. These side-effects 
have led to a search for simpler but effective treatment alternatives that match the effectiveness 
of CPAP. 
Over the past decades, intra-orally worn dental devices, commonly known as oral appliances, 
have gained increasing popularity as treatment alternative to CPAP therapy. There are several 
types of oral appliances, including tongue-retaining devices, which hold the tongue in an ad-
vanced position. The most common type of oral appliance is the mandibular repositioning ap-
pliance (MRA). An MRA aims at relieving upper airway obstructions by positioning the mandible 
and its attached soft tissues structures in a forward and downward position during sleep (19). 
Mandibular repositioning appliances can be divided into monoblock (one piece) and bi-block 
(two pieces) appliances. In monoblock appliances, the maxillary and mandibular acrylic compo-
nents are joined together and do not allow for any mandibular movements. Furthermore, these 
appliances advance the mandible in a predefined ventral position. However, when a patient needs 
another maxillomandibular relationship to improve effectiveness of treatment or to improve com-
fort, a new MRA must be produced or the two parts must be separated and joined together again 
in the desired maxillomandibular relationship. In some situations this can be undesirable because 
the patient may have to sleep without the device for a short period. Bi-block appliances consist of 
two separate parts for both the maxilla and mandible with various mechanisms to join these parts 
together and to adjust the mandible in the desired ventral position (see figure 1, chapter 2). Final 
adjustment of the MRA is usually realized on the basis of subjective complaints (i.e. decreased 
EDS and reduction in snoring levels). However, a subjective improvement of symptoms does not 
always imply a normalization of the number of upper airway obstructions (i.e. AHI <5) and should 
therefore always be objectified by polysomnography.
Nowadays, oral appliance therapy has been demonstrated to be an effective alternative in treat-
ing OSAS, especially in the mild and moderate spectrum of the disorder and in patients unwilling 
or unable to tolerate CPAP therapy (20, 21). For patients with severe OSAS, CPAP therapy remains 
superior. There is however a lack of controlled studies comparing the efficacy of oral appliance 
therapy and CPAP therapy in the long term (≥ 2 years) in OSAS patients representing the entire 
spectrum of the disorder (e.g. mild-to-severe).
Wearing an oral appliance may be associated with side-effects. A distinction can be made be-







of an MRA. Symptoms in the early stages of therapy are usually related to the unnatural ventral 
position of the mandible during sleep. Side-effects that occur after long-term use of an oral ap-
pliance are mostly related to the patients’ dentition. 
Aims of this study
The general aims of this study were:
1. To study changes in upper airway morphology in patients wearing an oral appliance.
2. To reveal to what extent oral appliance- and CPAP therapy is effective in the long-term (2 years) 
    in untreated patients, representing the entire spectrum of the disorder OSAS. 
3. To evaluate side-effects of oral appliance therapy on the long-term. 
Upper airway imaging provides insight into the complex pathophysiology of OSAS. There are 
several ways to image the upper airway in OSAS patients, including computed tomography (CT), 
magnetic resonance imaging (MRI) and videoendoscopy. Most of these imaging techniques are 
expensive, invasive or not readily available in clinical practice. Cephalometry is a widely available, 
less expensive, and easy to perform technique to examine upper airway craniofacial and soft tis-
sue structures. It has also been used to visualize changes in upper airway morphology with an 
oral appliance in situ. However, to our knowledge, it is unclear whether there is a relationship 
between changes in the upper airway morphology with an oral appliance and the treatment 
response to oral appliance therapy. 
In chapter 2, changes in upper airway morphology in OSAS-patients, wearing on oral appli-
ance, will be assessed by means of cephalometric analysis. 
Long-term efficacy of oral appliance therapy has already been described in a few studies. In 
some studies, respiratory parameters deteriorated in some patients during the follow-up period, 
even in patients who were treated successfully at the short-term. In some studies however, there 
was no (matched) control-group, no clear randomisation was described or only mild and moder-
ate OSAS patients were included. Moreover, some studies included patients who had already 
been surgically treated for their OSAS.
Chapter 3 will focus on the long-term objective and subjective treatment response to oral-
appliance- and CPAP therapy in untreated patients with mild-to-severe OSAS. 
After starting oral appliance therapy, common side effects are pain in the temporomandibular 
joints (e.g. arthralgia) (22, 23), painful chewing musculature and their tendons (i.e. tendomyalgia) 
(24) and pain in the teeth (e.g. odontalgia) (19). Furthermore, hypersalivation (25) or symptoms 
of a dry oral mucosa (26) have been reported. Most of these symptoms can be characterized as 
mild and transient (22). In the long term, a decreased overjet and overbite (24, 25, 27, 28) have 
been described. Furthermore, the inclination of the upper and lower incisors can change (25) 





In a recent study a distinction was made between negative and positive side effects (30). Positive 
side-effects include a correction of a class II into a class I occlusion or a decrease in overbite and 
overjet in class II occlusion. Negative side-effects are defined as shifts in occlusion, resulting in an 
end-to-end occlusion, a class III occlusion or a (bi)lateral open bite. When studying the literature 
regarding side effects as a result of long term oral appliance therapy, it can be concluded that 
most studies did not include a control group, small sample sizes were studied, only patients with 
mild or moderate OSAS were included or non-adjustable appliances were used. Therefore, it 
remains unclear to what extent side-effects occur, associated with long-term use of an adjust-
able oral appliance in patients representing the entire spectrum of the disorder. Furthermore, the 
possible association between the degree of mandibular protrusion and the extent of side-effects 
is not conclusive to date.
Chapter 4 will focus on possible side-effects of oral appliance therapy. Chapter 4.1 describes 
how we cephalometrically assessed possible side-effects on the craniofacial morphology associ-
ated with long-term use of a titratable oral appliance compared with CPAP. Secondly we studied 
the relationship between these possible side effects and the degree of mandibular protrusion 
during the follow-up period. In chapter 4.2 a controlled study is presented, in which dental 
side-effects of long-term oral appliance therapy are assessed on cast models. A controlled study 
on possible side-effects on the temporomandibular complex is finally described in chapter 4.3. 
Maxillomandibular advancement (MMA) surgery has gained increasing popularity as a therapeu-
tic alternative in OSAS patients as an extra-pharyngeal operation that enlarges and stabilizes the 
entire velo-oro-hypopharyngeal airway. This specific surgical procedure is indicated for treatment 
of severe OSAS in patients who cannot tolerate or who are unwilling to adhere to CPAP therapy, 
or in whom oral appliances, which are more often appropriate in mild and moderate OSAS pa-
tients, have been considered and found ineffective or undesirable (31). 
In chapter 5 a case is described in which a female patient, with morbidly severe OSAS and 
mandibular retrognathia, was treated with an oral appliance. Although very effective, the patient 
was not satisfied with her facial profile and would also like a more permanent solution for her 
remaining severe OSAS. She therefore choose to undergo MMA surgery, combined with a chin 
osteotomy and submental liposuction.
Chapter 6 discusses the main findings of the studies described in this thesis (chapter 2 through 
5) in a broader context and general conclusions are drawn.
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Effects of an oral appliance on the upper 
airway morphology: 
a cephalometric analysis
This chapter is an edited version of:
Doff M.H.J., Hoekema A., Pruim G., van der Hoeven J., de Bont, L.G.M., Stegenga B. Effects of a Mandibular 
Advancement Device on the Upper Airway Morphology: a Cephalometric Analysis.










The aims of this study were to assess changes in the upper airway morphology associated with 
an oral appliance in situ in patients suffering from the obstructive sleep apnoea-hypopnoea syn-
drome and to relate these changes to treatment response. 
Changes in upper airway morphology as a result of an oral appliance were assessed in 52 OSAS 
patients by means of cephalometric analysis. Lateral cephalograms were taken at baseline and af-
ter 2-3 months of treatment. Baseline and follow-up cephalograms were traced twice and cepha-
lometric variables were compared. The predictive value of changes in upper airway morphology 
for the treatment response was evaluated in univariate and multivariate regression analyses.
Oral appliance therapy resulted in an increased posterior airway space at the level of the second 
vertebra, the uvular tip and the base of the tongue. The increase of the posterior airway space at 
the level of the second vertebra and the uvular tip were the best predictors for relative improve-
ment of the apnoea-hypopnoea index. However, the predictive value for treatment response of 






The obstructive sleep apnoea syndrome (OSAS) is a sleep-related breathing disorder, character-
ized by repetitive partial (hypopnoea) or complete (apnoea) airway obstructions and disruptive 
snoring during sleep (1). These airway obstructions can cause recurrent arousals from sleep, ul-
timately resulting in excessive daytime sleepiness, neurocognitive impairment, a higher risk of 
motor-vehicle accidents and cardiovascular disease events (2-5).
Severity of the disorder is usually expressed by the apnoea-hypopnoea index (AHI), i.e., the 
mean number of apnoeas and hypopnoeas per hour sleep. OSAS may be classified as mild (AHI 
5-15), moderate (AHI 15-30) or severe (AHI >30) (6). OSAS of at least mild severity is diagnosed in 
2% of women and 4% of middle-aged men in the North-American population (7).
In order to improve upper airway patency during sleep, a variety of treatment options, ranging 
from non-invasive to surgical, is available. Continuous positive airway pressure (CPAP) is generally 
considered the treatment of first choice in severe OSAS cases (8). However, compliance with this 
relatively obtrusive therapy may be poor (9, 10). Oral appliance therapy is an effective alterna-
tive, and is especially effective in mild/moderate OSAS cases (2). Most oral appliances used in a 
clinical setting are mandibular advancement devices which keep the mandible and its attached 
musculature in a protruded position. 
Upper airway imaging provides insight into the complex pathophysiology of OSAS. There are 
several ways of imaging the upper airway in OSAS-patients, including computed tomography 
(CT), magnetic resonance imaging (MRI) and videoendoscopy. Most of these imaging techniques 
are expensive, invasive or not readily available in clinical practice. Cephalometry is a widely avail-
able, less expensive, and easy to perform technique to examine upper airway craniofacial and 
soft tissue structures (11). It has also been used to visualize changes in upper airway morphology 
with an oral appliance in situ (12, 13). However, to our knowledge, it is unclear whether there is 
a relationship between changes in the upper airway morphology with an oral appliance and the 
treatment response to oral appliance therapy. To answer this question we determined changes in 
upper airway morphology in OSAS-patients by means of cephalometric analysis.
Materials & Methods
Patient selection
The effectiveness of an oral appliance in the treatment of OSAS, as compared to CPAP, has been 
determined in a separate randomized controlled trial (15). In that trial, patients with OSAS (ap-
noea-hypopnoea index > 5) (6) were recruited at the Department of Home Mechanical Ventilation 
of the University Medical Center Groningen, the Netherlands. Based on dental, medical and psy-
chological criteria (Table 1), patients were selected for that trial and consequently randomized for 
either CPAP- or oral appliance therapy (15). In the course of that study, several patients switched 
from CPAP to oral appliance therapy.







as well as patients who had switched from CPAP to oral appliance therapy before follow-up (n=6) 
were included. Of the latter patients, five were considered non-compliant to CPAP and CPAP was 
nonsuccessful in one patient. Of the fifty-one patients, randomized to oral appliance-therapy, two 
were lost to follow-up. Furthermore, three patients were excluded because of an inadequate qual-
ity of the cephalograms, resulting in 52 patients for analysis. The present study was approved by 
the Groningen University Medical Center’s Ethics Committee (METc2002/032). Written informed 
consent was obtained from patients before enrolment.
Study design
To determine whether there is a relationship between changes in upper airway morphology with 
an oral appliance in situ and treatment response to oral appliance therapy, patients had been 
subjected to a polysomnographic evaluation at baseline. In addition, a lateral cephalogram of all 
patients was taken. The oral appliance used in this study (Thornton Adjustable Positioner, Airway 
Management Inc., Dallas, TX, USA) consisted of two separate parts, fixing the patient’s mandible in 
a protruded and downward position (Fig. 1). The mandibular protrusion could be adjusted with 0.2 
mm increments with a propulsion screw, which was incorporated anteriorly in the oral appliance. 
Before starting oral appliance therapy, the maximal range of mandibular protrusion of each patient 
was determined with a George-Gauge™ (H-Orthodontics, Michigan City, IN, USA). When initiat-
ing oral appliance therapy, the mandible was set at approximately 50% of the patient’s maximal 
protrusion. After having adapted to this position during a two-week period, patients were allowed 
to further adjust the oral appliance during a 6 weeks period. After this “titration” period, the treat-
ment effect was assessed with a second polysomnogram. This period was, if necessary, continued 
Table 1. Criteria for exclusion.
Medical and psychological criteria Dental criteria
Previous treatment of OSAS (continuous positive 
airway pressure [CPAP], oral appliance therapy, 
or uvulopalatopharyngoplasty)
Extensive periodontal disease or tooth 
decay
Morphological airway abnormalities requiring 
treatment 
Active temporomandibular joint disease 
(including severe bruxism).
Endocrine dysfunction Restrictions in mouth opening (<25 mm) 
or advancement of the mandible (<5 
mm).
A reported or documented history of severe 
cardiac or pulmonary disease 
Partial or complete edentulism (<8 teeth 
in upper or lower jaw). 
Moderate or severe periodic limb movement
disorder (periodic limb movement index >25)
A psychological condition precluding informed 
consent (mental retardation or psychiatric 





until the AHI was <5 or until the adjustments became uncomfortable for the patient. Follow-up 
review ended with a final polysomnographic evaluation or when the patient discontinued treat-
ment (e.g., because of poor tolerance). Furthermore, a second lateral cephalogram was taken 
with the oral appliance intra-orally. The degree of protrusion and the vertical dimension of the oral 
appliance were kept constant during the follow-up measurements (e.g. second cephalogram and 
polysomnographic evaluation). Mandibular protrusion and the mouth opening (including the verti-
cal overbite) were measured with a digital sliding calliper with a 0.01 mm accuracy.
The primary outcome measure was the change in upper airway morphology, associated with 
wearing an oral appliance. Secondary outcome measures were the relative improvement of the 
AHI, an AHI <5 and the criterion of “effectiveness of treatment” as suggested by Hoekema et al, 
(2) defined as an AHI <5 or a reduction in the AHI of at least 50% from the baseline value to a 
value of <20 in a patient without subjective OSAS symptoms (6) while using therapy (no excessive 
daytime sleepiness and <2 subjective OSAS symptoms) (appendix).
Polysomnography
Polysomnography (Embla® A10 digital recorder, Medcare, Reykjavik, Iceland) for baseline and 
follow-up evaluations was conducted ambulatory in the patient’s home. Based on the AHI, pa-
tients were classified as having non-severe (AHI 5-30) or severe (AHI >30) OSAS. All polysomno-
grams were evaluated and scored by the same neurophysiologist (JH), who was unaware of the 
patient’s treatment assignment.  
Cephalometric analysis
All lateral cephalograms were recorded using a ProMax Cephalostat (Planmeca, Helsinki, Fin-
land). The “mirror position” (16) was used in order to get a reproducible position of the head. 
Patients were instructed to swallow and to close their mouths with the mandible in maximal in-







tercuspation and the lips in a relaxed position. After a short period of relaxed tidal breathing the 
cephalogram was taken at end-expiration. A trace-protocol (Table 3, Fig. 2) was designed and all 
tracings were performed using Viewbox 3.1.1.6 software® (dHal software. Kifissia, Greece). As a 
first step, to determine inter-observer reliability, 10 baseline cephalograms were randomly chosen 
and traced by two experienced clinicians (GP, MD). Next, to minimize identification error, all 52 
cephalograms were traced blindly with respect to treatment outcome by one observer (MD) and 
repeated after a one week period. Mean outcomes of both tracings were used for further statisti-
cal analysis. All linear cephalometric measurements were converted to values of life size.
Statistical analyses
All statistical analyses were performed using the Statistical Package for the Social Sciences (ver-
sion 14.0, SPSS Inc., Chicago, IL, USA). To assess inter-observer reliability of the tracings, the 
interclass correlation coefficient (ICC) was calculated for each variable. ICCs < 0.4 were consid-
ered poor, ICCs of 0.4 to 0.75 were considered fair to good, and those > 0.75 were considered 
excellent (17).
All variables were normally distributed (AHI at baseline and follow-up after log transformation) 
and their means ± standard deviation are reported. To compare outcomes between demographic 
and cephalometric variables at baseline and follow-up, paired Student’s t-tests were performed. 
α was set at 5%. 
The differences in upper airway morphology between baseline and follow-up variables were 
selected for regression analysis. For matters of broad inclusion of possible determinants, was set 
at 0.2 for the univariate analyses. The dependent variable was the relative improvement of the 






of the  
difference
Age (years) 50.8 ± 9.5 - -
Male / female ratio 45 / 7 - -
Epworth sleepiness scale 12.8 ± 5.7 6.8 ± 5.4 p < 0.05
Apnoea-hypopnoea index (no/hour) 35.8 ± 27.5 7.3 ±13.6 p < 0.05†
OSAS severity Non-severe: n=28 (54%)
Severe: n=24 (46%)
- -
Body-mass index (kg/m2) 31.8 ± 5.8 31.9 ± 5.9 NS
Neck circumference (cm) 43.6 ± 3.1 43.7 ± 3.0 NS
minSaO2 (%) 79 ± 8 88 ± 7 p < 0.05
* Plus-minus values are means ± standard deviations.
Abbreviations: minSaO2 = lowest oxyhemoglobin saturation during sleep, NS = not significant.
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apnoea-hypopnoea index following treatment for the linear regression analysis, and the pres-
ence or absence of “effectiveness of treatment” and an AHI < 5 following treatment for the 
logistic regression analysis. All significant variables concerning pharyngeal dimensions resulting 




Demographic variables of all patients and variables regarding treatment response at baseline 
and follow-up are summarized in table 2. According to Hoekema’s definition of success, treat-
ment was “successful” in 42 patients (81%). The average mandibular protrusion for patients with 
effective treatment according to Hoekema (successful) at the follow-up review was 79.9 ± 18.1 
% (mean ± s.d.) and 76.2 ± 18.1 % for the patients in which treatment was not effective (non 
successful). The difference in mandibular protrusion between the successful and nonsuccessful 
responder was not significant (t-test, p > 0.05). The average mouth opening at follow-up, when 
Figure 2. Cephalometric landmarks and 
reference lines traced on lateral cephalo-
grams. 
Seventeen reference points were identi-
fied on lateral cephalograms: A (point A) 
, B (point B), BT (Base of Tongue intersec-
tion; intersection point of the line con-
necting B-Go with the Base of Tongue), 
C2a (most antero-inferior point on the 
second vertebra), C3a (most antero-
inferior point on the third vertebra), Gn 
(gnathion), Go (gonion), Hy (hyoid: the 
most antero-superior point on the body 
of the hyoid bone), Me (menton), N (na-
sion), Pg (pogonion), pns (posterior 
nasal spine), P2a (point created by the 
intersection of a perpendicular line from 
C2a with the anterior pharyngeal wall), 
P2p (point created by the intersection of 
a perpendicular line through C2a with 
the anterior pharyngeal wall, located on the posterior pharyngeal wall), PPW’ (Posterior Pharyngeal Wall 
intersection; intersection point of the line connecting B-Go with the Posterior Pharyngeal Wall), S (sella), 
Ut (uvular tip; tip of the velum).
Three reference lines where identified on lateral cephalograms: MP (mandibular plane according to 
Steiner: the line through gonion and gnathion), PPW (posterior pharyngeal wall: the anterior outline of 





the patient was wearing the oral appliance, was 13.2 ± 2.8 mm in the successful responder group 
and 12.2 ± 2.4 mm in the nonsuccessful responder group. The latter difference between these 
two groups was not significant (t-test, p > 0.05). 
Reliability 
An “excellent” agreement between both examiners was found for all cephalometric variables 
(Table 4), except for the posterior airway space at the level of the base of the tongue (Pas-BT) 
which demonstrated “fair to good” agreement (17). 
Cephalometric analysis
Regarding the sagittal jaw relationship the SNB-angle increased 1.5 (± 1.9) degrees and the 
ANB-angle decreased 1.8 (± 2.0) degrees as a result of wearing an oral appliance (Table 3). Con-
cerning pharyngeal dimensions, increases were found for the posterior airway space at the level 
of the base of the tongue (Pas-BT) (1.2 ± 3.6 mm), at the level of the second vertebra (Pas-C2) 
(1.6 ± 3.7 mm), and at the level of the uvular tip (Pas-Ut) (1.8 ± 2.6 mm) with the oral appliance 
intra-orally. Moreover, both the distance from the hyoid to the mandibular plane (Hy-MP) and the 
distance between hyoid and the sella-nasion line (Hy-SN) had decreased (-9.2 ± 3.8 mm and -3.4 
± 4.1 mm, respectively), indicating a more cranial position of the hyoid bone. 
Table 4. Interobserver reliability for tracings from random baseline cephalograms (n=10).
Variable ICC 95% CI
Sagittal jaw relationship
SNA 0.97 [0.69 − 0.99]
SNB 0.86 [0.31 − 0.97]
ANB 0.91 0.69 − 0.98]
Pharyngeal dimensions
C2a-P2a 0.96 [0.30 − 0.99]
C2a-P2p 0.83 [0.49 − 0.96]
Pas-BT 0.69 [0.18 − 0.91]
Pas-C2 0.95 [0.78 − 0.99]
Pas-Ut 0.90 [0.6 − 0.97]
PSN-Ut 0.94 [0.78 − 0.99]
Hyoid bone position
Hy-C3a 0.93 [0.22 − 0.99]
Hy-MP 0.92 [0.70 − 0.98]
Hy-SNL 0.95 [0.81 − 0.99]
See legend fig.2 








Univariate linear regression analysis demonstrated that an increased posterior airway space at 
the level of the second vertebra (Pas-C2) and at the level of the uvular tip (Pas-Ut) was signifi-
cantly associated with a relative improvement of the AHI (Table 5). Logistic regression analysis 
for predicting an AHI <5 or “effectiveness of treatment” did not yield any significant predictive 
cephalometric variables.
Multivariate linear regression analysis for predicting the extent of the relative improvement of 
the AHI, yielded a model with the increase in posterior airway space at the level of the uvular tip 
(Pas-Ut) as strongest predictor (beta = -5.40, 95% CI [-9.16;-1.56], p<0.05).
Table 5. Univariate analysis of cephalometricvariables predicting a relative improvement of the apnoea-hypo-
pnoea index with oral appliance therapy and logistic regression analysis for predicting an AHI<5 or ‘effective-










SNB (degrees) -0.07 [-5.60 − 5.47] 1.36 [1.0 − 1.86] 0.98 [0.68 − 1.41]
ANB (degrees) 0.74 [-4.70 − 6.18] 0.76 [0.55 − 1.03] 1.08 [0.75 − 1.55]
Pharyngeal dimensions
C2a-P2a (mm) -0.23 [-3.57 − 3.12] 0.93 [0.78 − 1.11] 1.00 [0.80 − 1.24]
Pas-C2 (mm) -3.37 [-6.11 − -0.63]* 0.85 [0.70 − 1.02] 0.91 [0.77 − 1.07]
Pas-BT (mm) -2.70 [-5.53 − 0.13] 0.89 [0.75 − 1.06] 0.90 [0.76 − 1.07]
Pas-Ut (mm) -5.36 [-9.16 − -1.56]* 0.99 [0.80 − 1.23] 0.77 [0.58 − 1.01]
Hyoid bone position
Hy-MP (mm) -0.54 [-3.34 − 2.27] 0.94 [0.81 − 1.10] 0.95 [0.78 − 1.14]
Hy-SN (mm) -0.86 [-3.45 − 1.74] 0.92 [0.79 − 1.07] 0.97 [0.80 − 1.16]
* p<0.05.
† Relative decrease of the apnoea-hypopnoea index as a result of oral appliance therapy.
‡ Treatment was considered effective when the AHI either was <5 or showed substantial reduction, defined 
as reduction in the AHI of at least 50% from the baseline value to a value of <20 in a patient without symp-
toms while using therapy. 






The results of this study show that an oral appliance in situ improves the antero-posterior di-
mensions of the posterior airway space at the level of the second vertebra (Pas-C2), the uvular 
tip (Pas-Ut), and the base of the tongue (Pas-BT). At the former two sites the increased posterior 
airway space was associated with a relative improvement of the AHI. 
No significant changes could be demonstrated in the linear distance between point C2a and 
P2p, suggesting that the increase of the posterior airway space at the level of C2 is caused by a 
more ventral position of the anterior pharyngeal wall. The increase in the posterior airway space 
can be attributed to the oral appliance, which holds the mandible in an anterior position. Isono 
et al (18) proposed possible mechanical interactions in the pharyngeal region. Since the tongue is 
directly connected to the mandible, a more anterior position of the mandible most likely displaces 
the tongue anteriorly, thus increasing the retroglossal airway space. Considering the working 
mechanism of an oral appliance (i.e. protruding the mandible and its attached soft tissue struc-
tures) one would expect the largest increase in posterior airway space to be located at the level 
of the base of the tongue. However, we found the largest increase at the level of the uvular tip. 
The first explanation for this finding is that in most OSAS patients the base of the tongue opposes 
the anterior wall of the soft palate because of macroglossia and/or a longer uvula associated 
with the disorder (19). By forcing the tongue in a more anterior position, the gravitational effect 
on the soft palate may be decreased. The resulting increase of the velopharyngeal airway space 
(Pas-Ut) with oral appliance therapy might be explained by this theory. A second explanation may 
be the decrease in snoring levels accompanied with oral appliance therapy, which might result in 
a decrease in oedematous tissue of the velum. Both explanations seem viable but it is unknown 
to what extent each of both mechanisms contributes to this increase in velopharyngeal airway 
space. 
In several studies a more inferiorly positioned hyoid bone has been described in OSAS patients 
when compared to healthy subjects (14, 20, 21). In this study we demonstrated a more cranial 
position of the hyoid bone as a result of an oral appliance, as indicated by a decrease in the linear 
distance between hyoid and the sella-nasion line (Hy-SN) and the linear distance between hyoid 
and the mandibular plane (Hy-MP). Although the decrease in Hy-SN indicates a more cranial posi-
tion of the hyoid bone, the decrease in distance between hyoid and the mandibular plane Hy-MP 
most likely results from the mouth opening associated with wearing an oral appliance. The more 
cranial position of the hyoid bone might also be the result of the more protruded position of the 
mandible and tongue with the oral appliance intra-orally. Consequently, the tongue muscula-
ture might pull the hyoid bone to a more anterior-superior position. However, contrary to other 
results, (22) we could not demonstrate a more anterior position of the hyoid bone with an oral 
appliance as indicated by a non-significant change in the linear distance between point hyoid (Hy) 
and the most antero-inferior point on the third vertebra (C3a). This difference in hyoid position 
could be explained by the fact that Tsuiki et al (23) recorded their cephalograms in the supine 







larger in supine position than in the upright position. This gravitational effect could have resulted 
in a more posteriorly located hyoid bone at baseline and consequently in a more anterior position 
with an oral appliance. 
In this study, cephalograms were taken in an upright rather than a supine position. Ingman et 
al (24) reported that OSAS patients are prone to significant narrowing of their oropharyngeal air-
way, but not of their naso- or hypopharyngeal airway in the supine position. The findings in our 
patients may not be completely representative of the “normal” situation during sleep. However, 
in selecting suitable patients for oral appliance therapy in a clinical setting, the added value of 
supine cephalometry should be questioned because of its more laborious nature. 
Sophisticated techniques like sleep nasendoscopy and a remotely controlled mandibular po-
sitioner have been suggested to predict the response to oral appliance therapy (25, 26). These 
techniques may be of additional value in selecting suitable candidates for oral appliance therapy. 
However, unlike cephalometry, most of these techniques are expensive and complex or not avail-
able in a dental or orthodontic practice. Cephalometry provides two-dimensional information. 
Imaging techniques providing three-dimensional information could be of additional value in as-
sessing the complex pathophysiology of OSAS and the working mechanism of an oral appliance 
during sleep. On the other hand, these imaging techniques would be impractical and expensive in 
large groups of patients. Therefore, the present study aimed at providing predictive upper airway 
variables convenient for the clinical situation. 
Multivariate linear regression analyses yielded a single-variate predictive model, with a positive 
change in posterior airway space at the level of the uvular tip (Pas-Ut) being the best predictor 
for a relative improvement of the AHI. However, logistic regression analysis for predicting an AHI 
<5 or “effective treatment” did not yield any predictive variables. Therefore, it could be hypoth-
esized that the actual positive changes in upper airway dimensions with an oral appliance during 
sleep are not the main contributors to treatment response. In Table 3 it is shown that these actual 
changes are rather small (i.e. 0.1-2.2 mm). Therefore, it seems a plausible explanation that the 
effectiveness of an oral appliance is largely based on protecting the posterior airway space from 
collapsing during sleep rather than on increasing it. Another possible explanation is that obstruc-
tive sleep apnoea patients experience a greater degree of lateral than antero-posterior increase 
in airway size with an oral appliance (27). Therefore we conclude that, considering these possible 
mechanisms and some methodological limitations of this study (i.e. awake, upright position, two-
dimensional), the predictive value for treatment response of these cephalometric upper airway 
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In this study we report about the subjective and objective treatment outcome of oral appliance 
therapy and continuous positive airway pressure (CPAP) in a two-year follow-up of a cohort of 
103 patients of a previously conducted randomized controlled trial.
Objective and subjective parameters were assessed after one year and two years of treatment. 
Treatment was considered “successful” when the apnoea-hypopnoea index (AHI) was <5 or 
showed ‘substantial reduction’, defined as reduction in the index of at least 50% from the base-
line value to a value of < 20 in a patient without OSAS-symptoms while using therapy. 
Regarding the proportions of successful treatments, no significant difference was found be-
tween oral appliance therapy and CPAP in treating mild-to-severe OSAS in a two-year follow-up. 
CPAP was still successful in 67.3% of the patients and oral appliance therapy in 52.9% of the 
patients (p=0.14) after two years of treatment. More patients dropped out under oral appliance 
therapy (47%) compared to CPAP (33%). Both therapies showed substantial improvements in 
polysomnographic and neurobehavioral outcomes. However, CPAP was more effective in lower-







Obstructive sleep apnoea syndrome (OSAS) is a sleep-related breathing disorder, characterized by 
snoring and repetitive pharyngeal collapse (1). It is associated with excessive daytime sleepiness, a 
decreased quality of life, increased cardiovascular morbidity, and a higher risk of traffic accidents 
(2, 3). The standard treatment, i.e. continuous positive airway pressure (CPAP), reduces upper 
airway obstructions and improves quality of life (4). However, because of its cumbersome nature, 
patients may have problems to adhere to or even abandon the treatment. Oral appliance therapy 
has been shown to be non-inferior to CPAP regarding treatment-success in mild-to-moderate 
OSAS patients in the short-term (5). Furthermore, many patients prefer oral appliance therapy to 
CPAP (6).
Long-term outcomes of oral appliance therapy have already been described in a few studies 
(7-11). In four studies, respiratory parameters deteriorated in some patients during the follow-up 
period, even in patients who were treated successfully at the short-term follow-up (7, 8, 10, 11). 
Some studies have been restricted to only mild and moderate OSAS-patients or included patients 
who had already been surgically treated for their OSAS. To our knowledge, no published parallel 
study has evaluated the two-year outcome of oral appliance- versus CPAP therapy in previously 
untreated patients with mild-to-severe OSAS.
The primary aim of this parallel cohort study was to evaluate the two-year objective and subjec-
tive outcome of oral appliance- and CPAP therapyin OSAS patients, representing the entire spec-
trum of the disorder and to gain more insight in the specific indications for both treatments. In this 
study we report about the two-year follow up of a cohort of a previously conducted randomized 
controlled trial (RCT) (5).
Materials & Methods
Patients and study protocol
After assessing 228 OSAS patients, 103 participants were finally recruited (between September 
2002 and August 2005) for the previously conducted and reported RCT (ISRCTN18174167) (5) at 
the Department of Home Mechanical Ventilation of the University Medical Center Groningen, The 
Netherlands. Individuals over 20 years old who underwent polysomnography were eligible and 
were selected based on predefined medical, dental and psychological criteria (appendix). This study 
was approved by the Groningen University Medical Center’s ethics committee (METc2002/032). 
Written informed consent was obtained from all patients before enrolment. Block randomization 
was used to allocate participants to either oral appliance therapy or CPAP therapy (12). It was 
not possible to blind patients or clinicians to treatment assignment. At baseline, each partici-
pant underwent a physical examination (appendix). Severity of disease was assessed based on the 
apnoea-hypopnoea index (AHI), i.e. the mean number of apnoeas and hypopnoeas per hour of 
sleep. Participants were classified as having non-severe (AHI 5-30) or severe (AHI ≥ 30) OSAS. More 








For this follow-up study, polysomnographic and subjective evaluations were carried out after 
one year (T15) and two years (T27) of treatment. Treatment was considered successful when the 
AHI was <5 or showed a substantial reduction, defined as a reduction in the index of at least 50% 
from the baseline value to a value of < 20 in a patient without subjective OSAS-symptoms while 
using therapy (no excessive daytime sleepiness and <2 subjective OSAS symptoms) (appendix). 
Participants not meeting these criteria at any follow-up review were considered nonsuccessful. 
Patients for whom oral appliance- or CPAP therapy was successful continued the treatment. If 
either treatment was not successful at any time during the follow-up period, patients were of-
fered the alternative therapy (CPAP or oral appliance, respectively), which was thereupon titrated 
in the same fashion as the initial therapy. Patients who discontinued treatment for any reason 
were considered nonadherent to treatment (worst-case scenario). More detailed information on 
the results of the two-month follow-up (T2) has been published previously (5).
Interventions
The oral appliance (Thornton Adjustable Positioner type-1, Airway Management, Inc., Dallas, 
TX, USA) positioned the patient’s mandible in a forward and downward position. This type of 
oral appliance is also known as a mandibular advancement device. By turning a propulsion screw, 
which was incorporated anteriorly into the appliance, patients could adjust the mandibular ad-
vancement in 0.2 mm increments. When initiating oral appliance therapy (T0), the mandible was 
set at 50% of the patient’s maximal protrusion. After having adapted to this position during a 
two-week period, patients were allowed to further adjust the oral appliance during a six-week 
period. They were instructed to advance the mandible until symptoms abated or until further ad-
vancement caused discomfort. Subsequently, the treatment effect was assessed with a polysom-
nographic evaluation (T2). If necessary, the adjustment period was extended until the AHI was <5 
or until the adjustments became uncomfortable for the patient. The titration period ended with 
a final polysomnographic evaluation or when the patient discontinued treatment (e.g., because 
of poor tolerance).
CPAP titration, aimed at abolishing all signs of apnoeas, hypopnoeas and snoring was per-
formed during an afternoon nap (13).
Polysomnography
Polysomnographic studies (Embla® A10 digital recorder, Medcare, Reykjavik, Iceland) for base-
line and all follow-up reviews were conducted while participants slept at home and were evalu-
ated according to standardized criteria (appendix). All polysomnographic evaluations were evalu-
ated and scored by the same neurophysiologist (JH), who was unaware of the patient’s treatment 
assignment.
Physical and neurobehavioral examinations





weight, neck circumference, alcohol consumption, tobacco use, and current medications. For 
the neurobehavioral examinations, patients completed the following questionnaires at all time-
points: the Epworth Sleepiness Scale (ESS), the Functional Outcomes of Sleep Questionnaire 
(FOSQ) addressing OSAS-related symptoms (14, 15), and the 36-item short-form health survey 
(SF-36) evaluating health perceptions (16) (appendix). Furthermore, compliance rates were scored 
at all time points using a questionnaire. 
Analysis
Statistical analyses were performed using the Statistical Package for the Social Sciences (version 
16.0, SPSS Inc., Chicago, IL, USA). All continuous baseline variables were normally distributed 
and their means with standard deviations (s.d.) are reported. The AHI in the oral appliance- and 
CPAP group at baseline was normally distributed after logarithmic transformation. Medians and 
interquartile ranges are reported for variables with a skewed distribution. Details about the sam-
ple size calculation regarding the previously conducted two-month RCT have previously been 
described (5) and is also described in the appendix.
The primary outcome measure of this follow-up study was the difference in proportions of suc-
cessful treatments between oral appliance- and CPAP therapy at different time-points. 
Secondary outcome measures were polysomnographic and neurobehavioral outcomes at dif-
ferent time-points. To compare polysomnographic and neurobehavioral outcomes at different 
time-points, Student’s t-tests were performed for outcomes with a normal distribution and Mann-
Whitney U tests for outcomes with skewed distributions. Although proper randomization is ex-
ecuted, a (small) difference in the average values of a determinant for the two treatment arms 
may occur. To statistically correct this regression-to-the-mean phenomenon in our analysis when 
comparing T27 values with baseline values, the baseline value was at all times included in the 
regression model (i.e. auto-regression analysis model).
Comparison of the proportions of successful treatments between both treatments (Chi-square 
test) was also performed as function of disease severity (pre-specified subgroup analysis). The 
difference in dropout rates between both treatments was analyzed, using Chi-square test. The 
significance level of all analyses was set at 5%.
Results
One hundred and three patients were enrolled into the RCT. Randomization resulted in an 
oral appliance group of 51 patients and a CPAP group of 52 patients (Table 1). A flow diagram, 
summarizing the distribution of the patients is shown in figure 1. In the oral appliance group, 
27 patients (53%) completed the two-year follow-up successfully still using their oral appliance 
(figure 1; group A). Seven more patients of this group completed the follow-up after switching to 
CPAP therapy (figure 1; group C), because they were considered nonsuccessful to oral appliance 
therapy (Table 1, appendix). In the CPAP group 35 patients (67%) completed the two-year follow-







appliance therapy during the follow-up period (3 were considered nonadherent to CPAP therapy, 
and 1 patient nonsuccessful). Of these 4 patients, 2 completed the two-year follow-up (figure 1; 
group B). The 7 patients (group C) who had switched to CPAP after oral appliance therapy had 
a higher baseline AHI (p=0.17), Body Mass Index (BMI) (p=0.02) and age (p=0.28) than the 4 
patients (group B) who had switched from CPAP to oral appliance therapy (table E1, appendix).
In the oral appliance group 1 patient switched to CPAP after the two-month follow-up because 
of his profession as a truck driver, although treatment with an oral appliance was considered suc-
cessful (AHI dropped from 69 to 17). Though, from a judicial point of view, an AHI of 17 is still 
considered as moderate OSAS and is not allowed in his profession in the Netherlands. From that 
point he refused further participation in this study. In the CPAP group, 1 patient dropped out be-
cause of adherence problems after the two-month follow-up although treatment was effective. 
He was treated with an oral appliance from that point but refused further participation in this 
study. Demographic variables of the patients that completed the two-year follow-up are provided 
in table 2 of the appendix.
Notwithstanding the fact that weight loss was always encouraged, the BMI did not significantly 
change in both treatment groups during the follow-up period.
The follow-up period (including the RCT period) started in October 2002 and ended in October 
2007. The mean follow-up for the oral group was 2.3 ± 0.2 years (mean ± s.d.) and 2.4 ± 0.3 
years for the CPAP group. This difference was not significant.
Subjective compliance rates did not significantly differ between both treatments. CPAP and oral 
appliance mean use was 6.8 ± 0.8 and 6.7 ± 0.7 nights per week respectively. Furthermore CPAP- 
and oral appliance therapy was used 6.9 ± 1.2 and 7.2 ± 0.8 hours per night. 
More patients (not significant) dropped out under oral appliance therapy (47%) compared to 
CPAP (33%). 





Male/female ratio 43/8 49/3
Non-severe sleep apnoea (no. patients) 25 25
Severe sleep apnoea (no. patients) 26 27
Apnoea-hypopnoea index (no/hour) 39 ± 31 40 ± 28
Age (years) 49 ± 10 49 ± 10
Body-mass index (kg/m2) 32 ± 6 33 ± 6
Neck circumference (cm) 44 ± 4 45 ± 4
* Plus-minus values are means ± standard deviations.




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2 shows the proportions of successful treatments at the different time-points. After two 
years, treatment of the 51 patients randomized to the oral appliance group was successful for 
27 (52.9%) patients ((14 out of 25 patients with non-severe OSAS (56.0%) and 13 of the 26 
severe OSAS patients (50.0 %)). Of the 52 patients intentionally treated with CPAP, 35 (67.3%) 
were successfully treated (15 out of 25 patients with non-severe OSAS (60.0%), and 20 out of 
27 patients (74.1%) with severe OSAS). The differences in proportions of successful treatments 
between both treatments were not significant. Proportions of successful treatments after apply-
ing the criterion AHI<5, are provided in table 3 of the appendix.
Polysomnographic outcomes
The AHI was significantly lower in the CPAP group after one year (0.0 (0.0-13.0)) (median with 
range) compared to oral appliance therapy (2.0 (0.0-15.0)), and after two years of treatment with 
CPAP (0.0 (0.0-27.0) versus oral appliance therapy (2.0 (0.0-42.0)) (table 3). This significant dif-
ference in advantage of CPAP therapy was also found for the lowest oxyhemoglobin saturation at 
the one- and two-year follow-up (at both time points 91 ± 4% with CPAP versus 88 ± 5% with 
oral appliance therapy). 
Neurobehavioral outcomes
Both treatments yielded comparable improvements in the Epworth sleepiness score, the FOSQ-
score and scores of the SF-36 at all time-points (table 4). Most of the variables improved sig-
nificantly compared to the baseline values. No significant differences were found between both 
treatments.
Side-effects
Mild and ‘transient’ side-effects were commonly reported in the initial period of oral appliance 
therapy and include tooth pain, temporomandibular joint pain, myofascial pain, dry mouth and 
excessive salivation. Furthermore, we found that long-term oral appliance therapy and CPAP may 
result in dental changes in OSAS patients. Concerning this cohort, more detailed information 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The results of this study indicate that, regarding treatment success, there is no significant dif-
ference between oral appliance therapy and CPAP in treating mild-to-severe OSAS in a two-year 
follow-up. CPAP, however, showed a tendency towards a higher (non-significant) overall success 
rate than oral appliance therapy. This tendency was most pronounced in patients with severe 
OSAS. Both therapies had positive effects on polysomnographic variables during the follow-up 
but CPAP therapy was significantly more effective in lowering the AHI and in improving minimal 
oxygen saturation levels at the one- and two-year follow-up. In this study, more people (not 
significant) dropped out in the oral appliance group compared to the CPAP group as they were 
considered nonadherent or nonsuccessful. Both treatments seemed to be comparable in improv-
ing subjective sleepiness, functional outcomes and health perceptions.
To our knowledge this is the first follow-up of an RCT, comparing the two-year outcome of oral 
appliance- and CPAP therapy in patients with mild-to-severe OSAS. From this present follow-up 
study, short-term (2 months) results have previously been described (5), concluding that the out-
come (in terms of proportions of successful treatments) of oral appliance therapy was not inferior 
to CPAP therapy. In that study, sub-group analysis showed a tendency towards a higher, but not 
significant success rate of oral appliance therapy in patients with non-severe OSAS (AHI 5-30) 
compared with CPAP (84.0% versus 80.0%). The follow-up of these patients, as described in 
this study, shows that CPAP therapy generally yielded more successful treatments (not significant 
difference of 14.4%) after two years of therapy. This difference can first be explained by the fact 
that we included patients with severe OSAS. In a systematic review (4) it is described that CPAP 
is more effective than oral appliance therapy in reducing respiratory disturbances, especially in 
patients with moderate and severe OSAS. Secondly, patients switched to the alternative therapy 
because of adherence problems or nonsuccess of their treatment after the two-month follow-up. 
Several studies indentified specific predictors for treatment success with oral appliance therapy 
(20-22). A lower baseline AHI, lower BMI and younger age were all associated with better treat-
ment responses to oral appliance therapy. In this follow-up study, seven patients who were older, 
more obese and with predominantly severe OSAS, switched from oral appliance therapy to CPAP 
therapy because oral appliance therapy appeared to be nonsuccessful. More obese patients show 
an enlargement of upper airway adipose tissue, assessed by magnetic resonance imaging (23, 
24). It was found that mandibular advancement increases the retropalatal airway space in non-
obese, but not in obese patients (25). This may explain why the above-mentioned 7 patients were 
not treated successfully with an oral appliance. Notwithstanding this outcome, oral-appliance 
therapy was still successful in 50.0% of the patients with severe OSAS who completed the two-
year follow-up. According to the latest practice parameters of the American Academy of Sleep 
(26), an oral appliance is indicated in patients with mild-moderate OSAS who
- prefer an oral appliance to CPAP
- do not respond to CPAP





- who fail treatment attempts with CPAP.
However, our results indicate that an oral appliance can also play an important role in treating 
specific patients with severe OSAS in the long-term. 
Oral appliance therapy had a tendency to be less stable during the two-year follow-up, resulting 
in more dropouts compared to CPAP therapy. This finding is consistent with other studies, show-
ing deterioration in success with oral appliance therapy, even in patients who were treated ef-
fectively in the short-term (7, 8, 10). We currently assume that the working mechanism of an oral 
appliance is based on advancement of the mandible and its attached soft tissue structures and 
musculature, especially the genioglossus muscle, resulting in an increased tone with increased an-
teroposterior and lateral dimensions of the upper airway (27, 28). Bearing the above-mentioned 
considerations in mind, this deterioration in treatment success is possible due to loosening and 
adaptation of soft tissue structures and musculature of the upper airway as a result of long-term 
overnight mandibular advancement. It could be hypothesized that patients with more severe 
OSAS need to protrude the mandible more extensively to gain the desired effect, with in the long 
term, a possible overstretching which negatively affects the morphology of the upper airway soft 
tissue structures and tonus of the musculature. Furthermore, it has been described that the mus-
cle tone of the genioglossus is negatively correlated with age (29). Therefore, a second explana-
tion is that the increasing age of our study group results in a decreased success of oral appliance 
therapy. It is unknown to what extent both possibilities contribute to this change in outcome.
Subjective improvements in sleepiness, functional outcomes and health perceptions were found 
in both treatment groups (no significant differences), underlining the therapeutic success of oral 
appliance and CPAP therapy at all time-points during the follow-up, even in patients with severe 
OSAS. Similar findings in different studies using the same questionnaires (pooled) were reported 
in a review article by Chan and co-workers (30). However, most of these studies included only 
mild and moderate OSAS patients.
The present study has some potential limitations. Patients were allowed to switch therapy dur-
ing the follow-up if they were considered nonadherent or if treatment was considered nonsuc-
cessful. This may have biased our results because patients could pretend to be nonadherent after 
randomization in a possible non-preferred study group. However, only small numbers of patients 
switched, and except for one patient, all patients switched after two months of therapy. We 
also believe that a serious disorder, such as OSAS, should be treated as effective as possible and 
the possibility to switch during the follow-up period provides a better picture of the true clinical 
situation. We furthermore considered all patients who discontinued treatment for any reason as 
dropout, even if they were treated effectively (worst-case-scenario). Success rates therefore may 
be underestimated. 
Another limitation is the sample size that was determined for the two-month RCT (5). There 
was a priori risk of having ended up with an insufficient number of patients for reliable long-term 
results as dropouts in the long term were not anticipated in the power-analysis. Future studies 
should therefore focus and power on the long-term outcome of both oral appliance- and CPAP 







In conclusion, regarding the percentage of successful treatments, no significant differences were 
found between oral appliance therapy and CPAP in treating mild-to-severe OSAS in a two-year 
follow-up. However, CPAP was more effective in lowering the AHI and showed higher minimal 
oxygen saturation levels compared to oral appliance therapy. Furthermore it shows a tendency 
to be more successful in severe OSAS patients. Though, even in a two-year follow-up, oral appli-
ance therapy seems a viable alternative to CPAP in the treatment of mild and moderate OSAS. 
Oral appliances may be considered as a long-term alternative in severe OSAS patients who do not 
respond to CPAP or who fail treatment attempts with CPAP. Further research with larger groups 
of patients is needed to investigate which specific patients with severe OSAS are treated success-
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Long-term oral appliance therapy in 
obstructive sleep apnoea syndrome; 
a cephalometric study on craniofacial 
changes 
This chapter is an edited version of: 
Doff M.H.J., Hoekema A, Pruim G.J., Huddleston Slater J.J.R., Stegenga B. Long-Term Oral Appliance Therapy 
in Obstructive Sleep Apnea: a Cephalometric Study of Craniofacial Changes.









The aim of this controlled study was to cephalometrically assess possible changes in craniofacial 
morphology associated with long-term use of an adjustable oral appliance compared with con-
tinuous positive airway pressure (CPAP) in patients with the obstructive sleep apnoea syndrome 
(OSAS). In addition, we wanted to study the relationship between these possible changes and the 
degree of mandibular protrusion associated with oral appliance therapy.
Fifty-one patients were randomized to oral appliance therapy and fifty-two patients to CPAP 
therapy. At baseline and after follow-up (2.3 ± 0.2 years), a lateral cephalogram of all patients 
was made in maximum intercuspation to determine relevant cephalometric variables. Both base-
line and follow-up cephalograms were traced digitally whereupon cephalometric variables were 
compared. Changes in craniofacial morphology between the oral appliance- and CPAP group 
were evaluated with a linear regression analysis.
Compared with CPAP, long term use of an oral appliance resulted in small but significant (dental) 
changes. Overbite and overjet decreased, 1.0 (±1.5) mm and 1.7 (±1.6) mm, respectively. Fur-
thermore we found a retroclination (-2.0 (± 2.8) degrees) of the upper incisors and a proclination 
(3.7 (± 5.4) degrees) of the lower incisors. Moreover, the lower- and total anterior facial height 
increased significantly, 0.8 (± 1.5) mm and 0.9 (± 1.4) mm, respectively. No changes in skeletal 
variables were found. Linear regression analysis revealed that the decrease in overbite was associ-
ated with the mean mandibular protrusion during follow-up (β = -0.029, SE = 0.014, p<0.05).
Oral appliance therapy should be considered as a life long treatment, and there is a risk of 
craniofacial changes to occur. Therefore, patients treated with an oral appliance, need a thorough 






The obstructive sleep apnoea syndrome (OSAS) is a sleep-related breathing disorder, character-
ized by disruptive snoring and repetitive partial or complete obstructions of the upper-airway (i.e. 
hypopnoeas and apnoeas, respectively) (1). The severity of the disorder is usually expressed by the 
apnoea-hypopnoea index (AHI), i.e., the mean number of apnoeas and hypopnoeas per hour of 
sleep. OSAS may be classified as mild (AHI 5-15), moderate (AHI 15-30), or severe (AHI >30) (2). 
As a result of the condition patients may suffer from excessive sleepiness, an increased risk of ac-
cidents, and an impaired quality of life. Furthermore, patients have an increased risk of ischemic 
heart disease, congestive heart failure, and stroke (3, 4).
For OSAS patients, continuous positive airway pressure (CPAP) is generally considered the treat-
ment of choice (5). However, because of the obtrusive character of the device, patients may 
abandon therapy. An oral appliance aims at relieving upper airway obstructions during sleep by 
repositioning the mandible in a forward and downward position (6). Oral appliance therapy has 
been demonstrated to be effective especially in mild and moderate OSAS cases (7, 8). However, 
in severe OSAS cases, CPAP is still the treatment of first choice.
When commencing oral appliance therapy, side effects are commonly reported in the initial 
period of use. These usually transient and mild side effects include tooth pain, occlusal changes 
in the morning, dry mouth or excessive salivation, gum irritation, temporomandibular joint pain, 
temporomandibular joint sounds and myofascial pain (7, 9-16). Some authors report that some 
of these side effects can be more severe and continuous (17-20).
Craniofacial changes related to long-term oral appliance use have been studied with cepha-
lometry (15, 17, 21-24). Reported long-term changes (2-3 yrs) in craniofacial morphology were 
generally related to the patient’s dentition. Most studies found a significant decrease in overjet 
and overbite (9, 13, 15, 22-25). Furthermore a retroclination of the maxillary incisors, a procli-
nation of the lower incisors (9, 13, 15, 23-25) and a more downward (17, 21, 22) and forward 
(22) position of the mandible have been reported. In the majority of these studies, however, a 
control group was absent. In addition, in most studies only patients with mild-to-moderate OSAS 
or asymptomatic snorers were included. Furthermore, all studies except for one (24) evaluated 
the effects of an oral appliance that was non-adjustable and fixed the mandible in a predefined 
position at 50-75% of the maximum mandibular protrusion. Therefore, the relationship between 
the amount of mandibular protrusion during follow-up and the extent of craniofacial changes is 
an aspect that needs further study. 
The aim of the present study was to cephalometrically assess possible changes in craniofacial 
morphology associated with long-term use (2 yrs) of a titratable oral appliance and compared 
with a CPAP control group, in patients with mild to severe OSAS. Secondly, we studied the re-
lationship between the occurrence of these changes and the degree of mandibular protrusion 










The effectiveness of an oral appliance compared with CPAP therapy for OSAS was evaluated in 
a separate randomized controlled trial (8). All patients in that study were recruited through the 
Department of Home Mechanical Ventilation of the University Medical Center Groningen, The 
Netherlands. Subjects over 20 years of age and diagnosed with OSAS (AHI > 5) based on polys-
omnography (2) were eligible, and if they obeyed predefined medical, psychological, and dental 
inclusion criteria, patients were randomized for either oral appliance- (n = 51) or CPAP therapy 
(n = 52) (Table 1). 
For the present study, we assessed changes in the craniofacial morphology as a result of long-
term oral appliance therapy in OSAS patients. After two years, 37 patients (including those who 
had switched) in the CPAP group and 31 patients (including those who had switched) in the oral 
appliance group completed the follow-up. Details of patient selection criteria for our study are 
provided in Figure 1. Patients randomized for oral appliance therapy who had switched to CPAP 
therapy were excluded if they had been using the appliance for more than 3 months. Patients 
who were nonsuccessful or nonadherent to treatment and patients who underwent upper airway 
surgery during the follow-up period were also excluded. 
The present study was approved by the Groningen University Medical Center’s Ethics Commit-
tee. Written informed consent was obtained from each patient before enrolment.
Study Design
At baseline, patients had been subjected to a polysomnographic evaluation, based on which 
they were classified as having non-severe (AHI ≥ 5 to 30) or severe (AHI > 30) OSAS. In all patients 
a digital lateral cephalogram was obtained at baseline to determine cephalometric variables re-
lated to the craniofacial morphology (23, 26-29). The oral appliance used in this study (Thornton 
Adjustable Positioner, Airway Management Inc., Dallas, TX, USA) consisted of two separate parts, 
fixing the patient’s mandible in a forward and downward position. By turning a propulsion screw 
that was incorporated anteriorly in the appliance, patients could gradually adjust the mandibular 
advancement with 0.2 mm increments. The maximal range of mandibular protrusion was first de-
termined with a George-Gauge™ (H-Orthodontics, Michigan City, IN, USA). When initiating oral 
appliance therapy, the mandible was set at approximately 50% of the patient’s maximum pro-
trusion. After having accustomed to this protrusive position during a two-week period, patients 
were allowed to adjust the oral appliance during a 6-week period. When OSAS symptomatology 
(snoring, excessive daytime sleepiness, apnoeas and/or hypopnoeas) appeared to persist, patients 
were instructed to advance the mandible each night with 1 to 2 increments (i.e. 0.2-0.4 mm). 
Adjustment of the oral appliance was continued until symptoms had improved to the patient’s 
satisfaction, or until further protrusion of the mandible resulted in discomfort. 
CPAP-adjustment was performed during an afternoon nap. This technique, aimed at abolishing 





for the effective adjustment of CPAP (30). 
Following CPAP- and oral appliance adjustment, an eight week follow-up period was arranged 
that allowed for habituation and, if necessary, adjustment of CPAP or the oral appliance. After 
this period, a second polysomnographic study was performed. If polysomnography indicated an 
apnoea-hypopnoea index ≥5, CPAP or the oral appliance was further adjusted. A third polysom-
nographic study was performed 4 weeks after that adjustment. 
Treatment was considered successful when the apnoea-hypopnoea index either was <5 or 
showed substantial reduction, (8) defined as reduction in the index of at least 50% from the 
baseline value to a value of <20 in a patient without subjective OSAS-symptoms while using 
therapy. Patients, for whom oral appliance or CPAP therapy was successful, continued this treat-
ment. If either treatment was not successful at any time during the follow-up period, patients 
were offered the alternative (CPAP or oral appliance, respectively) therapy, which was thereupon 
titrated in the same way as with the initial therapy.
After a two-year follow-up period all patients were subjected to a final polysomnographic evalu-
ation and a second digital lateral cephalogram. The mean mandibular protrusion during the 
follow-up period (expressed as percentage of the maximum mandibular protrusion) was used for 
further analysis. The vertical dimension of the oral appliance was kept constant during the entire 
follow-up period. Both mandibular protrusion and mouth opening (including the vertical over-
bite) were measured with a digital sliding calliper with 0.01 mm accuracy. These measurements 
were carried out at baseline, after two months, one year and two years of treatment. At these 
intervals also other clinical measurements (weight, length, neck circumference and intoxications) 
were carried out. 
The primary outcome measure was the change in craniofacial morphology, measured using 
cephalometric variables, between baseline and the final follow-up visit. Secondly the relationship 
between the mean mandibular protrusion during the follow-up and the magnitude of changes in 
the craniofacial morphology was studied.
Cephalometric analysis
All digital lateral cephalograms were recorded using a ProMax Cephalostat (Planmeca, Helsinki, 
Finland). The mirror position (31) was used in order to obtain a reproducible position of the 
head. Patients were instructed to swallow and close their mouth with the mandible in maximum 
intercuspation and the lips in a relaxed position. After a short period of relaxed tidal breathing 
the cephalogram was taken at end-expiration. Early morning visits were avoided because some 
patients were not able to close in maximum intercuspation at that time but were habituated to 
bite with the mandible in a more protrusive position.
A predefined trace-protocol (Table 2, Fig. 2) was used to perform all tracings using Viewbox 
software® (version 3.1.1.6, Dhal Software, Kifissia, Greece). To minimize identification error, one 
blinded observer (MD) performed all tracings. Furthermore, for sagittal and vertical measure-
ments, superimposition was performed on the anterior contour of the sella turcica and sella-na-








nasion were, after superimposition, transferred from the baseline to the follow-up cephalogram 
in order to obtain exactly the same coordinates on both cephalograms. All linear cephalometric 
measurements were corrected for a radiographic enlargement of 12%.
Statistical Analysis
Statistical analyses were performed using the Statistical Package for the Social Sciences (version 
16.0, SPSS Inc., Chicago, IL, USA). All variables were normally distributed and their means and 
standard deviations (s.d.) are reported. The AHI of the oral appliance and CPAP patients at base-
line was distributed normally after logarithmic transformation. To compare outcomes between 
cephalometric variables (intention-to-treat) at baseline and follow-up, paired Student’s t-tests 
were performed. Although proper randomization is executed, a (small) difference in the average 
values of a determinant for the two treatment arms may occur. To correct for this regression-to-
the-mean phenomenon statistically in our analysis, the baseline value was at all times included in 
the regression model.
For continuous cephalometric measures, ‘between groups’ effect sizes are reported as Cohen’s 
d, the standardized mean difference, based on mean group change scores divided by the pooled 
standard deviation. The differences in craniofacial morphology between the oral appliance and CPAP 
group d reflect the net side-effects associated with oral appliance therapy, a measure that controls 
for spontaneous changes in the control group and pre-existing random group differences at baseline. 
Cohen’s d effect sizes are interpreted as small (0.20), medium (0.50), or large (>0.80) (33). 
For the oral appliance group, linear regression analysis was used to determine the relationship 
between the changes in craniofacial morphology and the mean mandibular protrusion during the 
follow-up period. A significance level of 0.05 was predefined in all cases.
Table 1: Baseline characteristics of 103 patients treated with an oral appliance or CPAP.




Male / female ratio 43 / 8 49/3
Age (years) 49 ± 10 49 ± 10
Body-mass index (kg/m2) 32 ± 6 33 ± 6
Apnea-hypopnea index (no/hour) 39 ± 31 40 ± 28
Neck circumference (cm) 44 ± 4 45 ± 4
minSaO2 (%) 78 ± 9 78 ± 10




* Plus-minus values are means ± standard deviations.












































































































































































































































For analysis, 31 (group A+C) and 37 (group B+D) patients were included in the oral appliance 
group and the CPAP group, respectively (Fig. 1). The mean follow-up period was 2.3 (± 0.2) years 
in the oral appliance group (range 2.1-3.1 years) and 2.4 (± 0.3) years in the CPAP group (range 
2.1-3.2 years).
In the oral appliance group, the mean mandibular protrusion during the follow-up period was 
79 (± 20) % of the maximal mandibular protrusion. The mean mouth opening (including overbite) 
while wearing the oral appliance was 13 (± 3) mm.
Cephalometric analysis 
In the oral appliance group, no significant changes were found in the variables pertaining to 
the base of the skull. Concerning maxillary measurements, the angle between the upper incisor 
line and the maxillary plane (Ui-MxP) decreased 2.0 (± 2.8) degrees as a result of long-term oral 
appliance therapy compared with CPAP therapy, indicating a retroclination of the maxillary inci-
sors (Table 2). 
Mandibular measurements showed that the position of the mandible in relation to the skull 
base, i.e. the SNB-angle, was reduced 0.4 (± 0.9) degrees and the angle between the lower inci-
sor line and the mandibular plane (Li-MnP) increased 3.7 (± 5.4) degrees, indicating a proclination 
of the mandibular incisors. Furthermore, a downward and backward rotation of the mandible 
was observed, as the shortest linear distance from menton to line SN-perp (Me-hor) decreased 
0.7 (± 1.6) mm and the shortest linear distance between menton and line SN (Me-ver) increased 
0.7 (± 1.4) mm. 
Regarding the intermaxillary relationships, the ANB-angle increased 0.3 (± 0.9) degrees and 
the interincisal angle (Ui-Li) decreased 2.3 (± 5.8) degrees. Furthermore, the overbite and overjet 
decreased 1.0 (± 1.5) mm and 1.7 (±1.6) mm, respectively. 
Concerning facial height there was an increase in the lower anterior facial height (0.8 ± 1.5 mm) 
and the total anterior facial height (0.9 ± 1.4 mm), resulting in a decrease of the anterior facial 
height ratio (0.8 ± 1.9 percent). No significant changes were observed in any of the variables 
regarding the posterior facial heights.
When adjusted for regression-to-the-mean effects, our data show significant, mainly dental 
changes in the craniofacial morphology in the oral appliance group compared with the CPAP 
group following two years of treatment (Table 2, Fig. 3). A retroclination of the upper incisors 
(d=0.6) and a proclination of the lower incisors (d=0.7) was found, the overjet (d=1.3) and over-
bite (d=0.6) had decreased, and the lower anterior facial height (d=0.6) as well as the total 
anterior facial height (d=0.5) had increased in the oral appliance group compared with the CPAP 
group. Conversely, the anterior facial height ratio did not change significantly when comparing 
the oral appliance and CPAP group. 
Linear regression analysis revealed that the decrease in overbite was significantly associated with 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2. Cephalometric landmarks and 
reference lines traced on lateral cephalo-
grams.
The following eighteen reference points 
were identified on lateral cephalograms: 
A (point A: the deepest midline concav-
ity on the anterior maxilla), ans (anterior 
nasal spine: the tip of the median, sharp 
bony process of the maxilla at the lower 
margin of the anterior nasal opening), 
Ara (Anterior articulare: the point of 
intersection of the inferior cranial base 
surface and the averaged anterior sur-
faces of the mandibular condyles), Arm 
(Articulare midpoint; the midpoint of 
the line between Aa-Ar), Ar (articulare; 
the point of intersection of the inferior 
cranial base surface and the averaged 
posterior surfaces of the mandibular 
condyles), B (point B: the deepest mid-
line concavity on the mandibular symphysis), Ba (Basion; the median point of the anterior margin of the 
foramen magnum, Gn (gnathion: the most anterior-inferior point on the contour on the bony chin sym-
physis, determined by bisecting the angle formed by the mandibular plane and a line through pogonion 
and nasion), Go (gonion: the constructed point of the intersection of the ramus plane and the tangent 
to the body of the mandible), Lia (lower incisor apex), Lie (lower central incisor edge: the incisal tip of 
the mandibular central incisor), Me (menton: the intersection of the bony inferior symphysis with the 
inferior margin of the mandibular body), N (nasion: the most anterior point on the frontonasal suture), 
Pg (pogonion: the most anterior point on the contour of the bony chin, determined by a tangent through 
nasion), pns (posterior nasal spine: the intersection of a continuation of the anterior wall of the pterygo-
palatine fossa and the floor of the nose, marking the dorsal limit of the maxilla), S (sella; the midpoint of 
the pituitary fossa), Uia (upper incisor apex), Uie (upper incisor incisal edge: the incisal tip of the maxil-
lary central incisor).
The following six reference lines were identified on lateral cephalograms: Li (lower incisor line: the line 
through the lower incisor apex and the lower incisor incisal edge), MnP (mandibular plane according 
to Steiner: the line through gonion and gnathion), MxP (Maxillary plane: the line through the posterior 
nasal spine (pns) and the anterior nasal spine (ans)), SN (sella-nasion line: the line through sella and na-
sion), SN-perp (SN-perpendicular: the line through Sella (S) perpendicular on line SN), Ui (upper incisor 








(CPAP) group did not reveal any significant changes in the craniofacial morphology after two 
years of treatment.
Discussion
To our knowledge, this is the first study in which changes in craniofacial morphology as a result 
of long-term oral appliance therapy are evaluated in a controlled study concerning patients from 
the full OSAS spectrum. The results of this study indicate that changes in craniofacial morphology 
should be anticipated in OSAS patients using an oral appliance for two years when compared 
with CPAP therapy. These changes, however, were predominantly dental in nature. Furthermore, 
by using linear regression analysis, an association was observed between the mean mandibular 
protrusion during the follow-up period and the decrease in overbite. 
Changes in overbite and overjet, retroclination of the upper incisors and a proclination of the 
lower incisors have also been described in previous studies (9, 15, 23, 24). These changes have 
been attributed to a labially directed force to the mandibular incisors and a palatally directed 
force to the maxillary incisors while the appliance is in place and the mandible attempts to return 
to a less constrained position. Conversely, Ringqvist and co-workers (21) did not find significant 
changes in overbite, overjet, and inclination of the upper or lower incisors after two years of oral 
appliance use. A first explanation for this erratic result could be the different design of the oral 
appliance used in their study. The frontal parts of both tooth arches were not covered by acrylate. 
Therefore, the palatally and labially directed forces were not applied directly to the upper and 
lower incisors, respectively. Another explanation could be the degree of mandibular protrusion 
of 50% while wearing the oral appliance. Both explanations seem viable but it is unclear to what 
extent each of these possibilities contributes to the observed differences. 
Protrusive positions of the mandible over 75% of the patient’s maximum were applied in some 
patients in the present study. This could be explained by the fact that patients with mild, moder-
ate, and severe OSAS were included. Severe OSAS patients may need more pronounced protru-
sive positions of the mandible in order to experience sufficient benefit from the oral appliance. 
Ringqvist et al (21) only included patients with mild-to-moderate disease. As dose dependency 
of oral appliance therapy has previously been described (34), it is conceivable that the oral appli-
ance in this category is already effective in a less protrusive position, resulting in less severe dental 
side-effects.
In the oral appliance group, we found a backward (decreased Me-hor) and downward (in-
creased Me-ver) rotation of the mandible, resulting in small but significant increases in the lower 
and total anterior facial heights, but not in the anterior facial height ratio. These findings corrobo-
rate the results from previous studies (17, 23, 24). It could be hypothesized that over-eruption of 
the molars, caused by possible inadequacies in the oral appliance’s fit during follow-up, results in 
an increase in anterior facial height. However, in the present study the quality and fit of the oral 
appliances was checked annually and adjusted if required. Therefore, it seems unlikely that this 





small increase in anterior facial height is most likely the result of oral appliance-induced dental 
changes. The retroclination of the upper incisors and the proclination of the lower incisors result 
in a downward rotation of the mandible through incisal guidance, most likely resulting in a small 
but significant increase in the total and lower anterior facial height (35).
Bondemark (22) found an increase in mandibular length after two years of oral appliance use. 
We did not observe any significant changes in mandibular length (Arm-Me), ramus length (Arm-
Go) or mandibular body length (Go-Me) in our patients. This discrepancy could be explained by 
the differences in mandibular landmarks used. Bondemark used the linear distance between con-
dylion (Cd) and pogonion (Pg). We calculated mandibular length as the linear distance between 
articulare midpoint (Arm) and menton (Me). Pogonion could be an unreliable landmark if rotation 
of the mandible occurs, because the most anterior point of the mandibular symphysis will be 
displaced. However, menton is an anatomical landmark rather than a constructed landmark and, 
therefore, is more reliable when mandibular rotation is to be expected. Furthermore, it has been 
suggested that articulare is more reproducible than condylion on cephalograms exposed in ha-
bitual occlusion (36). We constructed the landmark articulare midpoint (Arm) as we hypothesized 
that this point is less susceptible to displacement when rotation of the mandible occurs (37).
It could be hypothesized that the long-term use of CPAP causes changes in the dental or skeletal 
morphology as a result of its tight-fitting (mouth-) nose mask. However, in the present study we 
did not find any changes in either dental- or skeletal variables in the CPAP group. Therefore, in 
retrospect the CPAP group appeared to be adequate as a control group. 
In this study an adjustable oral appliance was used. The regression analysis showed that there 
appears to be an association between the decrease in overbite and the extent of mandibular pro-
trusion. Therefore, it appears to be of importance to keep the mandibular protrusion associated 
with oral appliance use to a minimum. This finding may become increasingly important, as with 
increasing age OSAS symptomatology may worsen in patients who require a more extended pro-
trusive mandibular position. It could be hypothesized that the extent of dental side effects might 
be more pronounced with adjustable appliances as there is a risk of advancing the mandible be-
yond an optimum position. As a result of including severe OSAS patients in this study, the mean 
mandibular protrusion might be larger in the present sample when compared with other studies 
that only studied patients with mild-moderate OSAS or snorers without OSAS. 
Martinez-Gomis and co-workers (38) found a significant reduction in the number of posterior 
occlusal contacts after two years use of oral appliance. This tendency however, reversed during 
the period of 2 to 5 years of treatment. Therefore it seems viable that most dental changes occur 
during the first years of treatment with an oral appliance but tend to stabilize over time.
Inter- and intraobserver reliability measurements were not carried out in this study. However, in 
a recent study (26), interclass correlation coefficients (ICCs) were calculated for two experienced 
observers (MD and GP) after digital tracings using Viewbox 3.1.1.6 software®. Except for one, all 
ICCs were considered excellent (range 0.69-0.97). 
Notwithstanding the fact that this study was prospective in design, the randomization and sam-








controlled trial by Hoekema and co-workers (8). A post-analysis power calculation, using the 
change in overjet as clinical most important outcome variable, yielded a power of 88% (n1=31, 
n2=37, α=0.05).
In conclusion, our results show that the long-term use of an oral appliance causes predominant-
ly dental changes in the craniofacial morphology in OSAS patients. All effect sizes of the observed 
significant changes, expressed as Cohen’s d, were medium-to-large and should be considered as 
clinically important. Nevertheless, a disorder with serious cardiovascular consequences should be 
treated as effective as possible. This supersedes the maintenance of a patients’ baseline cranio-
facial morphology. Discontinuation of oral appliance therapy because of the development of 
craniofacial side-effects should only be considered in patients who are able to tolerate or accept 
another effective treatment modality for the OSAS. However, in agreement with Almeida and co-
workers (24), we endorse the importance of collecting clinical data as cast-models and intra-oral 
photographs before and during treatment with an oral appliance. Thus, patients treated with an 
oral appliance need a thorough follow-up by a dentist or dental-specialist experienced in the field 
of dental sleep medicine.
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 chapter 4.2
Long-term oral appliance therapy in 
obstructive sleep apnoea syndrome; 
a controlled study on dental side-effects
This chapter is an edited version of:
Doff M.H.J., Finnema K.J., Hoekema A, Wijkstra P.J., de Bont L.G.M., Stegenga B. Long-Term Oral Appliance 










The objectives of this study were to assess possible dental side-effects associated with long-term 
use of an adjustable oral appliance compared with continuous positive airway pressure (CPAP) 
in patients with the obstructive sleep apnoea syndrome (OSAS) and to study the relationship be-
tween these possible side-effects and the degree of mandibular protrusion associated with oral 
appliance therapy.
As part of a previously conducted randomized controlled trial, 51 patients were randomized to 
oral appliance therapy and 52 patients to CPAP therapy. At baseline and after a two-year follow-
up, dental plaster study models in full occlusion were obtained which were thereupon analyzed 
with respect to relevant variables.
Long term use of an oral appliance resulted in small but significant dental changes compared 
with CPAP. In the oral appliance group, overbite and overjet decreased, 1.2 (±1.1) mm and 1.5 
(±1.5) mm, respectively. Furthermore, we found a significantly larger anterior-posterior change 
in the occlusion (-1.3 ± 1.5 mm) in the oral appliance group compared to the CPAP group (-0.1 
± 0.6 mm). Moreover, both groups showed a significant decrease in number of occlusal contact 
points in the (pre)molar region. Linear regression analysis revealed that the decrease in overbite 
was associated with the mean mandibular protrusion during follow-up (Regression coefficient 
(β)= -0.02, 95% Confidence Interval (CI) (-0.04 to -0.00)).
Oral appliance therapy should be considered as a life long treatment, and there is a risk of dental 
side-effects to occur. Therefore, patients treated with an oral appliance, need a thorough follow-






Obstructive sleep apnoea syndrome (OSAS) is characterized by repetitive episodes of pharyngeal 
collapse with increased airflow resistance during sleep (1) and is often accompanied by extensive 
snoring. OSAS is associated with excessive daytime sleepiness (EDS), (sexual) dysfunction, neuro-
cognitive deficits and higher rates of cardiovascular and cerebrovascular morbidity and mortality 
(2-5). In the North-American population, OSAS affects approximately 4% of the male and 2% of 
the female adults (4). Severity of the disorder is usually expressed by the apnoea-hypopnoea index 
(AHI), i.e. the mean number of apnoeas and hypopnoeas per hour of sleep and is classified as 
mild (AHI 5-15), moderate (AHI 15-30) or severe (AHI >30) (6). Standard treatment with Continu-
ous Positive Airway Pressure (CPAP) is highly efficacious for OSAS but adherence to the treatment 
limits its overall effectiveness (7). Oral appliance therapy is a viable alternative in the treatment of 
OSAS, especially in the mild and moderate cases and in patients unwilling or unable to tolerate 
CPAP (8). Generally, oral appliances aim at enlarging the upper airway during sleep by holding the 
mandible in a forward and downward position (9). 
Mild and ‘transient’ side-effects are commonly reported in the initial period of oral appliance 
therapy and include tooth pain, temporomandibular joint (TMJ) pain, myofascial pain, dry mouth, 
excessive salivation, and gum irritation (10-18). In several studies, dental side-effects related to 
long-term use of an oral appliance have been studied with study model analysis (16, 19-22). 
However, most of these studies were retrospective, comprised small study samples, did not in-
clude a control group or only included snorers or mild and moderate OSAS patients. Furthermore, 
all studies except for two (21, 22) evaluated the effects of an oral-appliance that was nonadjust-
able and fixed the mandible in a predefined position at 50–75% of the maximum mandibular 
protrusion. Therefore, the relationship between the amount of mandibular protrusion during 
follow-up and the extent of dental side-effects is an aspect that needs further study.
The objectives of this parallel controlled follow-up study were to assess:
1. the occurrence of dental side-effects following long-term (2 yrs) oral appliance therapy com-
pared with CPAP in a prospective study in patients with mild-to-severe OSAS. 




The efficacy of an oral appliance in the treatment of OSAS, compared with CPAP, has been eval-
uated in a previously executed randomized controlled trial (23). The materials and methods of this 
specific study are briefly summarized below. All patients were recruited through the Department 
of Home Mechanical Ventilation of the University Medical Center Groningen, the Netherlands. 
Subjects over 20 years of age and diagnosed with OSAS (apnoea-hypopnoea index (AHI) > 5) 








cal, and dental inclusion criteria, they were selected for the study and subsequently randomized 
for either oral appliance (n=51) or CPAP therapy (n=52).
For the present study, we assessed dental side-effects in the group of patients treated with 
an oral appliance compared to those treated with CPAP. Patients considered nonsuccessful or 
nonadherent (23) were offered to switch to the alternative therapy at any time during the follow-
up. Patients that switched from oral appliance therapy to CPAP or vice versa were excluded 
from analysis. Furthermore, patients were excluded if they received upper airway surgery during 
follow-up or if the oral appliance was used <5 nights a week or <5 hours per night. Details of 
patient selection criteria for our study are provided in figure 1.
The present study was approved by the Groningen University Medical Center’s Ethics Committee 
(METc2002/032). Written informed consent was obtained from each patient before enrolment.
Study design
At baseline, patients had been subjected to a polysomnographic evaluation, based on which 
they were classified as having non-severe (AHI 5–30) or severe (AHI >30) OSAS. From all pa-
tients, dental plaster study models were obtained at baseline and after two years of treatment 
to determine variables related to the dental morphology and the (dental) occlusion. The oral ap-
pliance used in this study (Thornton Adjustable Positioner, Airway Management Inc., Dallas, TX, 
USA) consisted of two separate parts, fixing the patient’s mandible in a forward and downward 
position. This type of an oral appliance is often referred to as a Mandibular Repositioning Ap-
pliance (MRA). By turning a propulsion screw that was incorporated anteriorly in the appliance, 
patients could adjust the mandibular advancement with 0.2 mm increments with each turn. 
The maximum range of mandibular protrusion was first determined with a George-Gauge™ 
(H-Orthodontics, Michigan City, IN, USA). When initiating oral appliance therapy, the mandible 
was set at 50% of the patient’s maximum protrusion. After having accustomed to this protrusive 
position during a two-week period, patients were allowed to further adjust the oral appliance 
during a 6-week period. When subjective OSAS symptomatology (6) appeared to persist, patients 
were instructed to advance the mandible each night with 1 to 2 increments (i.e. 0.2-0.4 mm). 
This adjustment period had extended until symptoms were adequately improved or until further 
protrusion of the mandible resulted in discomfort. The mean mandibular protrusion during the 
follow-up period (expressed as percentage of the maximum mandibular protrusion) was used 
for further analysis. The vertical dimension of the oral appliance was kept constant during the 
entire follow-up period. Both mandibular protrusion and mouth opening (including the vertical 
overbite) imposed by the oral appliance were measured with a digital sliding calliper. These meas-
urements were carried out at baseline, after two months, one year and two years of treatment. 
At these time-points, also other clinical measurements (weight, length and neck circumference) 
were carried out. At baseline and after two years of treatment, dental plaster study models in full 
occlusion were obtained for all patients. 
CPAP-titration was performed during an afternoon nap. This technique, aimed at abolishing all 





the effective titration of CPAP (24).
Following CPAP- and oral appliance adjustment, an eight week follow-up period was arranged 
that allowed for habituation and, if necessary, adjustment of CPAP or the oral appliance. After 
this period, a second polysomnographic study was performed. If polysomnography indicated an 
AHI ≥5, CPAP or the oral appliance was further adjusted by the physician (not during polysom-
nography). A third polysomnographic study was performed 4 weeks after that adjustment. Treat-
ment was considered successful when the AHI either was <5 or showed “substantial reduction,” 
(23) defined as a reduction in the index of at least 50% from the baseline value to a value of <20 
in a patient who had no OSAS symptoms (6) while using therapy. Patients for whom oral appli-
ance or CPAP therapy was successful continued this treatment. If one of both treatments was not 
Table 1. Baseline characteristics, therapeutic use and cast analysis of patients who completed the two-year 
follow-up.






Age (years) 49.7 ± 8.9. 50.6 ± 10.1 NS
Male/female ratio 22/7 32/2 NS||
Apnoea-Hypopnoea Index (no/hour) 35.6 ± 22.3 44.2 ± 27.9 NS
Body-mass index (kg/m2) 31.4 ± 5.7 33.7 ± 5.7 NS
Therapeutic use :
- nights per week










































Delta overbite (mm) -1.2 ± 1.1 -0.1 ± 0.6 p<0.00
Delta overjet (mm) -1.5 ± 1.5 -0.2 ± 0.7 p<0.00
Anterior-posterior movement (mm) -1.3 ± 1.5 -0.1 ± 0.6 P<0.00
* values are means ± standard deviations.
† unpaired t-test.
‡ paired t-test.
|| Fischers’ exact test. 








successful at any time during the follow-up period, patients were offered the alternative therapy 
(CPAP or oral appliance, respectively), which was titrated as described above. After a two-year 
follow-up period all patients were subjected to a final polysomnographic evaluation. Patients 
were always encouraged to contact our clinic between regular follow-up appointments when 
problems were faced concerning the oral appliance, CPAP device, or treatment effect. 
Study model analysis
At baseline and after two years of treatment, dental plaster study models in full occlusion, based 
on alginate impressions of the upper and lower dental arches, were obtained from all patients 
to determine clinically relevant variables related to the patient’s occlusion (16, 21, 25). The inter-
maxillary relationship between the upper and lower arch was recorded with the vinyl polysiloxan 
registration material Exabite II NDSTM (GC America Inc, Alsip, Il, USA) in maximal occlusion. Mod-
els were also placed and rimmed into maximal occlusion in order to perform measurements with 
a digital sliding calliper with a 0.01 mm resolution (26). All measurements were carried out on 
models in full occlusion, mounted in an articulator (Artex®, Girrlach Dental, Koblach, Germany) 
with a bilateral sagittal condylar inclination of 32.5 degrees and Bennett-angle of 17.5 degrees. 
The degree of mandibular protrusion and mouth opening, associated with wearing an oral appli-
ance, was also measured with a digital sliding calliper while the oral appliance was fixed on the 
models in the therapeutic position, which were subsequently mounted in the articulator. Meas-
urements were performed twice by one observer (K.F.) who was blinded for the patient’s treat-
ment. For continuous variables the mean of both measurements was used for further analysis. 
Anterior overjet and overbite were calculated as the mean of the overjet or overbite measured 
at both maxillary central incisors. Anterior overjet was defined as the horizontal distance from the 
mesial end of the incisal edge of the upper central incisor to the labial plane of the lower central 
incisor. Anterior overbite was defined as the vertical distance of the incisal edge of the lower cen-
tral incisor to the horizontal projection of the incisal edge of the upper central incisor on the labial 
plane of the lower central incisor. The difference (baseline versus follow-up) in anterior-posterior 
relationship was measured at the buccal sites of the first molars. In order to obtain reproducible 
measurements, the position of the buccal groove of the mandibular first molar was marked on 
the buccal site of the maxillary antagonist. Negative values are related to a mesial shift of the 
dentition in the mandible and positive values are related to a distal shift of the dentition in the 
mandible. If the first permanent molars were missing, the second permanent molars were used 
for measurements.
Angle’s classification system (27) of malocclusion was used to identify the anterior-posterior re-
lationship of the upper and lower first molars and upper and lower cuspids and was classified as 
Class I (neutrocclusion), Class II (distocclusion) and Class III (mesiocclusion). Angle classifications 
were determined at baseline and follow-up for the left and right molar-occlusion (if the upper and 
lower first molars were present; Table 2) and for the left and right cuspid-occlusion (if the upper 
and lower cuspid were present; Table 3). When models were missing, damaged or if too many 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Occlusal contact points (relationship between maxillary and mandibular teeth in maximal occlu-
sion) were made visible using articulation paper directly on the models. Biting forces were not 
applied in a standardized way as we did not have the disposal of such equipment. Subsequently 
the number of teeth in contact was determined, not the size of the contact points. The number 
of occlusal contact points was determined for the (pre)molar region and for the cuspid-incisor 
region of the maxillary model. 
The left and right transversal relation between the maxillary and mandibular teeth in the (pre)
molar region was determined as normal, end-to-end or cross bite. If the transversal relation of one 
or more teeth at the (pre)molar region changed after the follow-up period, this was recorded.
Crowding was defined (visually) as an altered tooth position as a result of inadequate space in 
the alveolar arch and was scored as increased, decreased or no change after the follow-up period. 
Evaluation of interproximal spaces (diastemas) was done at baseline and after follow-up for both 
arches and was classified as unchanged, increased or decreased. Interproximal spaces at follow-
up that were the result of tooth extractions during the follow-up period were not counted.
Dummies incorporated in fixed bridges were included in all analyses but were not counted as 
present permanent teeth.
Statistical Analysis
Statistical analyses were performed using the Statistical Package for the Social Sciences (version 
16.0, SPSS Inc., Chicago, IL, USA). All variables were normally distributed and their means and 
standard deviations (s.d.) are reported. The AHI of the oral appliance- and CPAP patients at base-
line was distributed normally after logarithmic transformation. To compare outcomes between 
continuous variables at baseline and follow-up, paired Student’s t-tests were performed. For com-
paring outcomes for continuous variables between the oral appliance and CPAP group, unpaired 
Student’s t-tests were performed. For comparing categorical variables within and between both 
treatment groups, the Fischer’s exact test was applied. Linear regression analysis was used to 
determine the relationship between possible dental side-effects and other therapy- or patient-
related variables during the follow-up period (e.g. mandibular protrusion, degree of OJ and OB). 
Regression coefficients (β) and their 95% Confidence Intervals (CI) are reported. Other analyses 
were exploratory. A significance level of 0.05 was predefined in all cases.
Results
For analysis, 29 and 34 patients were included in the oral appliance group and the CPAP group 
respectively, after two years of treatment (Fig. 1). The mean follow-up period was 2.3 (± 0.2) 
years in the oral-appliance group (range 2.1-3.1 years) and 2.4 (± 0.3) years in the CPAP group 
(range 2.1-3.2 years). The mean mandibular protrusion during the follow-up period was 79 (± 
19) % of the patient’s maximum protrusion. The numbers of nights and hours per night that both 
therapies were used did not significantly differ between both treatment groups (Table 1).
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Study model analysis
Regarding baseline characteristics of the patients included in the analysis, (Table 1), no significant 
differences were found between the oral appliance- and CPAP group. 
A significant decrease in overbite (-1.2 ± 1.1 mm; (p<0.00)) and overjet (-1.5 ± 1.5 mm; (p<0.00)) 
was found in the oral appliance group compared to the CPAP group as well as a significantly 
(p<0.00) larger anterior-posterior change in occlusion (-1.3 ± 1.5 mm) compared to the CPAP 
group (-0.1 ± 0.6 mm) (Table 1). For the oral appliance group, linear regression analysis revealed a 
significant association between the change in overbite and the amount of mandibular protrusion 
(β=-0.02, 95% CI (-0.04 to 0.00)). We did not find a significant association between the baseline 
OJ or OB and the change in OJ or OB after long-term oral appliance- or CPAP use.
When evaluating the number of occlusal contact points between the upper- and lower dental 
arch in the cuspid-incisor region, there was no tendency towards the occurrence of an open bite in 
the frontal region in either the oral appliance- or CPAP group. We found a significant decrease in 
the number of occlusal contact points in the (pre)molar region in both the oral appliance- (p<0.00) 
and CPAP group (p=0.03) after two years of treatment (Table 1). 
Transversal relation of the teeth in the (pre)molar region did change in 8 patients in the oral ap-
pliance group and in 2 patients in the CPAP group after two years of treatment. In 4 patients from 
the oral appliance group, the bilateral transversal relation changed from normal to end-to-end 
and in 1 patient only the right side transversal relation changed from normal to end-to-end. In 1 
patient a bilateral cross bite changed to a complete reversed transversal relation (maxillary inner 
bite). However, this patient was familiar with a mid-face hypoplasia and a class III malocclusion 
before starting oral appliance therapy. Furthermore, in 4 patients the bilateral transversal rela-
tion changed from end-to-end to a bilateral cross bite. In the CPAP group one patients’ bilateral 
transversal relation changed from normal to a bilateral cross bite and one changed from a normal 
bilateral transversal relation to a bilateral end-to-end relation. 
For the CPAP group, left side molar occlusion could be assessed at baseline in 25 patients and 
right side molar occlusion in 29 patients (Table 2). After two years of treatment, a change in right 
side molar occlusion was observed in 3 patients (10%) and in the left side molar occlusion also in 
3 patients (12%). Furthermore, left side cuspid occlusion was determined in all 34 patients and 
right side cuspid occlusion for 33 patients (Table 3). After two years of treatment, a change in 
right side cuspid occlusion was verified in 4 patients (12%) and in 1 patient (3%) for the left side 
cuspid occlusion. 
For the oral appliance group, both left and right side molar occlusion could be determined at 
baseline in 21 patients (Table 2). After two years of treatment, a change in right side molar occlu-
sion was observed in 4 patients (20%) and in the left side molar occlusion also in 4 patients (20%). 
Furthermore, left side cuspid occlusion was assessed for all 29 patients and right side cuspid occlu-
sion for 28 patients (Table 3). After two years of treatment, a change in right side cuspid occlusion 
was observed in 6 patients (21%) and in 8 patients (28%) for the left side cuspid occlusion. 
No significant differences in crowding were observed after two years of treatment for both treat-











dental arch while one patient showed less crowding for the lower dental arch. In the CPAP group 
one patient showed less crowding for the upper dental arch, one showed less crowding and one 
more crowding for the lower dental arch.
No significant differences in interproximal spaces were found for the upper and lower arch be-
tween the oral appliance- and the CPAP group. In the oral appliance group, an increase in inter-
proximal spaces in the upper dental arch was found in 2 patients and a decrease in 2 patients. For 
the lower dental arch, an increase in interproximal spaces was found in 7 patients. In the CPAP 
group, an increase in interproximal open spaces of the upper dental arch was found in 1 patient 
whereas for the lower dental arch, interproximal spaces were increased in 4 patients. 
Discussion
To our knowledge, this is the first study in which changes in dental morphology as a result of 
long-term oral appliance therapy are evaluated in a controlled study concerning mild-to-severe 
OSAS patients. Oral appliance therapy is generally considered a life-long treatment modality. This 
study demonstrated that a decrease in overjet, overbite, number of occlusal contact points and a 
different anterior-posterior relationship are dental changes most likely to occur. Furthermore, we 
found an association between the decrease in overbite and the amount of mandibular protrusion 
associated with wearing an oral appliance. Moreover, there was a tendency towards a mesiocclu-
sion after two years of oral appliance therapy compared to CPAP therapy. In the oral appliance 
group we also found a tendency towards the development of a (bi)lateral crossbite in the (pre)
molar region. In the oral appliance group, more patients had a shift in molar- and cuspid occlu-
sion from class I to class III or a shift from class II to class I or III compared to the CPAP group.
Changes in overbite, overjet and anterior-posterior relationship of the occlusion as a result of 
long-term oral appliance therapy have also been described in previous studies (16, 18, 19, 21, 
28). It is generally hypothesized that these changes can be attributed to a labially directed force 
to the mandibular incisors and a palatally directed force to the maxillary incisors during oral ap-
pliance therapy while the mandible attempts to return to a more dorsal position. However, in a 
study of Ringqvist and co-workers (12), no significant changes in overjet and overbite were found 
after 2 years of oral appliance therapy. This may be explained by differences in appliance design. 
The oral appliance used in our study was made of hard acrylate which covers the entire upper and 
lower dental arch, while, in the appliance that was used by Ringqvist and co-workers both frontal 
parts were not covered by acrylate, possibly resulting in less forces applied to the upper and lower 
incisors. This can be a possible explanation for the absence of significant changes in overjet and 
overbite. In a study by Ghazal and co-workers, a significant decrease in overbite but not overjet 
was found (25). The appliance used in that study was a Thornton Adjustable Positioner (TAP) like 
the one used in this study. However, in the latter mentioned studies, only patients with mild and 
moderate OSAS patients were included (12, 25). In this study, patients with mild, moderate and 
severe OSAS were included and protrusive positions of the mandible over 75% were applied in 
some patients. The relationship between the amount of mandibular protrusion and efficacy of 





different findings regarding changes of the overjet and overbite could be that an oral appliance 
is already effective in a less protrusive position in mild and moderate OSAS patients, resulting in 
less severe dental side-effects.
Regression analysis showed that there appears to be an association between the decrease in 
overbite and the extent of mandibular protrusion. This result confirms the finding of a previ-
ous cephalometric study conducted in the same patient population (11). Both separate findings 
suggest that it is important to coach patients which are treated with an oral appliance, as with 
an adjustable appliance, there is a risk that patients advance the mandible beyond the optimal 
protrusive position.
Like in several other studies (16, 21, 22) we found a significant decrease in the number of oc-
clusal contact points in the (pre)molar region in both the oral appliance group and CPAP group. 
As long-term oral appliance use results in a decrease in overjet and overbite it is conceivable that, 
because of the incisal guidance phenomenon, the bite tends to open in the (pre)molar region, 
resulting in a decrease in the number of occlusal contact points in the (pre)molar region. Mar-
tinez-Gomis and co-workers (31) also found a significant reduction in posterior occlusal contact 
points after 2 years of oral appliance use. This tendency, however, reversed during the period of 
2-5 years of treatment. The reason for this phenomenon can be the development of a new oc-
clusal equilibrium overtime. Therefore, it seems viable that these dental changes tend to stabilize 
over time. In this study, we also found a decrease in the number of occlusal contact points in the 
CPAP group. It has recently been advocated that nasal CPAP may change craniofacial form and 
may alter the relationship between the dental arches (32). A retroclination of the maxillary inci-
sors after long-term nasal CPAP use has also been reported in the latter study. As nasal CPAP is 
administered through a tight fitted (nose)-mask, it could be hypothesized that the pressure of this 
mask results in palatally directed forces on the frontal part of the upper dental arch. The same in-
cisal guidance phenomenon as mentioned before could therefore explain the decrease in number 
of occlusal contact points in our CPAP patients. Nevertheless, none of the patients using CPAP 
in our study did report any changes in occlusion. In a study, published by Ueda and co-workers 
(33), it was suggested that in patients using an oral appliance, certain jaw exercises might help 
to relieve stiffness of the masticatory muscles and accelerate the repositioning of the mandible to 
the normal position after a night of oral appliance use. It furthermore may inhibit or minimize the 
occlusal functional changes in predisposed patients. These results may indicate the importance of 
such additional exercises in patients using an oral appliance that are prone to occlusal changes.
The results presented in table 2 and 3 suggest that there is a tendency towards a mesial shift 
of the molar- and cuspid-occlusion after long-term use of an oral appliance. This result is in 
agreement with previously reported findings (16, 19-21). However, as proposed by Almeida and 
co-workers (21), not all occlusal changes, which could be the result of long-term oral appliance 
therapy, should be interpreted as unfavourable. Regarding the patients in this study, favourable 
changes were more likely to be class II and the unfavourable changes seem to occur more in pa-
tients with class I baseline occlusion. We furthermore found a tendency towards the development 








explained by the fact that, with a mesial shift in occlusion, the broader part of the mandibular 
dental arch will occlude with the narrower part of the maxillary dental arch. These results rein-
force the importance of good pre-therapeutic information to our patients, especially in patients 
in whom larger occlusal changes are to be expected.
In conclusion we found that long-term oral appliance therapy and CPAP may result in dental 
changes in OSAS patients. However, when treating a serious and sometimes life threatening 
disorder as OSAS, therapeutic efficacy should supersede the maintenance of a patients’ baseline 
craniofacial morphology. Discontinuation of oral appliance therapy because of the development 
of dental side-effects should only be considered in patients who are able to tolerate or accept 
another effective treatment modality for their OSAS. Regarding possible dental side-effects that 
may occur, we would like to emphasize the importance of providing adequate information to the 
patients before commencing oral appliance therapy. At least it should be mentioned that there 
is a chance that the overjet and overbite will decrease which can result in a suboptimal occlusion 
(e.g. less occlusal contact points and a possible development of (bi)lateral crossbite in the (pre)
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The objective of this study was to assess variations in the occurrence of temporomandibular 
disorders (TMDs) and the risk of developing pain and function impairment of the temporoman-
dibular complex in obstructive sleep apnoea syndrome (OSAS) patients treated with either an oral 
appliance or continuous positive airway pressure (CPAP) in a two-year follow-up study. In addition 
we assessed the relationship between the mean mandibular protrusion, and the frequency of 
wearing the appliance during follow-up with the occurrence of pain and function impairment of 
the temporomandibular complex.
Fifty-one patients were randomized to oral appliance therapy and fifty-two patients to CPAP 
therapy. TMDs (diagnosed according to the Axis I Research Diagnostic Criteria for TMD), pain 
intensity and disability, and mandibular function impairment were recorded at baseline, after 2 
months, 1 year and 2 years of therapy.
Only in the initial period of treatment, the occurrence of pain-related TMDs was considerably 
higher (24%) in the oral appliance group compared to CPAP (6%). Oral appliance therapy fur-
thermore resulted in more temporomandibular pain compared to CPAP (Odds ratio [OR] 2.33, 
95% Confidence Interval [CI] (1.22–4.43)). However, there were no limitations in mandibular 
function in both groups during the (entire) follow-up period.
Although generally not serious and of transient nature, oral appliance therapy results in more 
pain related TMDs in the initial period of use compared with CPAP therapy. Because of the tran-
sient nature, this pain is not a reason to contra-indicate an oral appliance in OSAS patients. More-
over, TMDs and the risk of developing pain and function impairment of the temporomandibular 






Obstructive sleep apnoea syndrome (OSAS) is a highly prevalent sleep-related breathing disorder 
affecting approximately 4% of the male and 2% of the female adults in the North-American 
population (1). The disorder is characterized by disruptive snoring and repetitive partial or com-
plete obstructions of the upper airway (i.e. hypopnoeas and apnoeas, respectively) during sleep 
(2). This disrupted sleep may result in various (serious) neurobehavioral and cardiovascular seque-
lae, ultimately depriving the patient’s quality of life and life expectancy (3, 4). Standard treatment 
with Continuous Positive Airway Pressure (CPAP) is very effective in reducing symptoms (5, 6). 
However, because of the obtrusive nature of CPAP, patients may abandon or adhere poorly to 
this therapy (7). Oral appliance therapy has been demonstrated an effective alternative in treating 
OSAS, especially in the mild and moderate spectrum of the disorder and in patients unwilling or 
unable to tolerate CPAP (8). Oral appliances generally aim at relieving the upper airway obstruc-
tions by positioning the mandible in a forward and downward position (9).
Mild and ‘transient’ side effects are commonly reported in the initial period of oral appliance use 
(10-13). Known side effects, associated with long-term use of an oral appliance are predominant-
ly dental in nature and include a decreased overjet and overbite (14-16). Furthermore, a change 
in inclination of the mandibular and maxillary incisors has been reported (14-16). Moreover, some 
authors have reported a downward and forward displacement of the mandible as a result of oral 
appliance therapy (15, 17, 18). 
Temporomandibular disorders (TMDs), is a collective term that embraces a number of clinical 
problems that involve the masticatory muscles, the temporomandibular joint, and the associated 
structures (19). When using an oral appliance during sleep, the mandible is positioned in an un-
natural forward and downward position, which could ultimately result in TMDs. Studies regard-
ing TMDs associated with oral appliance therapy for the management of OSAS are still limited 
in number and quality (20-25). Most studies to date have been retrospective, comprised small 
study samples or did not include a (matched) control group. Furthermore, in most studies the 
oral appliance was not adjustable but fixated the patients’ mandible in a predefined protrusive 
position (50-75% of the maximal mandibular protrusion). Therefore, a clear association between 
the mandibular protrusion and the occurrence of TMDs is still unknown. It could be hypothesized 
that more serious TMD-related complaints will occur in patients with the mandible positioned in 
a more forward position or in patients using the oral appliance more frequently.
The objectives of this parallel randomized controlled study were to assess:
1. Variations in the occurrence of TMDs and the risk of developing pain and function impairment 
of the temporomandibular complex in OSAS patients treated with an oral appliance compared 
with CPAP during a two-year follow-up.
2. The relationship between the mean mandibular protrusion, and the frequency of wearing the 











The effectiveness of an oral appliance in the treatment of OSAS, compared with CPAP, has been 
evaluated in a previous executed randomized controlled trial (26). The materials and methods of 
this specific study are briefly summarized below. All patients were recruited through the Depart-
ment of Home Mechanical Ventilation of the University Medical Center Groningen, the Nether-
lands. Subjects over 20 years of age and diagnosed with OSAS (apnoea-hypopnoea index (AHI) 
≥ 5) based on polysomnography (27) were eligible. If patients fulfilled predefined medical, psy-
chological, and dental inclusion criteria, they were selected for the study (26) and subsequently 
randomized for either oral appliance- (n = 51) or CPAP therapy (n = 52).
For the present study, we assessed the occurrence of disorders of the temporomandibular com-
plex as a result of long-term use of an oral appliance compared to CPAP in OSAS patients (Table 
1). Patients considered nonsuccessful or nonadherent (26) were offered to switch to the alterna-
tive therapy at any time during the follow-up. Details of patient selection criteria for our study 
are provided in figure 1.
The present study was approved by the Groningen University Medical Center’s Ethics Commit-
tee. Written informed consent was obtained from each patient before enrolment.
Variables
At baseline clinical variables were determined (26). Prior to (T0), after two months (T2), one year 
(T15) and two years (T27) of therapy, the occurrence of TMDs was assessed based on Research 
Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I (Table 3) (28). The RDC/
TMD is developed for research purposes and constitutes a reliable system for the assessment of 
Table 1: Baseline characteristics of 103 patients treated with an oral appliance or CPAP.




Male / female ratio 43 / 8 49/3
Age (years) 49 ± 10 49 ± 10
Body-mass index (kg/m2) 32 ± 6 33 ± 6
Apnoea-hypopnoea index (no/hour) 39 ± 31 40 ± 28
Neck circumference (cm) 44 ± 4 45 ± 4
minSaO2 (%) 78 ± 9 78 ± 10




* values are means ± standard deviations.

























































































































































































































































TMDs (28, 29). Axis I from the RDC/TMD is based on clinical signs and symptoms. The RDC/TMD 
Axis II was designed to grade chronic pain severity (Graded Chronic Pain Scale). Examinations 
were standardized and two experienced observer (MD, AH) were responsible for all examinations 
throughout the study. The observers reviewed the RDC/TMD procedure after being thoroughly 
instructed by an orofacial pain specialist (BS). According to the RDC/TMD guidelines, clinical 
diagnoses were made (Table 3). For this study, the patient rather than the joint was the entity of 
research. In theory, each patient can have multiple RDC diagnoses (maximum of 5). In practice, 
patients with more than 3 RDC diagnoses are very rare (28). 
To assess pain of the temporomandibular complex, the RDC/TMD Axis II was used. This scale has 
been specifically designed to grade chronic pain severity, ranging from grade 0 to grade IV (Table 
2) (28). At all time-points (T0, T2, T15 and T27) patients filled out the seven-item Graded Chronic 
Pain Scale. Two clinical cut-off points were defined, i.e. grade > 0 represents ’pain’ and grade > 
II represents ‘pain induced limitation’. 
At all time-points (T0, T2, T15 and T27), the Mandibular Function and Impairment Questionnaire 
(MFIQ) was filled out by all patients to subjectively assess function impairment of the temporo-
mandibular complex during therapy. The MFIQ is a validated questionnaire to assess the impact 
of TMDs on mandibular function and movements in patient’s daily life circumstances (30). This 
questionnaire scores perceived difficulty of 17 representative mandibular functions in relation to 
joint or muscle complaints. The possible answers are scored on a five-point Likert scale from 0-4, 
representing “no difficulty (0)” to “very great difficulty or impossible without help (4)”. The sum 
item score for function impairment ranges from 0-68. Then the raw component score was cal-
culated (range 0-1). From this raw component score the Function Impairment Rating Scale (FIRS) 
(range 0-5) was determined and thereupon, to enhance interpretation, the FIRS was converted to 
a more qualitative indication of the level of function impairment (low (FIRS 0 or 1)/ moderate (FIRS 
2 or 3)/ severe (FIRS 4 or 5)) (30). Finally, at each time-point, patients filled out a questionnaire 
about therapy use. In this questionnaire patients were asked how many nights per week and how 
many hours per night therapy was used.
Table 2: Classification of the outcome of the seven-item questionnaire for graded chronic pain; Research 
Diagnositic Criteria for Temporomandibular Disorders (RDC/TMD): Axis II.
Grade Description
Grade 0 No temporomandibular pain in the prior 6 months
Grade I Low disability – Low intensity pain
Grade II Low disability – High intensity pain
Grade III High disability – Moderately limiting
Grade IV High disability – Severely limiting







































































































































































































































































































































































































































































































































































































































































































The oral appliance used in this study (Thornton Adjustable Positioner, Airway Management Inc., 
Dallas, TX, USA) consisted of two separate parts, fixing the patient’s mandible in a forward and 
downward position. This type of oral appliance is often referred to as a Mandibular Advancement 
Device (MAD). By turning a propulsion screw that was incorporated anteriorly in the appliance, 
patients could adjust the mandibular advancement with 0.2 mm increments with each turn. 
The maximum range of mandibular protrusion was first determined with a George-Gauge™ (H-
Orthodontics, Michigan City, IN, USA). When initiating oral appliance therapy, the mandible was 
set at approximately 50% of the patient’s maximum protrusion. After having accustomed to this 
protrusive position during a two-week period, patients were allowed to further adjust the oral 
appliance during a 6-week period. When subjective OSAS symptomatology appeared to persist, 
patients were instructed to advance the mandible each night with 1 to 2 increments (i.e. 0.2-0.4 
mm). This “titration” of the oral appliance was continued until subjective OSAS symptoms (27) 
were adequately improved or until further protrusion of the mandible resulted in discomfort. 
The mean mandibular protrusion during the follow-up period (expressed as percentage of the 
maximum mandibular protrusion) was used for further analysis. The vertical dimension of the oral 
appliance was kept constant during the entire follow-up period. Both mandibular protrusion and 
mouth opening (including the vertical overbite) imposed by the oral appliance were measured 
with a digital sliding calliper. These measurements were carried out at baseline, after two months, 
one year and two years of treatment. At these time-points also other clinical measurements 
(weight, length, neck circumference and intoxications) were carried out.
CPAP-titration was performed during an afternoon nap. This technique, aimed at abolishing all 
signs of apnoeas, hypopnoeas and snoring, has been shown to be an appropriate procedure for 
the effective titration of CPAP (31).
Following CPAP- and oral appliance adjustment, an eight week follow-up period was arranged 
that allowed for habituation and, if necessary, adjustment of CPAP or the oral appliance. After 
this period, a second polysomnographic study was performed. If polysomnography indicated an 
apnoea-hypopnoea index ≥5, CPAP or the oral appliance was further adjusted by the physician 
(not during polysomnography). A third polysomnographic study was performed 4 weeks after 
that adjustment. 
Treatment was considered effective when the apnoea-hypopnoea index either was <5 or showed 
“substantial reduction,” (26) defined as a reduction in the index of at least 50% from the base-
line value to a value of <20 in a patient who had no OSAS-symptoms while using therapy. Pa-
tients for whom oral appliance or CPAP therapy was effective continued this treatment. If one of 
both treatments was not effective at any time during the follow-up period, patients were offered 
the alternative therapy (CPAP or oral appliance, respectively), which was titrated as described 
above. After a two-year follow-up period all patients were subjected to a final polysomnographic 
evaluation. Patients were always encouraged to contact our clinic between regular follow-up ap-







Statistical analyses were performed using the Statistical Package for the Social Sciences (ver-
sion 16.0, SPSS Inc., Chicago, IL, USA). All continuous demographic variables at baseline were 
normally distributed and their means and standard deviations (s.d.) are reported. The AHI of the 
oral appliance and CPAP patients at baseline was normally distributed after logarithmic transfor-
mation.
An “intention-to-treat” analysis (Fig. 1: group A+C versus group B+D) was carried out for all 
measurements (i.e., all patients were analyzed in the group to which they were randomized, 
regardless of whether they complied with the assigned treatment). Statistical analysis for lon-
gitudinally, repeated measurements were performed using Stata (version 10.1, StataCorp, Col-
lege Station, TX, USA) by means of Generalized Estimating Equations (GEE). With GEE the joint 
relationship of different variables (e.g. difference in pain, pain induced limitations and the MFIQ 
score) at different time-points is analyzed.
For oral appliance therapy, the mean mandibular protrusion during the follow-up, therapy use 
or possible switching of therapy were related to the MFIQ scores or pain in the temporomandibu-
lar complex with GEE models. Odds ratios (OR) for dichotomous variables and regression coef-
ficients (β) for continuous variables and their 95% confidence intervals (CI’s) are reported. The 
significance level α of all analyses was set at 5%. The occurrence of TMDs at different time-points 
is reported in a descriptive way.
Results
After two years, 36 out of 51 patients randomized to an oral appliance (71%) and 39 out of 52 
patients randomized to CPAP (75%) completed the follow-up. In the oral appliance group, 29 
patients (57%) completed the 2-year follow-up still using their oral appliance, while in the CPAP 
group, 37 patients (71%) completed the 2-year follow-up using CPAP. Eleven patients switched 
to the alternative therapy during the follow-up (Fig. 1: group B and group C). Seven patients 
switched from oral appliance therapy to CPAP therapy (all considered nonsuccessful). Four pa-
tients switched from CPAP therapy to oral appliance therapy (1 was considered nonsuccessful and 
3 nonadherent), of whom 2 completed the 2-year follow-up (Fig. 1: group B). 
In the oral appliance group (n=36), the mean (± s.d.) mandibular protrusion during the follow-
up period was 76 (± 25) % of the maximum mandibular protrusion. The mean mouth opening 
(including overbite) while wearing the oral appliance was 12.8 (± 2.7) mm. Patients in the oral 
appliance group used their device on average 6.7 (± 0.6) nights per week and 7.2 (± 0.8) hours 
per night. In the CPAP group (n=39) patients used their device on average 6.9 (± 0.4) nights per 
week and 6.9 (± 1.3) hours per night. No patient withdrew from the study during the follow-up 
period because of signs or symptoms of TMDs.
Clinical measurements









and CPAP group could be classified as ‘no-TMD’ at all time-points (Table 3). At baseline, 12 out 
of 52 patients (23%) in the CPAP group and 18 out of 51 patients (35%) in the oral appliance 
group were diagnosed with TMDs, of which a disc displacement with reduction (2a) was the 
most prevalent in both groups. In the oral appliance group, however, this diagnosis was twice as 
prevalent when compared with the CPAP-group. Two patients in the CPAP-group were diagnosed 
with osteoarthrosis (3c) at baseline, whereas this condition was not observed in the oral appliance 
group. After two months of therapy (T2), there was an increase in occurrence of 5% and 10% 
of total TMDs compared to baseline in the CPAP- and oral appliance group, respectively. At the 
one-year follow-up (T15) a decrease in the occurrence of TMDs was observed in both CPAP (7%) 
and oral appliance group (12%) when compared with the 2-month follow-up. Compared to the 
one-year follow-up, only small changes in the occurrence of TMDs occurred after two years (T27) 
of treatment in both groups (1%). 
At baseline (T0), 2 out of 52 patients (4%) in the CPAP-group and 4 out of 51 patients (8%) in 
the oral appliance group were diagnosed with either one or a combination of pain-related diag-
noses (i.e. tendomyalgia (1a), arthralgia (3a) and osteoarthritis (3b)). After 2 months, an increase 
in occurrence of 2% and 16% of one or a combination of pain-related TMDs was observed in the 
CPAP- and oral appliance group, respectively. At the one-year follow-up, there was an increase in 
the occurrence of pain-related TMDs in the CPAP group (4%), while in the oral appliance group 
a decrease (16%) was observed when compared with the 2-month follow-up. Compared to the 
one-year follow-up, only small changes in the occurrence of pain-related TMDs occurred after 
two years (T27) of treatment in both groups.
Questionnaires
A significant difference was found in pain intensity between oral appliance and CPAP therapy 
at different time-points. Patients receiving oral appliance therapy have a higher risk of developing 
pain than patients using CPAP therapy during a two-year follow-up (OR=2.33, 95% CI (1.22–
4.43)). No associations were found between pain intensity and mandibular protrusion (OR=1.02 
(0.84–1.24)), therapy use (OR=1.13 (0.90–1.44)) or switching of therapy (OR=0.87 (0.33–2.28)) 
during the follow-up. No significant differences were found in pain induced limitations between 
CPAP- and oral appliance therapy. Pre-therapeutically, one patient in the CPAP group was classi-
fied as suffering from pain induced limitation. However, this patient was also familiar with oro-
facial pain complaints. These complaints did not increase during the follow-up period and were 
no reason for the patient to cease CPAP-therapy. In the oral appliance group, also one patient 
was pre-therapeutically classified as suffering from pain induced limitation. During the follow-up 
period these complaints disappeared.
Regarding mandibular function impairment, no significant differences between oral appliance 
therapy and CPAP therapy were observed at the different time-points (β=0.56, 95% CI (-1.77-
2.88)). For the oral appliance group, no association was found between the mean mandibular 
protrusion during the follow-up (β=-0.23 (-2.83–13.90)), therapy use (β=0.96 (-0.29–2.21)), pos-
sible switching of therapy (β=0.02 (-1.24-1.28)) and the MFIQ scores at different time-points. 
101
Regarding the function impairment score, at baseline, all patients could be classified as ‘low’ 
impairment (FIRS 0 or 1). After two months of treatment (T2), 1 patient using an oral appliance 
and 1 patient using CPAP was classified with ‘moderate’ impairment. At the one-year follow-up 
(T15), the same patient in the oral appliance group remained being classified with ‘moderate’ 
impairment. In the CPAP group, 2 patients suffered from ‘severe’ impairment at the one year 
follow-up (T15). At the last follow-up visit (T27), 1 patient in the oral appliance group still suffered 
from ‘moderate’ impairment, and one of the patients who was ‘severely’ impaired in the CPAP 




To our knowledge this is the first study in which the occurrence of different TMDs as a result 
of long-term oral appliance therapy at different time-points has been evaluated in a controlled 
study concerning patients from the full OSAS spectrum. This study shows that in the initial period 
after initiating oral appliance or CPAP therapy, the occurrence of (particularly pain-related) TMDs 
increases, being substantially higher (24%) in the oral appliance group than in the CPAP group 
(6%). Furthermore, we found that oral appliance therapy results in significantly more pain during 
a two-year follow-up compared with CPAP therapy. This pain did not induce limitations of the 
temporomandibular complex, neither in the oral appliance- nor in the CPAP group. No differ-
ences were found in mandibular function impairment during the two-year follow-up between 
oral appliance- and CPAP therapy. No relationship could be found between the mean mandibular 
protrusion, and the frequency of wearing the appliance during follow-up with the occurrence of 
pain and function impairment of the temporomandibular complex.
The occurrence of TMDs as a result of long-term oral appliance therapy has been described 
previously by Martinez-Gomis and co-workers (23). They found that the occurrence of TMDs at 
different time-points was not affected by long-term oral appliance therapy in OSAS patients. In 
the present study, the occurrence of pain-related TMDs after 2-3 months of using an oral appli-
ance (T2) was considerably higher as compared to baseline, in contrast to the CPAP group. This 
could be the result of the strain in the muscles of the temporomandibular complex or the capsu-
lar ligament of the temporomandibular joint (TMJ) when protruding the mandible during sleep. 
The condyle of the mandible is positioned out of its natural resting position into a more forward 
and downward position, resulting in possible strain of the retro-discal tissue. Another possible 
explanation is the increase in occlusal vertical dimension while wearing an oral appliance. Le 
Belle and co-workers showed that after applying artificial occlusal interferences, the occurrence 
of temporomandibular pain symptoms increased, but decreased after a few days (32). Therefore, 
the authors suggest that patients can adapt to a new vertical occlusal situation. In a study by 
Giannasi and co-workers, the intensity of TMDs symptoms decreased significantly after oral ap-
pliance therapy (25). Particularly the occurrence of jaw fatigue decreased during the follow-up 











the TMJ and related structures. Unfortunately, a matched control group was absent in this study, 
so it remains unclear to what extent oral appliance therapy contributes to these phenomena. 
Furthermore, in the latter study, the Helkimo Anamnestic Dysfunction Index was used. This index 
has been developed for epidemiological purposes and not, like the RDC/TMD Axis I used in this 
study, for clinical purposes. The Helkimo Anamnestic Dysfunction Index furthermore classifies 
patients into three “dysfunction” groups rather than clinical diagnoses. In the present study we 
did not find a clinical relevant change during the follow-up of different TMDs occurrences in the 
oral appliance group compared with the CPAP group. After the initial increase of different (pain-
related) TMDs and combinations thereof in the oral appliance group, the occurrence decreased to 
values similar to baseline during the follow-up. This finding suggests that the temporomandibular 
complex has adaptive capacities to the unnatural protrusive position during sleep while wearing 
an oral appliance. After 2-3 months of therapy, all pain-related TMDs had decreased in the oral 
appliance group in the remaining period of the follow-up. From that perspective it appears that 
an oral appliance could have a therapeutic effect in patients with TMDs. It has been described 
that treatment with an anterior repositioning splint reduces reciprocal clicking of the TMJ (33). 
Because the oral appliance used in this study also positions the mandible in a forward position, 
it could be hypothesized that patients with a TMD experience a favourable effect. However, sci-
entific evidence for this possible phenomenon is weak (34). Furthermore the number of patients 
in our study may be too low to draw conclusions with respect to this possible effect. Moreover, 
it has been described that in some patients with disc displacement without reduction, symptoms 
did resolve spontaneously over time without treatment (35). 
The results of this study show that patients with OSAS, treated with an oral appliance, have 
a higher risk of developing pain in the temporomandibular complex (OR 2.33) as compared 
to CPAP therapy. However, this pain is most pronounced in the initial period of oral appliance 
treatment and tends to decrease afterwards. These findings correspond with the results of other 
studies (10, 20, 22, 25). It has been described that OSAS patients with TMDs could benefit from 
mandibular exercises during oral appliance therapy (36). This might suggest that support therapy 
could reduce TMD-related pain, probably resulting in higher compliance rates in the initial phase 
of oral appliance therapy. However, in a research setting, the risk of nonadherence in patients 
suffering from oromandibular pain may be little as patients are frequently monitored. Conversely, 
in a regular clinical setting, nonadherence due to TMD problems might hamper the outcome of 
the results.
No significant differences were found in mandibular function impairment between the oral 
appliance- and CPAP group. Since a dose dependency of oral appliance therapy on the AHI has 
previously been described (13, 37), it is conceivable that in severe OSAS patients, oral appliance 
therapy might result in more mandibular function impairment. However, we did not find an 
association between the mandibular protrusion during the follow-up, and the MFIQ scores at 
different time-points. This finding corresponds with the results of another study (13) that also 
did not show a difference in adverse effects on the stomatognatic system between patients with 





sociation between therapy use or switch of therapy and MFIQ scores or pain intensity. This could 
partially be explained by the fact that there were only minor differences in therapy use, making 
it more difficult to discriminate between these patients. Moreover, only few patients switched to 
the alternative therapy during the follow-up period. 
In the present study, patients with active TMDs (e.g. osteoarthritis) and restrictions in mouth 
opening (< 25 mm) or advancement of the mandible (< 5 mm) were excluded. This resulted in 
a total occurrence of single TMD or combinations of TMDs in 29% of our total study group as-
sessed with the RDC/TMD. In another study (24) the occurrence of TMDs at baseline was 52%. 
These findings suggest that standardized criteria for TMDs diagnosis, such as the RDC/TMD, 
should be part of a standard examination in order to discriminate between active and inactive 
TMDs, prior to oral appliance therapy, as it should be considered a life-long treatment unless 
alternative therapies can bring help. 
After randomisation, a difference in TMDs between both groups at baseline (23% for CPAP and 
35% for oral appliance) was observed and more women (16%) were allocated to the oral appli-
ance group compared to the CPAP group (6%). As it is known that TMDs occur more frequently 
in women than men (38), this could be a possible confounding factor. However, we believe that 
the total amount of women in our study was too low to distort our results. Nevertheless, we did 
not study these possible effects in detail.
Considering the fact that OSAS is a disorder with serious cardiovascular consequences, it should 
be treated as effective as possible. Discontinuation of oral appliance therapy because of the 
development of TMDs should only be considered in patients who are able to tolerate or accept 
another effective treatment modality for their OSAS.
In conclusion, our results show that the occurrence of (pain-related) TMDs increases in the initial 
period of oral appliance therapy but tends to return to baseline values during a 2-year follow-up. 
In OSAS patients, oral appliance therapy results in more pain of the temporomandibular complex 
compared to CPAP therapy, but does not cause pain-induced limitations in these patients. Man-
dibular function was not impaired in OSAS patients using an oral appliance or CPAP therapy for 
two years. These findings suggest that the possible development of TMDs or temporary pain of 
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Obstructive sleep apnoea syndrome (OSAS) is a sleep-related breathing disorder, characterized 
by disrupted snoring and repetitive upper airway obstructions (1). Patients suffering from OSAS 
have a predisposition to repetitive upper airway collapse during sleep, which can be the result 
of anatomical abnormalities or fat depositions surrounding the upper airway. The latter is most 
pronounced in overweighed patients. OSAS is associated with an increased risk of cardiovascular 
events and associated morbidity and mortality. The condition also results in excessive daytime 
sleepiness, fatigue and neurocognitive deficits (2). Severity of OSAS is usually expressed by the 
apnoea-hypopnoea index (AHI), i.e., the mean number of apnoeas and hypopnoeas per hour 
sleep. By convention, OSAS is classified as mild (AHI 5-15), moderate (AHI 15-30) or severe (AHI 
>30) (3). 
The standard treatment, continuous positive airway pressure (CPAP), relieves upper airway ob-
structions and improves quality of life (4). Because of the cumbersome nature of CPAP, patients 
may abandon or adhere poorly to this treatment. Oral appliance therapy is an effective alterna-
tive, and is especially effective in mild-to-moderate OSAS cases (5). Most oral-appliances used in 
a clinical setting are mandibular advancement devices (MAD’s), which keep the mandible and its 
attached musculature in a protruded position. Successful oral appliance therapy has been sug-
gested as a predictor for successful maxillomandibular advancement (MMA) surgery in OSAS 
patients (6). MMA surgery has gained increasing popularity in this field since this procedure is 
associated with an enlargement of the entire velo-oro-hypopharyngeal airway. This specific surgi-
cal procedure may be indicated for treatment of severe OSAS patients who cannot tolerate or 
are unwilling to adhere to CPAP therapy. MMA surgery may also be contemplated in patients in 
whom oral appliances, which are more often appropriate in mild and moderate OSAS patients, 
have been considered undesirable (7). The aims of this case report were:
1. to describe the value of MMA surgery after (partially) successful oral-appliance therapy in a 
patient with morbidly severe OSAS and CPAP intolerance.
2. to gain insight in the three-dimensional upper changes associated with MMA surgery.
Case report
A 32-year-old female was referred by the Department of Home Mechanical Ventilation to the 
Department of Oral and Maxillofacial Surgery of the University Medical Center Groningen be-
cause of respiratory problems and CPAP intolerance. She suffered from morbidly severe OSAS 
(AHI=139) and was morbidly obese (body mass index (BMI) = 40). Her lowest oxyhemoglobin 
saturation during sleep was 73%. Daily functioning was severely compromised because of exces-
sive daytime sleepiness (EDS). Furthermore, she was diagnosed with left ventricular hypertrophy 
(LHV) and was treated for essential hypertension. She tried CPAP therapy (pressure 9 cmH2O) 
for a month but this resulted in discomfort in the maxillary sinuses and distress during the night. 





comental fat deposition was observed (Fig. 1A). Intra-oral examination revealed a bulky tongue, 
which obscured visualization of the soft palate and uvula (modified Mallampati class IV). Because 
of inadequate oral hygiene there was some marginal gingivitis. Further intra-oral examination 
revealed a healthy dentition without active periodontal disease. To improve oral hygiene, the 
patient was referred to an oral hygienist for plaque removal and oral hygiene instructions. The 
lateral cephalogram showed a narrow posterior airway space at the level of the base of the 
tongue (Fig. 2A).
After full examination of the temporomandibular complex it was decided to make an oral ap-
pliance. The oral appliance (Thornton Adjustable Positioner, Airway Management Inc., Dallas, TX, 
USA) consisted of two separate parts, fixing the patient’s mandible in a protruded and downward 
position. The mandibular protrusion could be adjusted with a propulsion screw, which was in-
corporated anteriorly in the oral appliance. When initiating oral-appliance therapy, the mandible 
was set at approximately 60% of the patient’s maximum protrusion. After having adapted to 
this position during a two-week period, the patient was allowed to further adjust the oral appli-
ance until OSAS symptoms abated or adjustments became uncomfortable. At the final follow-up 
review, 4 weeks later, the patient reported that she slept and felt much better. She also reported 
a substantial decrease in her daytime sleepiness. To quantify the result of oral-appliance therapy, 
a polysomnographic study with oral appliance in place was conducted 6 weeks after initiating 
therapy. The AHI decreased from 139 to 40, which was considered a major reduction. Low-
est oxyhemoglobin saturation during sleep improved from 73% to 76%. The patient was very 
positive about the treatment effects and was treated with an oral appliance for about 4 months. 
However, her severe OSAS persisted despite oral appliance therapy. Furthermore, she indicated 
to prefer a more “permanent” solution for her condition. Since she also complained about a lack 
of chin projection in her profile, she opted for MMA surgery, combined with a genioplasty and 
cervicomental liposuction. Presurgical orthodontics was regarded cumbersome in combination 
with the oral appliance. Moreover, the temporary use of CPAP during orthodontic treatment was, 
due to earlier negative experiences, not a serious option in this specific case. Therefore it was 
decided to perform orthognathic surgery without orthodontic treatment. Her class 1 occlusion 
would therefore be preserved following surgery. 
Based on soft- and hard tissue cephalometric analyses, using the true vertical line (TVL), a surgi-
cal plan was made. MMA surgery was planned in such a manner that an optimal airway enlarge-
ment was combined with an aesthetically pleasing surgical outcome. For this reason a counter 
clockwise rotation of the maxillomandibular complex was planned. As a result a large advance-
ment of the mandible is accompanied with a posterior downgraft of the maxilla and thereby 
relatively less advancement of the upper jaw. This results in less paranasal puffiness which may 
be expected when a straight forward advancement of the maxillomandibular complex of 10 mm 
would be planned. A modified genioplasty, comparable to Plenier and Delaire (8), with advance-
ment of the suprahyoid and genioglossal musculature was also planned. This procedure consists 
of a trapezoid-shaped advancement osteotomy of the chin to establish an additional forward 







labial cortex of the advanced chin can be removed and used as bonegraft at the zygomatic but-
tresses at the Le Fort 1 level. 
After preoperative placement of orthodontic brackets MMA surgery was performed under gen-
eral anaesthesia. A bilateral sagittal split osteotomy (BSSO) of the mandible was performed with 
counter clockwise rotation and advancement of 10 mm at B point and fixed with two miniplates 
on both sides. After this, a standard le Fort 1 osteotomy was performed with posterior down-
graft of 3 mm at the level of the first molars and advancement of 8,5 mm at the incisal edge of 
the central incisors leaving the existing occlusion practically unchanged. The maxilla was fixed 
with four miniplates. The modified genioplasty, as described previously, was performed with an 
advancement of 6 mm. After this a cervicomental liposuction was performed using a small stab 
incision just behind the submental fold in the facial midline. At the end of the surgery, the zy-
gomatic buttresses were grafted with mandibular bonegrafts from the chin. The bony defect 
between the proximal and distal segments of the mandible that resulted from the BSSO was 
grafted with a mix of bone particles and hydroxyapatite. The wounds were closed primarily and 
miniscrews were placed in the anterior region of mandible and maxilla in order to put the patient 
on postoperative skeletal elastics in combination with dental elastics on the brackets. The patient 
was extubated at the end of the surgery and stayed overnight in the recovery room to guarantee 
Figure 1. Thirty-three year old female with 
morbidly severe obstructive sleep apnoea syn-
drome. Photograph of the (A) preoperative 
profile and (B) postoperative profile. 
Figure 2. Cephalogram of the (A) preoperative 





continuous (oxyhemoglobin) monitoring. There were no surgical or medical complications in the 
direct post-operative period. 
Four months after surgery another polysomnographic study was performed. There was almost 
a complete resolution of the patients’ OSAS with a postoperative AHI of 6, which consisted only 
of hypopnoeas and no apnoeas. The lowest oxyhemoglobin saturation during sleep was 86%. 
The patient reported to feel ‘reborn’ after surgery. She experienced her sleep as undisturbed and 
reported a resolution of her excessive daytime sleepiness. Furthermore, she was very pleased 
with her new facial appearance (Fig. 1B). The tracings (Fig. 5) of the preoperative (Fig. 2A) and 
postoperative (Fig. 2B) cephalograms illustrate the profound skeletal and soft-tissue changes as 
a result of surgery.
3-D Image acquisition and analysis
Maxillofacial noncontrast conebeam-CT (CBCT) scans were taken pre- and postoperative (i-CAT, 
Imaging Sciences International, Hatfield, USA). At each acquisition the patient was seated in an 
upright position, asked to hold their breath at end-expiration with the dentition in maximal occlu-
sion and the lips in relaxed contact position. The CBCT scans were imported in Simplant Crystal 
software (Materialize Dental, Leuven, Belgium). In the axial slides the superior boundary of the 3D 
airway figure was set at the posterior nasal spine and the inferior boundary was set at the base of 
the epiglottis. The minimum retropalatal and retroglossal cross-sectional area (CSA) of the upper 
airway was calculated pre-, and postoperatively. After surgery, a substantial increase was found 
in anterior-posterior and lateral airway dimensions of the upper airway at the retropalatal level 
(increase minimal cross-sectional area from 114 mm2 to 276 mm2) and retroglossal level (increase 
minimal cross-sectional area from 109 mm2 to 188 mm2) (Fig. 3 and 4). 
Discussion
This case report shows the effectiveness of MMA surgery after positive results of oral-appliance 
therapy in a patient with severe OSAS and CPAP intolerance. This finding confirms the results 
of the study performed by Hoekema and co-workers (6), in which patients with a substantial 
reduction in the baseline AHI with oral appliance therapy appeared to be good candidates for 
MMA surgery. However, that study was retrospective in design and included only four patients 
undergoing MMA surgery. It would therefore be of great value to perform a prospective study to 
investigate the predictive value of oral appliance therapy outcome for MMA surgery in a larger 
group of patients. 
The patient described in this case report had a baseline AHI of 139, which may be considered 
morbidly severe OSAS. Oral appliance therapy resulted in a major decrease of the AHI to 40 
but the remaining OSAS was still severe. It is known that oral appliance efficacy declines with 
increasing OSAS severity (10). This is explained by the fact that patients with severe OSAS are 







(10). Furthermore, oral appliance therapy only protrudes the mandible while the maxillary posi-
tion remains unchanged. In MMA surgery, the mandible as well as the maxilla are positioned 
anteriorly, which could explain the superior efficacy of MMA surgery over oral appliance therapy 
in our patient. The additional maxillary advancement pulls the velum and velopharyngeal muscles 
forward, most possibly creating more space at the velopharyngeal level of the upper airway. In a 
systematic review it has been reported that the degree of maxillary advancement was indicative 
for surgical success (11). Furthermore, in a cephalometric analysis it was found that the increase 
of the posterior airway space at velopharyngeal level, associated with wearing an oral appliance, 
was the best predictor for a decrease in the AHI (12). These findings suggest the importance of 
maxillary advancement in addition to mandibular advancement when treating OSAS patients by 
means of MMA surgery.
Fairburn and co-workers reported varying results regarding efficacy of MMA surgery in severe 
OSAS patients (13). In a few of their patients, respiratory parameters deteriorated after MMA 
surgery. One of their explanations for this finding is the negative effect of scarring as a result of 
previous upper airway surgery (e.g. uvulopalatopharyngoplasty). Our patient did not undergo any 
type of upper airway surgery before the present procedure, which could have had a favourable 
effect in this specific case. Younger age, lower preoperative BMI and AHI are considered predic-
tors of successful MMA surgery in OSAS patients (7). However, our patient was morbidly obese 
and had an extremely high AHI but was still treated very effectively following this procedure. This 
finding may be explained by the fact that our patient was additionally treated with a genioplasty 
and cervicomental liposuction. These procedures may have added to the positive effect of MMA 
Figure 3. Minimal cross-sectional area of the upper airway at retroglos-
sal level (A) preoperative (B) postoperative.
Figure 4. Minimal cross-sectional area of the upper airway at retropala-




surgery on upper airway patency.
As a result of the enlargement of the lateral and anterior-posterior dimensions of the upper 
airway following MMA surgery, an increase in the cross sectional area of the upper airway was 
found at retropalatal and retroglossal levels. This finding is consistent with results, published in 
previous studies (13, 14). Studies evaluating upper airway changes as a result of wearing an oral 
appliance also show an increase of the cross sectional area of the upper airway at different levels 
(15, 16). Choi and co-workers report a decrease of the cross-sectional area (range 36.5%-75.5%) 
of the upper airway during midazolam-induced sleep in the supine position. In most studies in-
cluding this case report, patients were evaluated during upper airway assessment in an upright 
position while being awake. However, in this case report the pre- and postoperative CB-CT stud-
ies were performed, using exactly the same protocol. We therefore believe that the changes we 
found in the upper airway cross sectional areas after MMA surgery are of clinical importance.
In a recent conducted controlled study it was found that there was no significant difference in 
success rate between MMA surgery and CPAP in severe OSAS patients (17). These findings may 
indicate and confirm that, in the future, MMA surgery can take a prominent place in treating 
severe OSAS patients who do not tolerate CPAP or in patients who are unwilling to use CPAP. 
In conclusion this case report shows that MMA surgery combined with a modified genioplasty 
and cervicomental liposuction can be very effective in treating morbidly severe OSAS in a morbidly 
obese patient. MMA surgery was in fact the only effective treatment for this patient’s life-threat-
115
Figure 5. Superimposed (S-N) preopera-
tive (grey line) and postoperative tracings 







ening disorder. Furthermore, this case substantiates the observation that effective treatment with 
an oral appliance (mandibular advancement device) can be considered a good predictor for suc-
cessful MMA surgery in OSAS management. Lateral and anterior-posterior upper airway dimen-
sions increase at the retropalatal and retroglossal level as a result of MMA surgery combined 
with a genioplasty and submental liposuction. To clarify which patients would benefit from MMA 
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 Oral appliance therapy is currently considered a successful treatment for patients with mild and 
moderate obstructive sleep apnoea syndrome (OSAS) and has emerged as an increasingly popular 
alternative to continuous positive airway pressure therapy (CPAP). The advantages of oral appli-
ance therapy over CPAP include its high acceptance, reversibility, ease of use, the lack of noise, 
no power source required, and portability. 
Several clinical trials have confirmed the short-term success of oral appliance therapy in OSAS 
patients (1-8). As oral appliance therapy should be considered a life-long treatment, it is impor-
tant to know whether it is a successful treatment on the long-term and to gain insight into the 
specific side-effects, related to long-term use of an oral appliance. However, controlled trials, 
addressing the long-term success of oral appliance therapy and investigating the development 
of side-effects associated with long-term oral appliance use in mild-to-severe OSAS, are scarce.
The aims of this thesis were to evaluate:
1. morphological changes of the upper airway in patients wearing an oral appliance,
the objective and subjective outcomes of long-term (2-years) oral appliance- and CPAP therapy in 
mild-to-severe OSAS patients,
2. possible side-effects on the craniofacial morphology, the dentition and the temporomandibular 
complex associated with long-term (2-years) use of an oral appliance.
3. The present chapter discusses the main findings of this thesis. Furthermore, suggestions for 
future research in the field of sleep medicine are provided.
Upper airway morphology
It is assumed that the working mechanism of an oral appliance is based on the advancement 
of the mandible and its attached soft tissue structures and musculature, possibly resulting in an 
increased tone with increased anteroposterior and lateral dimensions of the upper airway (9, 10). 
Because of this working mechanism one would expect an increase in upper airway patency while 
wearing an oral appliance. There are several ways of studying the upper airway, each of which 
has its (dis)advantages. We studied the changes in upper airway morphology as a result of wear-
ing an oral appliance by cephalometry and found an increase in the anterior-posterior dimension 
of the upper airway at various levels (Chapter 2). It could be hypothesized that increasing the 
vertical dimension in occlusion, associated with wearing an oral appliance, might compromise the 
anterior-posterior upper airway dimensions by rotation of the mandible. However, our results did 
not show a decrease in anterior-posterior upper airway dimensions. The amount of mandibular 
protrusion probably overrules this possible negative effect of increasing the vertical dimension.
Advantages of cephalometry are its accessibility, low costs and relatively low radiation expo-
sure for the patient. However, this two-dimensional image only provides information about the 
anterior-posterior dimension of the upper airway and yields no information regarding lateral di-
mensions. Furthermore, cephalometric imaging is usually performed in an upright position, which 
does not resemble the patient’s natural sleeping position. Nowadays, three-dimensional com-





diagnostic tool in dentistry and oral- and maxillofacial surgery. Cone-beam CT has been used for 
diagnosis, treatment planning, and outcome assessment in patients with OSAS (11, 12). In OSAS 
patients, it has been demonstrated that there is an increase in lateral, in addition to anterior-
posterior, dimensions of the upper airway while wearing an oral appliance (13). In our case-report 
(Chapter 5) we used cone-beam CT analysis to study changes in upper airway dimensions as a 
result of maxillomandibular advancement (MMA) surgery in a patient with severe OSAS. In this 
study we also found an increase in anterior-posterior and lateral dimensions of the upper airway. 
However, cone-beam CT analysis is more expensive and less available in dental clinics. Though, 
the upper airway should preferably be studied in three dimensions. By doing so, one could gain 
more insight in the complex pathophysiology and working mechanisms of different treatment 
modalities for OSAS. After CT imaging, additional computational fluid dynamics can gain insight 
in the airflow and resistance of the upper airway in OSAS patients (14). Unfortunately, even this 
complex and expensive imaging technique, cannot completely reveal the complex and dynamic 
pathophysiology of OSAS. In clinical practice, a cephalogram with an anterior bite registration 
can be compared with a baseline cephalogram to gain insight in the changes in the anterior-
posterior upper airway dimensions. The baseline cephalogram can be used to study the amount 
of overbite and overjet, the maxilla-mandibular relationship and the vertical level of the hyoid, 
as these parameters might provide prognostic information about treatment success with an oral 
appliance (15).
Treatment outcome
There is increasing evidence that an oral appliance is a successful treatment alternative to CPAP 
in mild and moderate OSAS patients. Several comparative studies have been published, in which 
the effects of oral appliance therapy have been compared with CPAP (1-8, 16-18). All but three 
studies (2, 3, 18) used a crossover design. Two studies used a randomized controlled parallel 
design with only an oral appliance- and CPAP group (2, 3). In the study of Aarab and co-workers 
(3) it was found that treatment with an oral appliance as well as with CPAP significantly lowered 
the apnoea-hypopnoea index (AHI). However, no significant difference in changes in the AHI 
between both treatments was found. Hoekema and co-workers (2) concluded that oral appliance 
therapy was not inferior to CPAP with regard to the percentage of successful treatments in mild-
to-severe OSAS. It was also concluded that oral appliance therapy was specifically successful in 
patients with mild and moderate disease. 
From our two-year follow-up study of this specific patient cohort (Chapter 3) we can conclude 
that, regarding the percentage of successful treatments, oral appliance therapy was not inferior 
to CPAP in treating mild-to-severe OSAS. Nevertheless, regarding polysomnographic variables, 
CPAP showed a significantly lower AHI and higher oxygen saturation levels compared with oral 
appliance therapy. Even with respect to the two-year follow-up, our results endorse the latest 
practice parameters of the American Academy of Sleep (19), in which oral appliance therapy “is 







CPAP, are unsuitable for CPAP, or who fail to adhere to CPAP.” However, notwithstanding the 
fact that CPAP was more effective (74%) in treating severe OSAS, we found that in 50% of the 
patients with severe OSAS (AHI>30), treatment with an oral appliance appeared to remain suc-
cessful after a two-year treatment period. This latter finding corroborates the results of the study 
of Mehta and co-workers (20), who concluded that oral appliance therapy can be considered as 
a first-line treatment for certain severe OSAS patients. Further research is required to predefine 
which specific severe OSAS patients may benefit from oral appliance therapy.
Another aspect that requires consideration is the criterion for treatment success. In the litera-
ture many different definitions of ‘treatment success’ have been used, mostly solely based on 
lowering the AHI below a predefined threshold. In comparative studies ‘success’ is defined as 
AHI <10 (5-7, 17, 21, 22), as AHI <10 with a reduction in the AHI >50% (23), as AHI <15 (24), 
or as a reduction in the AHI >50% (25). According to the criteria of the American Academy of 
Sleep Medicine, OSAS is defined as AHI >5 in combination with OSAS-related symptoms (26). 
Therefore, we believe that ‘treatment success’ should be defined as an AHI <5. Furthermore, 
because of the regression-to-the-mean phenomenon, one could get the impression that despite 
much greater reductions in the AHI in severe patients, treatment is less successful as it is harder to 
reach an AHI <5 for a patient with a baseline AHI of 80 than for a patient with a baseline AHI of 
8. Moreover, OSAS-related symptoms are an important factor in the patients’ daily life and should 
be incorporated in the definition of ‘treatment success’. Because of the above mentioned reasons 
we adapted the criterion also used in other controlled trials (20, 27, 28) in which success was 
defined as an AHI <5 or an AHI <20 with at least a 50% reduction of the baseline AHI in a patient 
free of OSAS-related symptoms. Because of the various different criteria of treatment success it 
is hard to compare outcomes between different studies. Therefore, uniformly accepted success 
criteria should be used in order to compare results from different studies.
In our study more patients dropped out or switched oral appliance therapy (47%) compared to 
CPAP therapy (33%) during the two-years of follow-up. In a recent review (29) of nine conducted 
RCTs comparing oral appliance therapy with CPAP, it was described that patients preferred oral 
appliance therapy over CPAP in 6 studies (4, 6-8, 16, 17) and CPAP over oral appliance therapy in 
2 studies (1, 5). In one study, patient preference data were not described as that study was not 
a cross-over but a parallel design (2). Therefore, patients were not able to express their preferred 
treatment. However, patients’ preference is only one of the factors that determine dropout rates. 
In our two-year follow-up, ‘success of treatment’ also was an important variable that determined 
the dropout rates for both treatments. Two patients in the oral appliance group and 6 patients in 
the CPAP group dropped out or switched because of adherence problems during the follow-up 
period. Furthermore, 14 patients in the oral appliance group and 6 patients in the CPAP group 
dropped out or switched because of a nonsuccessful treatment. The difference in dropout rates 
in our study could be explained by the fact that we did not exclude severe OSAS patients. Most 
studies comparing oral appliance therapy with CPAP only included mild and moderate OSAS pa-
tients. After two months of treatment, 7 patients switched from oral appliance therapy to CPAP 





that switched from CPAP to oral appliance therapy. As a lower baseline AHI (15), younger age, 
lower BMI and smaller neck circumference (20, 30) are associated with better treatment out-
come, it is likely that those patients are treated nonsuccessfully with an oral appliance and were 
randomized for the unfavourable treatment group in retrospect. A second explanation could be 
the tendency of oral appliance therapy to decrease in efficacy in the long term (31). In our study 
more patients dropped out in the oral appliance group because of a nonsuccessful treatment 
response compared to CPAP during the two-year follow-up. A plausible explanation for this dete-
rioration in treatment response might be a stretching or loosening effect of the muscles and soft 
tissue of the upper airway as a result of long-term overnight mandibular advancement. Further 
research is needed to study the upper airway soft tissue responses (e.g. muscle tone and length) 
as a result of long-term oral appliance use and to evaluate which specific patients are prone to a 
relapse of treatment success in the long term.
Despite the above-mentioned considerations, our findings suggest that, for the long-term, oral 
appliance therapy may be considered as first-line treatment alternative for mild and moderate 
OSAS patients. Furthermore, oral appliance therapy seems to be successful in a substantial part 
of patients with severe OSAS but should only be considered in those patients unwilling or unable 
to tolerate CPAP.
Side-effects
In this thesis, three studies (Chapter 4.1, 4.2 and 4.3) address side-effects associated with 
long-term use of an oral appliance. All these three studies are unique compared to most other 
published studies concerning side effects associated with oral appliance therapy, as there al-
ways was a control group (CPAP). Therefore, we corrected for changes that might have occurred 
with increasing age. Little is known about long-term side-effects of oral appliance use in mild-
to-severe OSAS patients. In contrast, short-term side-effects of oral appliance therapy have been 
described extensively and include tooth pain, occlusal changes in the morning, dry mouth or ex-
cessive salivation, gum irritation, temporomandibular joint pain, temporomandibular joint sounds 
and myofascial pain (6, 21, 32-36). 
As oral appliance therapy can be considered a life-long treatment, it is important to know what 
consequences can be expected from long-term oral appliance use, as pre-therapeutically, pa-
tients need to be thoroughly and realistically informed about the possible side-effects of therapy. 
Our results demonstrate that long-term use of oral appliance causes small but significant dental 
changes. Our most prominent finding was a decrease of overjet and overbite measured with 
cephalometry (Chapter 4.1) and an association between the mean mandibular protrusion during 
follow-up and the decrease in overbite. Both findings were corroborated in the study on dental 
side-effects, assessed on plaster cast study models (Chapter 4.2). Furthermore, we found a retro-
clination of the upper incisors and a proclination of the lower incisors as a result of oral appliance 
therapy. Changes in overbite and overjet, retroclination of the upper incisors and a proclination 







Ringqvist and co-workers did not find significant changes in overbite, overjet, and inclination of 
the upper or lower incisors after two years of oral appliance use (39). First, oral appliance design 
might have contributed to these differences, as the appliance used by Ringqvist and co-workers 
did not cover the frontal parts of both tooth arches, probably causing less palatally directed forces 
on the upper incisors and less labially directed forces on the lower incisors. Another explanation 
could be the degree of mandibular protrusion during oral appliance therapy of only 50% of the 
maximum mandibular protrusion in the Ringqvist study. In our study, protrusive positions of the 
mandible over 75% of the patient’s maximum protrusion were applied in some patients. As we 
found an association between the amount of long-term mandibular protrusion and the decrease 
in overbite, it is conceivable that dental side-effects are more pronounced in our patients than 
observed in the study by Ringqvist and co-workers. 
In our study-model analysis (Chapter 4.2) we found a tendency towards a mesiocclusion after 
two years of oral appliance therapy compared to CPAP therapy. In the oral appliance group we 
also found a tendency towards the development of a (bi)lateral crossbite in the (pre)molar region 
and a decrease in occlusal contact points in the (pre)molar region. Some of these side-effects 
can be classified as ‘favourable’ or ‘unfavourable’ as suggested by Almeida and co-workers (37). 
We mostly found ‘favourable’ dental changes in patients with a baseline class II occlusion (e.g. 
correction to class I or decrease in overjet) and mostly found ‘unfavourable’ changes in patients 
with a baseline class I occlusion (e.g. change to class III occlusion or development of a (bi)lateral 
open bite). From that perspective, one should be alert when treating patients with a class I occlu-
sion with an oral appliance. Especially in these patients, but also in general, possible side-effects 
of oral appliance therapy should be discussed with the patient pre-therapeutically and informed 
consent should be obtained before starting treatment.
As already mentioned, oral appliance design might influence the development of (dental) side-
effects with long-term oral appliance use. However, no comparative studies are available, study-
ing long-term side-effects comparing different types of oral appliances. In our study we did not 
assess the possible relationship between the patient’s periodontal status and the extent of dental 
side-effects. One can hypothesize that a decreased number of healthy teeth or a decrease in peri-
odontal supporting tissue could speed up or worsen the development of dental side-effects as the 
forces, associated with oral appliance therapy, are transmitted to a reduced periodontal surface. 
In future studies it should be considered for future research to take the patient’s periodontal sta-
tus into account before and during oral appliance therapy and to relate this factor to the degree 
of dental-changes that occur.
Regarding side-effects on the temporomandibular complex (Chapter 4.3) we concluded that 
oral appliance therapy is associated with increased pain compared to CPAP in the initial period. 
This pain is usually of mild and transient nature. The development of temporomandibular disor-
ders (TMDs) and/or function impairment appears to be limited with long-term oral appliance use. 
TMDs were assessed using the Research Diagnostic Criteria (RDC) for TMD (Axis I). For assessing 
TMDs, no gold standard was available at the time the present study was started. The RDC/TMD 




could, therefore, be a reliable instrument for research purposes. However, there are some short-
comings to the RDC/TMD (Axis I). First, some outcomes are no diagnoses but rather describe a 
symptom or symptoms (e.g. myalgia, arthralgia). Secondly, it was found that the specificity of the 
RDC/TMD tests in patients with chronic dental pain was much lower (45%) than that in pain-free 
subjects (71%) (40). Third, the RDC/TMD do not contain a diagnostic taxonomy for TMD pain 
that is based on pathologic mechanisms and aetiology. However, despite these shortcomings, we 
believe that the RDC/TMD constitute a reproducible instrument for classifying and diagnosing 
TMDs for research purposes, which makes our outcomes comparable to other studies
In the three studies regarding side-effects of long-term oral appliance therapy, we showed that 
there are significant (dental) side-effects in a substantial number of our patients. Although the 
majority of these patients do not experience any inconvenience or impairment, serious problems 
can arise if side-effects are progressive over the years. Therefore, it could be advised to undergo 
alternative treatment like maxillomandibular advancement (MMA) surgery in an earlier phase, 
in patients treated successfully with an oral appliance. MMA surgery should only be applied in 
carefully selected patients as aesthetics are almost always changed after surgery. It can provide 
definitive treatment and, thus, eliminate problems regarding compliance with other treatments. 
In our case report (Chapter 5) we showed that MMA surgery can play a role in morbidly obese 
patients suffering from severe OSAS who do not tolerate CPAP therapy. Our patient showed a 
tremendous improvement in polysomnographic outcomes but also a substantial subjective im-
provement. There is however, still a lack of high-level scientific evidence. Furthermore, there is no 
universal treatment algorithm that includes polysomnographic parameters, health, performance 
and quality-of-life variables (41). 
Concluding remarks and future perspectives
The aims of this thesis were to evaluate the changes in upper airway morphology, to assess the 
objective and subjective treatment outcome of long-term oral appliance therapy, and to assess 
side-effects associated with long-term use of an oral appliance.
Conclusions and related future perspectives
The following conclusions can be drawn, giving rise to several related future perspectives.
Wearing an oral appliance results in increased anterior-posterior dimensions of the upper airway 
at the level of the second vertebra, the base of the tongue and the uvular tip. Future research 
should focus on 3-D imaging of the upper airway as lateral dimensional changes appear to play 
an important role in the working mechanism of oral appliance therapy. This should be studied 
with the patient in the supine position, preferably during sleep, as this resembles the clinical situ-
ation.
On the long-term, no significant difference was found regarding the percentage of successful 
treatments between oral appliance therapy and CPAP in treating mild-to-severe OSAS. However, 








higher oxygen saturation levels compared to oral appliance therapy.
Future research should focus on the role of oral appliance therapy in severe, but also mild and 
moderate OSAS and on specific characteristics that are predictive for treatment success of oral 
appliance therapy in these patients. This selection of OSAS patients, suitable for oral appliance 
therapy might prevent high drop-out rates during long-term treatment. In order to compare com-
pliance between both CPAP and oral appliance therapy, another aspect for future research is the 
option to covertly measure compliance to oral appliance therapy.
Most side-effects associated with long-term oral appliance therapy involve changes in the pa-
tient’s dental occlusion, of which a decrease in the overjet and overbite are the most striking man-
ifestations. Side-effects of long-term oral appliance therapy on the temporomandibular complex 
include myalgia and arthralgia but are mostly present in the initial phase of treatment therapy and 
are of mild and transient nature. Nevertheless, oral appliance therapy should be considered as a 
life-long treatment, and there is a risk of (sometimes serious) side-effects to occur. Therefore, it is 
of the utmost importance that patients treated with an oral appliance, need a thorough follow-
up by a dentist or dental-specialist, who is experienced in the field of dental sleep medicine.
Future research should focus on differences in oral appliance design in relation to the develop-
ment of side-effects as there are many different designs, each which their own (dis)advantages 
and different mechanisms in force distribution. Furthermore, the relationship between periodon-
tal status and the development of side-effects is still unknown and needs further investigation.
Other future perspectives
As our case report illustrates, maxillomandibular advancement (MMA) surgery can be a very ef-
fective and definitive surgical solution for severe OSAS patients. MMA surgery is now a surgical 
intervention which is, according to multiple treatment guidelines, at the end of the treatment 
spectrum for OSAS patients. It could be suggested to use MMA surgery as a permanent solution 
for OSAS patients in an earlier stage, for example, after a certain period of successful treatment 
with an oral appliance. It remains to be established whether successful oral appliance is a good 
predictor for successful treatment with MMA surgery. To clarify which patients would benefit 
from MMA surgery, a multidisciplinary evaluation remains recommended.
OSAS is a known risk factor for developing sustained periods of hypertension, cardiovascular 
diseases, or death. Though, little is known about the effects of oral appliance therapy on cardio-
vascular variables. Future randomized trials should focus on cardiovascular outcome parameters 
(e.g. blood pressure, advanced glycation end products (AGE) measurements and intima-media 
thickness (IMT) measurements of the arteries). These outcomes may affect general medical prac-
tice and medical costs can be studied from a societal perspective, including direct costs inside and 
outside the health care sector, as well as indirect costs.
In some patients with severe OSAS, CPAP needs to be adjusted to inconvenient high pressures, 
possibly resulting in compliance problems. Oral appliances can be used as alternative treatment 
although therapy is not always effective enough. A combination of CPAP and oral appliance 
therapy may provide another option for CPAP-intolerant patients with incomplete response to 
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Sleep disorders commonly occur in the general population and may give rise to serious repercus-
sions on general health, social life and daily functioning. The obstructive sleep apnoea syndrome 
(OSAS) is a sleep-related breathing disorder, which is characterized by intense snoring and recur-
rent obstructions of the upper airway during sleep. These upper airway obstructions can either 
be complete (apnoeas) or partial (hypopnoeas). The severity of OSAS is usually expressed as the 
apnoea-hypopnoea index (AHI), defined as the average number of apnoeas and hypopnoeas per 
hour sleep and is assessed through a sleep registration (e.g., polysomnography). Based on the 
outcome of this polysomnographic study, OSAS is classified as mild (AHI 5-15), moderate (AHI 
15-30) or severe (AHI> 30).
When treating OSAS, clinicians may consider various non-invasive, surgical or pharmacological 
treatment modalities. When conservative treatment is not applicable or effective, continuous pos-
itive airway pressure (CPAP) used to be the preferred intervention in OSAS patients. Although very 
effective, the obtrusive nature of the flow generator and (oro)nasal mask, may cause patients to 
cease or adhere poorly to CPAP therapy. Over the past decades, intra-orally worn dental devices, 
commonly known as oral appliances, have gained increasing popularity as treatment alternative 
to CPAP therapy. The most common type of oral appliance is the mandibular repositioning appli-
ance (MRA). An MRA aims at relieving upper airway obstructions by positioning the mandible and 
its attached soft tissues structures in a forward and downward position during sleep. 
Nowadays, oral appliance therapy has been demonstrated to be an effective alternative in treat-
ing OSAS. There is however a lack of controlled studies comparing the efficacy of oral appliance 
therapy and CPAP therapy in the long term in OSAS patients representing the entire spectrum 
of the disorder. Furthermore, controlled studies regarding side effects, associated with long-term 
oral appliance use are scarce.
Therefore, the general aims of the studies described in this thesis were to evaluate the long-term 
efficacy and side-effects of oral appliance- and CPAP therapy.
In chapter 2 a study is described assessing the change in upper airway morphology associ-
ated with an oral appliance in situ in patients suffering from OSAS and to relate these changes 
to treatment response. Lateral cephalograms were taken at baseline and after 2-3 months of 
treatment. Baseline and follow-up cephalograms were traced twice and cephalometric variables 
were compared. The predictive value of changes in upper airway morphology for the treatment 
response was evaluated in univariate and multivariate regression analyses. Our study shows that 
wearing an oral appliance results in an increased posterior airway space at the level of the second 
vertebra, the uvular tip and the base of the tongue. The increase of the posterior airway space at 
the level of the second vertebra and the uvular tip were the best predictors for relative improve-
ment of the apnoea-hypopnoea index. However, the predictive value for treatment response of 





In chapter 3 we describe the objective and subjective treatment outcome of oral appliance- and 
CPAP therapy in a two-year follow-up. In 103 patients, objective and subjective parameters were 
assessed after one year and two years of treatment. Treatment was considered “successful” when 
the AHI was <5 or showed ‘substantial reduction’, defined as reduction in the index of at least 
50% from the baseline value to a value of < 20 in a patient without OSAS symptoms while using 
therapy. Regarding the percentage of successful treatments, no significant difference was found 
between oral appliance therapy and CPAP in treating mild-to-severe OSAS in a two-year follow-up. 
CPAP was still successful in 67% of the patients and oral appliance therapy in 53% of the patients 
(p=0.14) after two years of treatment. Both therapies showed substantial improvements in poly-
somnographic and neurobehavioral outcomes. However, CPAP was more effective in lowering the 
AHI and showed higher oxygen saturation levels compared to oral appliance therapy (p<0.05). 
In chapter 4.1 a study is described in which the craniofacial morphology associated with long-
term use of an oral appliance compared with CPAP in patients with OSAS was assessed. Fifty-one 
patients were randomized to oral appliance therapy and fifty-two patients tot CPAP therapy. At 
baseline and after follow-up (2.3 ± 0.2 years) (mean ± standard deviation), a lateral cephalogram 
of all patients was made in maximum intercuspation to determine relevant cephalometric vari-
ables. Both baseline and follow-up cephalograms were traced digitally whereupon cephalometric 
variables were compared. Compared with CPAP, long- term use of an oral appliance resulted in 
small but significant (dental) changes. Overbite and overjet decreased, 1.0 (±1.5) mm and 1.7 
(±1.6) mm, respectively. Furthermore we found a retroclination (-2.0 ± 2.8 degrees) of the upper 
incisors and a proclination (3.7 ± 5.4 degrees) of the lower incisors. Moreover, the lower- and 
total anterior facial height increased significantly, 0.8 (± 1.5) mm and 0.9 (± 1.4) mm, respectively. 
No changes in skeletal variables were found. Linear regression analysis revealed that the decrease 
in overbite was associated with the mean mandibular protrusion during follow-up. 
Chapter 4.2 focuses on possible dental side-effects op long-term oral appliance therapy com-
pared with CPAP. As part of a previously described study (chapter 3), 51 patients were randomized 
to oral appliance therapy and 52 patients to CPAP therapy. At baseline and after a two-year 
follow-up, dental plaster study models in full occlusion were obtained which were thereupon ana-
lyzed with respect to relevant variables. Long-term use of an oral appliance resulted in small but 
significant dental changes compared with CPAP. In the oral appliance group, overbite and overjet 
decreased, 1.2 (±1.1) mm and 1.5 (±1.5) mm, respectively. Furthermore, we found a significantly 
larger anterior-posterior change in the occlusion (-1.3 ± 1.5 mm) in the oral appliance group com-
pared to the CPAP group (-0.1 ± 0.6 mm). Moreover, both groups showed a significant decrease in 
number of occlusal contact points in the (pre)molar region. Linear regression analysis revealed that 
the decrease in overbite was associated with the mean mandibular protrusion during follow-up.
Long-term oral appliance use is associated with dental side-effects. Therefore, patients treated 








While using an oral appliance during sleep, the mandible is positioned in an unnatural ventral 
position. On the longterm this could give rise to side-effects on the temporomandibular com-
plex. In chapter 4.3 variations in the occurrence of temporomandibular disorders (TMDs) and 
the risk of developing pain and function impairment of the temporomandibular was assessed. 
In addition, the relationship between the mean mandibular protrusion, and the frequency of 
wearing the appliance during follow-up with the occurrence of pain and function impairment of 
the temporomandibular complex was assessed. Fifty-one patients were randomized to oral appli-
ance therapy and fifty-two patients to CPAP therapy as part of the in chapter 3 described study. 
TMDs (diagnosed according to the Axis I Research Diagnostic Criteria for TMD), pain intensity 
and disability, and mandibular function impairment were recorded at baseline, after 2 months, 1 
year and 2 years of therapy. Only in the initial period of treatment the occurrence of pain-related 
TMDs was considerably higher (24%) in the oral appliance group compared to CPAP (6%). Oral 
appliance therapy furthermore resulted in more temporomandibular pain compared to CPAP 
(Odds ratio 2.33, 95% Confidence Interval (1.22 – 4.43)). However, there were no limitations in 
mandibular function in both groups during the (entire) follow-up period. Although generally not 
serious and of transient nature, oral appliance therapy results in more pain related TMDs in the 
initial period of use compared with CPAP therapy. Because of the transient nature, this pain is 
not a reason to contra-indicate an oral appliance in OSAS patients. Moreover, TMDs and the risk 
of developing pain and function impairment of the temporomandibular complex appear limited 
with long-term oral appliance use. 
Successful oral appliance therapy has been suggested as a predictor for successful maxillo-
mandibular advancement (MMA) surgery in OSAS patients. MMA surgery has gained increasing 
popularity in this field since this procedure is associated with an enlargement of the entire velo-
oro-hypopharyngeal airway. This specific surgical procedure may be indicated for treat-
ment of severe OSAS patients who cannot tolerate or are unwilling to adhere to CPAP 
therapy. In chapter 5 a case is described of a 32-year-old morbidly obese (BMI=40) 
female with morbidly severe OSAS (AHI=139) and micrognathia of the mandible. As she 
was considered CPAP intolerant, an oral appliance was made which made her AHI drop 
to 40. Afterwards, she underwent MMA surgery combined with a modified genioplasty and 
cervicomental liposuction. Post-surgically, there was almost a complete resolution of the patients’ 
OSAS with a postoperative AHI of 6, which consisted only of hypopnoeas and no apnoeas. The 
lowest oxyhemoglobin saturation during sleep was 86%. The patient reported to feel ‘reborn’ 
after surgery. She experienced her sleep as undisturbed and reported a resolution of her excessive 
daytime sleepiness.
In chapter 6 the main research outcomes of this thesis are discussed in broader context and 
general conclusions are drawn. Furthermore, this chapter discusses and suggests aspects that 
may be considered for future research in oral appliance therapy for OSAS. From the research 





considered as a first-line treatment, next to CPAP in mild and moderate OSAS patients. However, 
CPAP remains most effective in patients with severe OSAS. Furthermore, long-term oral appliance 
therapy is associated with various side-effects of which dental side-effects or the most prominent. 
Therefore, patients treated with an oral appliance should be regularly checked by a dentist or 












Slaapstoornissen komen regelmatig voor onder de algemene bevolking en kunnen ernstige 
gevolgen hebben voor de gezondheid, het sociale leven en het dagelijks functioneren. Het ob-
structief slaapapneu syndroom (OSAS) is een slaapgerelateerde ademhalingsstoornis, die wordt 
gekenmerkt door intensief snurken en herhaaldelijke obstructies van de bovenste luchtweg tij-
dens de slaap. De obstructies van de bovenste luchtweg kunnen volledig (apneu) of gedeeltelijk 
(hypopneu) voorkomen. De ernst van de aandoening wordt meestal uitgedrukt in de “apneu-
hypopneu index” (AHI), gedefinieerd als het gemiddelde aantal apneus en hypopneus per uur 
slaap en wordt beoordeeld middels een slaapregistratie (bijv. polysomnografie). Op basis van de 
uitkomst van dit polysomnografisch onderzoek, wordt OSAS geclassificeerd als mild (AHI 5-15), 
matig (AHI 15-30) of ernstig (AHI> 30).
Bij de behandeling van OSAS, staat de clinicus verschillende conservatieve, chirurgische of far-
macologische behandelmodaliteiten ter beschikking. Als conservatief behandelen niet toepas-
baar of ineffectief bleek bij OSAS patiënten, ging de voorkeur uit naar de behandeling middels 
continue positieve luchtwegdruk (Eng.; continuous positive airway pressure [CPAP]). Ondanks de 
hoge effectiviteit, kunnen patiënten door het belastende karakter van deze behandeling stoppen 
met de therapie of kan de therapietrouw te wensen overlaten. In de afgelopen decennia zijn 
intraoraal gedragen tandheelkundige apparaten gegroeid in populariteit als behandelalternatief 
voor CPAP. De meest voorkomende vorm van intraorale apparaten is het mandibulaire repositie 
apparaat (MRA). Behandeling met een MRA is gericht op het verminderen van de bovenste lucht-
weg obstructies door het verplaatsen van de onderkaak en de daaraan gehechte weke delen naar 
ventraal en caudaal tijdens de slaap.
Tegenwoordig is behandeling met intraorale apparaten een effectief alternatief gebleken in de 
behandeling van OSAS. Er is echter een gebrek aan gecontroleerde studies naar de effectiviteit 
van intraorale apparaten en CPAP-therapie op de lange termijn bij OSAS patiënten die het gehele 
spectrum van de aandoening vertegenwoordigen. Bovendien zijn gecontroleerde studies schaars 
welke betrekking hebben op neveneffecten, geassocieerd met langdurig gebruik van intraorale 
apparaten.
De algemene doelstellingen van dit proefschrift zijn het evalueren van de lange termijn effecti-
viteit en neveneffecten van intraorale apparaten en CPAP-therapie.
In hoofdstuk 2 wordt een studie beschreven waarin veranderingen van de bovenste luchtweg-
morfologie, geassocieerd met een intraoraal apparaat in situ, werden vastgesteld in patiënten 
met OSAS. Tevens werd gekeken of deze veranderingen gerelateerd waren aan de therapieres-
pons. Laterale schedelfoto’s werden vervaardigd bij aanvang van de therapie (zonder intraoraal 
apparaat) en 2-3 maanden nadien (met intraoraal apparaat in situ). De laterale schedelfoto’s van 
baseline en follow-up werden twee keer getraceerd en cephalometrische variabelen werden ver-
geleken. De voorspellende waarde van veranderingen in de bovenste luchtweg morfologie voor 





bleek dat het dragen van een intraoraal apparaat resulteert in een verruiming van de bovenste 
luchtweg op het niveau van de tweede cervicale wervel, de tip van het uvula en de tongbasis. 
De verruiming van de bovenste luchtweg op het niveau van de tweede cervicale wervel en de 
tip van het uvula waren de beste voorspellers voor een relatieve verbetering van de AHI. Echter, 
de voorspellende waarde voor therapierespons van deze cephalometrische veranderingen van de 
bovenste luchtweg dient met voorzichtigheid te worden geïnterpreteerd.
In hoofdstuk 3 beschrijven we de objectieve en subjectieve respons op therapie met een in-
traoraal apparaat en CPAP in een twee jaar durende follow-up bij een cohort van 103 OSAS 
patiënten welke eerder in een gerandomiseerde gecontroleerde studie hebben geparticipeerd. 
Objectieve en subjectieve parameters werden geëvalueerd na één en twee jaar behandeling. De 
behandeling werd als “succesvol” gezien als de AHI <5 was of als er sprake was van een “aan-
zienlijke reductie” van de AHI, gedefinieerd als een reductie van de AHI van ten minste 50% t.o.v. 
de baseline waarde tot een waarde van <20 in een patiënt zonder OSAS symptomen onder thera-
pie. Met betrekking tot het percentage succesvolle behandelingen, werd geen significant verschil 
gevonden tussen behandeling met een intraoraal apparaat en CPAP bij patiënten met een mild 
tot ernstig OSAS gedurende een follow-up van twee jaar. CPAP was nog steeds succesvol in 67% 
van de patiënten en behandeling met een intraoraal apparaat in 53% van de patiënten (p = 0.14) 
na twee jaar behandelen. Beide therapieën lieten aanzienlijke verbeteringen in polysomnografi-
sche en neurofysiologische variabelen zien. Desalniettemin was CPAP effectiever in het reduceren 
van de AHI en werden hogere zuurstofsaturatie waarden gezien vergeleken met de behandeling 
met een intraoraal apparaat (p <0.05).
In hoofdstuk 4.1 worden eventuele neveneffecten op de craniofaciale morfologie beschreven, 
welke veroorzaakt kunnen worden door langdurig gebruik van een intraoraal apparaat verge-
leken met CPAP bij OSAS patiënten. Eenenvijftig patiënten werden in het kader van een eerder 
uitgevoerde gecontroleerde klinische studie (hoofdstuk 3) gerandomiseerd voor behandeling 
met een intraoraal apparaat en tweeënvijftig patiënten voor CPAP. Bij aanvang en na de follow-
up (2.3 ± 0.2 jaar) (gemiddelde ± standaard deviatie), werd een laterale schedelfoto vervaardigd 
bij alle patiënten tijdens maximale occlusie om relevante cephalometrische variabelen te bepa-
len. Zowel de laterale schedelfoto’s van baseline en follow-up werden digitaal getraced waarna 
cephalometrische variabelen werden vergeleken. In vergelijking met CPAP, resulteerde langdu-
rig gebruik van een intraoraal apparaat in kleine, maar significante (dentale) veranderingen. De 
overbeet en overjet namen gemiddeld af met respectievelijk 1.0 (± 1.5) mm en 1.7 (± 1.6) mm. 
Verder vonden we een retroclinatie (-2.0 ± 2.8 graden) van de centrale bovenste snijtanden en 
een proclinatie (3.7 ± 5.4 graden) van de centrale onderste snijtanden. Bovendien is de onderste 
en de totale anterieure gezichtshoogte significant toegenomen, 0.8 (± 1.5) mm en 0.9 (± 1.4) 
mm, respectievelijk. Er werden geen veranderingen in skeletale variabelen gevonden. Lineaire 
regressie analyse liet zien dat een afname van de overbeet werd geassocieerd met de gemiddelde 








Hoofdstuk 4.2 richt zich op mogelijke tandheelkundige nevenwerkingen van intraorale appa-
raten in vergelijking met CPAP op lange termijn. Als onderdeel van een eerder beschreven studie 
(hoofdstuk 3), werden 51 patiënten gerandomiseerd voor behandeling met een intraoraal appa-
raat en 52 patiënten voor CPAP. Bij aanvang en na een twee jaar therapie, werden studiemodellen 
van het gebit in maximale occlusie verkregen en geanalyseerd. Langdurig gebruik van intraorale 
apparaten resulteerde in kleine, maar significante dentale veranderingen vergeleken met CPAP. 
In de groep die behandeld werd met een intraoraal apparaat nam de overbeet en overjet gemid-
deld af met 1.2 (± 1.1) mm en 1.5 (± 1.5) mm, respectievelijk. Verder vonden we een grotere 
gemiddelde anterieure-posterieure verandering in de occlusie (-1.3 ± 1.5 mm) in de groep die 
behandeld werd met een intraoraal apparaat vergeleken met de CPAP groep (-0.1 ± 0.6 mm). Bo-
vendien vertoonden beide groepen een significante daling in het aantal occlusale contactpunten 
in het (pre)molaar gebied. Uit lineaire regressie analyse bleek dat afname van de overbeet geas-
socieerd was met de gemiddelde mandibulaire protrusie tijdens de follow-up periode.
Geconcludeerd kan worden dat langdurig gebruik van een intraoraal apparaat geassocieerd 
wordt met dentale neveneffecten. Daarom moeten patiënten die behandeld worden met een 
intraoraal apparaat, regelmatig voor follow-up worden gezien door een tandarts(specialist) die 
ervaring heeft op het gebied van de tandheelkundige slaapgeneeskunde.
Tijdens het gebruik van een intraoraal apparaat tijdens de slaap, wordt de onderkaak in een on-
natuurlijk ventrale positie gehouden. Op de lange termijn kan dit aanleiding geven tot nevenef-
fecten op het temporomandibulaire complex. In hoofdstuk 4.3 worden variaties in het optreden 
van temporomandibulaire stoornissen en het risico op het ontwikkelen van pijn en functiebe-
perking van het temporomandibulaire complex beschreven bij patiënten die behandeld worden 
met een intraoraal apparaat of CPAP. Bovendien is gekeken naar de relatie tussen de gemiddelde 
mandibulaire protrusie, de draagfrequentie van het apparaat tijdens de follow-up en het optre-
den van pijn en functiebeperking van het temporomandibulaire complex. Eenenvijftig patiënten 
werden gerandomiseerd voor behandeling met een intraoraal apparaat en tweeënvijftig patiën-
ten voor CPAP als onderdeel van de in hoofdstuk 3 beschreven studie. Temporomandibulaire 
stoornissen (gediagnosticeerd volgens Axis I: Research Diagnostic Criteria for Temporomandibular 
Disorders), intensiteit van de pijn, beperking door de pijn en mandibulaire functiebeperking wer-
den bepaald bij aanvang van de therapie, na 2 maanden, na 1 jaar en na 2 jaar therapie. Vooral in 
de beginperiode van de behandeling waren pijn-gerelateerde temporomandibulaire stoornissen 
aanzienlijk frequenter aanwezig (24%) in de groep die behandeld werd met een intraoraal appa-
raat vergeleken met de CPAP groep (6%). Bovendien leidde behandeling met een intraoraal ap-
paraat tot meer temporomandibulaire pijn vergeleken met CPAP. Er werd echter geen mandibu-
laire functiebeperking waargenomen in beide groepen gedurende de (gehele) follow-up periode. 
Behandeling met een intraoraal apparaat leidt tot meer pijn-gerelateerde temporomandibulaire 
stoornissen in de eerste periode van gebruik in vergelijking met CPAP-therapie. Deze zijn echter 
mild en van voorbijgaande aard. Daarom is deze pijn geen reden om een intraoraal apparaat te 





risico op het ontwikkelen van pijn en functiebeperkingen van het temporomandibulaire complex 
beperkt bij langdurig gebruik van een intraoraal apparaat.
Er wordt gesuggereerd dat succesvolle behandeling met een intraoraal apparaat van voorspellen-
de waarde kan zijn voor succesvolle behandeling middels een maxillomandibulaire osteotomie bij 
OSAS patiënten. Een maxillomandibulaire osteotomie betreft een chirurgische verplaatsing van de 
boven- en onderkaak naar voren. De procedure wordt gezien als de meest effectieve chirurgische 
behandeling van het OSAS. De maxillomandibulaire osteotomie wordt mondiaal in toenemende 
mate toegepast bij OSAS patiënten sinds bekend is dat deze procedure gepaard gaat met een 
toename van het lumen van de gehele velo-oro-hypofaryngeale luchtweg. Deze specifieke chirur-
gische procedure kan worden geïndiceerd bij de behandeling van patiënten met een ernstig OSAS 
die CPAP niet kunnen verdragen of niet therapietrouw zijn aan CPAP. In hoofdstuk 5 wordt een 
casus beschreven van een 32-jarige vrouw met morbide obesitas (BMI = 40), een zeer ernstig OSAS 
(AHI = 139) en een onderontwikkeling van de onderkaak. Omdat CPAP therapie niet effectief was 
en dit gepaard ging met teveel neveneffecten, werd een intraoraal apparaat vervaardigd waarna 
een AHI van 40 werd bereikt. Hier opvolgend onderging zij een maxillomandibulaire osteotomie, 
gecombineerd met een gemodificeerde genioplasty en cervicomentale liposuctie. Postoperatief 
was er nog slechts sprake van een zeer mild OSAS met een postoperatieve AHI van 6, die enkel 
bestond uit hypopneus. De laagste zuurstofsaturatiewaarde tijdens de slaap was 86%. Patiënte 
voelde zich als ‘herboren’ na de operatie. Ze ervaart haar slaap als ongestoord en verder is er geen 
sprake meer overmatige slaperigheid overdag. 
Deze casus laat zien dat een maxillomandibulaire osteotomie ook effectief kan zijn bij een patiënt 
met een zeer ernstig OSAS als CPAP therapie niet geaccepteerd wordt.
In hoofdstuk 6 worden de belangrijkste onderzoeksresultaten van dit proefschrift in een bre-
der perspectief geplaatst en worden algemene conclusies getrokken. Verder worden suggesties 
gegeven voor toekomstig onderzoek naar behandeling met intraorale apparaten. Uit het onder-
zoek beschreven in dit proefschrift kan worden geconcludeerd dat, ook op lange termijn, be-
handeling met een intraoraal apparaat als behandeling van eerste keus kan worden beschouwd 
bij patiënten met mild en matig OSAS. CPAP blijft echter het meest effectief bij patiënten met 
ernstig OSAS. Verder wordt langdurige behandeling met een intraoraal apparaat geassocieerd 
met diverse neveneffecten, waarvan de dentale neveneffecten het meest prominent zijn. Daarom 
moeten patiënten die worden behandeld met een intraoraal apparaat regelmatig worden gecon-










 Appendix to chapter 3
Recruitment of patients
The University Medical Center Groningen has a catchment area that includes most of the north-
eastern part of The Netherlands. Patients suspected to have sleep apnoea are referred to this 
medical center by general practitioners from the region and physicians from departments of 
pulmonary medicine, neurology, and ear, nose, & throat surgery in several regional hospitals in 
order to possibly participate in a previously conducted randomized controlled trial (RCT) (10). We 
used the recommendations of the American Academy of Sleep Medicine to diagnose obstructive 
sleep apnoea (1) and are defined as:
1 or 2, plus criterion 3 of the following:
1. A clear decrease (>50%) from baseline in the amplitude of a valid measure of breathing during 
sleep. Baseline is defined as the mean amplitude of stable breathing and oxygenation in the two 
minutes preceding onset of the event (in individuals who have a stable breathing pattern during 
sleep) or the mean amplitude of the three largest breaths in the two minutes preceding onset of 
the event (in individuals without a stable breathing pattern).
2. A clear amplitude reduction of a validated measure of breathing during sleep that does not 
reach the above criterion but is associated with either an oxygen desaturation of >3% or an 
arousal.
3. The event lasts 10 seconds or longer.
Each patient diagnosed as having obstructive sleep apnoea consulted our Department of Home 
Mechanical Ventilation for treatment. 
Selection of patients and informed consent
To screen for any underlying disease, all eligible patients underwent a comprehensive physical 
evaluation, spirometry, thoracic radiography, electrocardiography, and blood tests. 
General criteria for inclusion in the study were: 
- age >20 years old.
- polysomnography showing an apnoea-hypopnoea index ≥ 5; i.e., the mean number of apnoeas 
  and hypopnoeas per hour of sleep in combination with:
     • Excessive daytime sleepiness that is not better explained by other factors or 
     • Two or more of the following that are not better explained by other factors:
          • choking or gasping during sleep, 
          • recurrent awakenings from sleep, 
          • unfreshed sleep, 
          • daytime fatigue, 
          • impaired concentration.
Medical and psychological criteria for exclusion from the study were: 
- previous treatment of obstructive sleep apnoea (continuous positive airway pressure (CPAP), 






- morphological airway abnormalities requiring treatment (a compromised nasal passage, en-
larged tonsils or adenoids, upper-airway or pulmonary neoplasm, or upper-airway soft tissue or 
craniofacial abnormality). 
- endocrine dysfunction (hypothyroidism, acromegaly, or pituitary adenoma).
- a reported or documented history of severe cardiac or pulmonary disease (daytime respiratory 
insufficiency, severe chronic obstructive pulmonary disease (Tiffeneau-index <40%) (2), heart fail-
ure, coronary disease, or severe cardiac arrhythmias).
- moderate or severe periodic limb movement disorder (periodic limb movement index >25). 
- a psychological condition precluding informed consent (mental retardation or psychiatric disor-
der; e.g., depression or schizophrenia). 
Dental criteria for exclusion from the study were: 
- extensive periodontal disease or tooth decay.
- active temporomandibular joint disease (including severe bruxism).
- restrictions in mouth opening (<25 mm) or advancement of the mandible (<5 mm).
- partial or complete edentulism (<8 teeth in upper or lower jaw). 
Patients who qualified for inclusion were informed about the study and their questions were 
answered by the pulmologist and dentist who evaluated the patients. Each patient was given a 
brochure with details about the study and had 1 week to decide whether or not they wanted to 
participate. Patients who decided to participate signed and returned an informed consent form. 
Randomization procedure
The clinical epidemiologist (B.S.) for the study made computer-generated randomization se-
quences, balancing for disease severity. The randomization sequences were used for selecting 
random permuted blocks with lengths of 2, 4, and 6 (3). The clinicians supervising oral appli-
ance- and CPAP therapy were not informed about how the randomization was performed. The 
randomization sequences were concealed and administered by the secretarial office of the De-
partment of Oral and Maxillofacial Surgery. After each patient’s serial number and diagnosis of 
disease severity was provided, the treatment was disclosed. Each serial number could be provided 
only once. It was not possible to blind patients or clinicians to treatment assignment.
Interventions, conservative measures, and adjustments
Oral appliance therapy was initiated in the Department of Oral and Maxillofacial Surgery and 
was supervised by two experienced dentists (M.D, A.H.). CPAP therapy was initiated in the De-
partment of Home Mechanical Ventilation. Oral appliance therapy was initiated within a 4-week 
period and CPAP therapy within a 2-week period after a patient was enrolled in the study. Before 
treatment was initiated, all patients were instructed to adopt conservative measures; specifically, 
to avoid using depressants (e.g., alcohol, sleep medication) and to have at least 7 to 8 hours 
of sleep each night. When indicated, patients were encouraged to give up smoking and loose 
weight. 







supported by the dentition of the maxilla and the lower part by the dentition of the mandible. 
By turning a propulsion screw incorporated anteriorly in the appliance, the patient could adjust 
the amount of mandibular advancement in 0.2-mm increments. The maximum advancement of 
the mandible was determined with a George-GaugeTM (H Orthodontics, Michigan City, IN, USA) 
before oral appliance therapy began. Initially, the mandible was set at 50% of the patient’s maxi-
mum advancement. After patients became accustomed to the oral appliance during a 2-week 
period, they returned for a check-up visit. They were instructed to adjust the oral appliance over 
the following 6 weeks, until the second polysomnographic study was performed—advancing 
the mandible by turning the propulsion screw each night with 1 or 2 clockwise turns (i.e., 0.2–
0.4 mm) until symptoms abated (i.e., snoring, apnoeas, hypopnoeas, or excessive sleepiness). If 
the second polysomnographic assessment indicated an apnoea-hypopnoea index ≥5, the oral 
appliance was adjusted, if possible, in an attempt to improve effectiveness. The oral appliance 
was adjusted to obtain the maximum advancement of the mandible with which the patient was 
comfortable. A third polysomnographic study was performed 4 weeks after that adjustment was 
made. 
CPAP titration was performed during an afternoon nap (5). All patients using CPAP received 
detailed instructions about this procedure and use of CPAP from a skilled nursing consultant. Pa-
tients were fitted with a comfortable CPAP mask before titration. After CPAP titration, all patients 
received a similar CPAP device (Breas® PV10, Mölnlycke, Sweden). Patients were permitted to 
become accustomed to CPAP during a 2-week period, after which they returned for a check-up 
visit. After another 6 weeks of treatment, a second polysomnographic study was performed. If 
polysomnography indicated an apnoea-hypopnoea index ≥5, we adjusted the CPAP, if possible, 
with a rise in pressure by 1 or 2 cm H2O, depending on the residual apnoea-hypopnoea index 
with CPAP. A third polysomnographic study was performed 4 weeks after that adjustment was 
made (T2). Adjustments of CPAP therapy were continued until the apnoea-hypopnoea index was 
<5 or until adjustments of CPAP became uncomfortable for the patient. 
Patients for whom oral appliance- or CPAP therapy was successful continued the treatment. 
Patients for whom treatment was not effective were offered the alternative CPAP or oral appli-
ance therapy. After one year (T15) and two years (T27) of treatment another polysomnographic 
study was performed. 
Polysomnography
Surface electroencephalography, submental electromyography, and left and right electroocu-
lography were used to stage sleep by using standardized criteria (6). A pulsoximeter (Oximeter 
Flex Sensor – 8000J-3, Medcare, Reykjavik, Iceland) was used to record oxyhemoglobin satura-
tion. Electrocardiography was used to monitor cardiac function. Oronasal airflow was recorded 
with a pressure cannula. Respiratory effort was monitored with thoracic and abdominal strain 
gauges. An anterior tibial electromyogram was recorded to screen for periodic limb movements. 
Each polysomnographic study started at 11 AM and ended at 9 AM the next morning. Polysom-






included total sleep time, sleep efficiency, apnoea-hypopnoea index, minimum oxyhemoglobin 
saturation, the percentage of non-rapid eye-movement sleep during stages 1 & 2 and 3 & 4, and 
the percentage of rapid eye-movement sleep. Baseline polysomnographic outcomes were those 
obtained at the time of diagnosis.
Neurobehavioral examinations
Patients completed the Epworth sleepiness scale to assess their propensity to fall asleep in eight 
different situations (7). Patients completed the functional outcomes of sleep questionnaire to 
assess the impact of excessive sleepiness on a number of activities of everyday living (8). This 
questionnaire consists of 30 different questions that yield a score for five different subscales and 
a total score. Patients completed the medical outcomes study 36-item short-form health survey 
to assess their perception of their health status (9). This questionnaire consists of 11 questions 
that yield a score for eight different dimensions and one item regarding changes in the patient’s 
health. 
Patients’ usage of their therapy was evaluated by asking patients how many nights each week 
and how many hours each night they used their treatment. Whereas CPAP usage can be moni-
tored covertly with a mechanism built into the device, oral appliance usage cannot be assessed 
covertly in any reliable way. To eliminate bias, we ensured that treatment usage was assessed in 
the same manner by basing the assessments on self-reports in both groups. Some patients did 
not use treatment during the entire week; for example, on weekends when they did not antici-
pate a strenuous day. Patients were considered non-adherent to therapy only if they voluntarily 
discontinued use of the therapy due to poor tolerance or any other reason.
Statistical analysis
Calculation of the sample size was performed with the PASS 2000 software package (NCSS, 
Kaysville, UT). Statistical analyses were performed by using the Statistical Package for the Social 
Sciences (version 16.0, SPSS Inc., Chicago, IL, USA). The clinical epidemiologist (B.S.) who col-
lected and analyzed all the data did not have any contact with the patients. Power analysis was 
done for a previously conducted two-month RCT (10) of which this study is the two-year follow-
up. For that RCT, a minimum of 46 patients would be required in each treatment group when a 
one-sided significance level of 5%, a power of 90%, and an assumed proportion of treatment 







Table E1. Characteristics of patients that switched to the alternative therapy during the follow-up.
Variable Oral appliance after CPAP*
(n = 4)
CPAP after oral appliance*
(n = 7)
Male/female ratio 4/0 5/2 
Apnoea-hypopnoea index (no/hour) 33 ± 15 60 ± 42
Age (years) 43 ± 11 51 ± 12
Body-mass index (kg/m2) 30 ± 2 39 ± 6
Neck circumference (cm) 44 ± 1 46 ± 5
* Plus-minus values are means ± standard deviations.
Abbreviations: CPAP = continuous positive airway pressure.





Male/female ratio 23/6 35/2
Apnoea-hypopnoea index (no/hour) 36 ± 22 44 ± 28
Age (years) 50 ± 9 51 ± 10
Body-mass index (kg/m2) 31 ± 6 34 ± 5
Neck circumference (cm) 43 ± 3 45 ± 4
* Plus-minus values are means ± standard deviations.
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 Na enkele jaren onderzoek doen is het dan zover, het proefschrift is af. Natuurlijk is dit hele pro-
ces geen eenmansactie geweest maar heb ik me gesteund gevoeld door de vele mensen om mij 
heen. Zonder iemand te kort te willen doen, wil ik een aantal personen in het bijzonder bedanken 
die elk op een eigen wijze hebben bijgedragen aan de totstandkoming van dit proefschrift.
Allereerst dank aan alle patiënten die zich hebben ingezet voor dit onderzoek. Ik wil jullie be-
danken voor het invullen van de uitgebreide vragenlijsten en het ondergaan van alle slaaponder-
zoeken. Zonder jullie was dit boekje er niet geweest!
Prof. dr. B. Stegenga, beste Boudewijn. In de afgelopen jaren ben je als promotor niet alleen een 
uiterst bekwame onderzoeksbegeleider gebleken maar ook op sociaal vlak heb je bewezen een 
echte coach te zijn. Vooral dat laatste aspect is voor mij erg waardevol geweest, juist op de mo-
menten dat de motivatie ver te zoeken was. Je wist me op een vrij directe maar ook invoelende 
manier weer met de oren bij het onderzoek te slepen. Dit alles maakt dat ik ontzettend blij ben 
geweest met jou als promotor en ik hoop dat we in de toekomst zowel op onderzoeksgebied 
maar ook op sociaal gebied nog veel met elkaar te maken zullen krijgen. Bedankt!
Prof. dr. L.G.M. de Bont, beste professor. Het is een voorrecht geweest om de afgelopen jaren 
onderzoek te hebben mogen doen op de afdeling kaakchirurgie. Het is een afdeling waar een 
ontzettend prettig onderzoeksklimaat heerst, waar iedereen toegankelijk is en waar ik als onder-
zoeker over alle nodige faciliteiten heb mogen beschikken. Ook was u het die mij als eerste (D)MD-
PhD student van de Junior Scientific Masterclass vanuit de studie tandheelkunde de kans gaf om 
het slaapapneu onderzoek verder gestalte te geven binnen uw afdeling. Het was vanaf het begin 
overduidelijk dat het obstructief slaapapneu syndroom en het daaraan gerelateerde onderzoek u 
erg aan het hart gaat. Menigmaal heb ik met veel plezier mogen luisteren naar de bevlogenheid 
waarmee u de verhalen uit de beginperiode van de slaapapneu behandeling in het UMCG met mij 
deelde. Dit heeft erg inspirerend gewerkt. Ik wil u danken voor de prettige begeleiding de afgelo-
pen jaren en voor het feit dat ik onder uw leiding de opleiding tot MKA-chirurg mocht starten. 
Dr. A. Hoekema, beste Aarnoud. Met jou als copromotor kon ik me geen betere directe bege-
leider wensen. De manier waarop je me wegwijs hebt gemaakt in het onderzoek dat jij zo uiterst 
nauwkeurig hebt opgezet heb ik als ontzettend waardevol ervaren. Ik zag het dan ook als een 
uitdaging dit onderzoek met eenzelfde nauwkeurigheid uit te voeren en tot een goed einde te 
brengen. Tegelijkertijd wilde ik ook mijn eigen stempel op het onderzoek drukken. Dit heb je 
gelukkig altijd erg aangemoedigd. Dat er ook een echte vriendschap is ontstaan in de afgelo-
pen jaren is bijzonder en zie ik als een ‘extraatje’. We hebben ontzettend veel leuke momenten 
beleefd op congressen en veel van die momenten staan nog vers in mijn geheugen. Ik hoop dat 
er nog veel van dit soort momenten zullen komen in de toekomst en tevens hoop ik dat we de 
tandheelkundige behandeling van het obstructief slaapapneu syndroom nog beter op de kaart 










Dr. P.J. Wijkstra. Beste Peter. Ook jou wil ik bedanken voor de uiterst prettige samenwerking 
tijdens het uitvoeren van het onderzoek. Je deur stond altijd open en even snel wat overleggen 
tussendoor was nooit een probleem. Terwijl ik nog wel eens met tandheelkundige ‘oogkleppen’ 
mijn manuscripten schreef was jij het die vanuit een ‘longarts perspectief’ met zeer scherpe op-
merkingen kwam waardoor de leesbaarheid van de manuscripten voor niet-tandheelkundigen 
zeker verbeterd is. In het vervolgonderzoek zullen we hopelijk nog veel met elkaar te maken 
krijgen.
Dr. J.H. van der Hoeven. Beste Han. Toen het onderzoek van Aarnoud afgerond was, kwam ik je 
nog twee jaar lastig vallen met de analyses van de vele slaaponderzoeken voor de lange termijn 
follow-up. Ondank dat ben je altijd uiterst nauwkeurig geweest in het vele werk dat je voor mijn 
onderzoek hebt verricht. Ik heb veel mogen leren van je precieze manier van werken. Ook was 
het erg fijn om als nieuwe onderzoeker het gevoel te hebben gehad al snel deel van de groep te 
zijn. Ik ben je voor dit alles zeer erkentelijk. 
De leden van de beoordelingscommissie: Prof. dr. Lobbezoo, prof. dr. Kerstjens en prof. dr. Ver-
braecken. Ik wil u allen danken voor de tijd die u, ondanks gevulde agenda’s, heeft gestoken in 
het beoordelen van het manuscript.
Dr. J.J.R. Huddleston-Slater. Beste James. Jouw epidemiologisch en statistisch overwicht is zeer 
waardevol geweest tijdens dit onderzoek. Door jouw manier van uitleggen heb je mij aardig in-
geleid in de klinische epidemiologie en statistiek en mij er van overtuigd dat het nog leuk kan zijn 
ook! Ondanks alle hectiek de afgelopen jaren stond je altijd voor me klaar. Ontzettend bedankt!
Dr. G.J. Pruim. Beste Gerard. Al tijdens mijn scriptieonderzoek over de cephalometrische analyse 
van de bovenste luchtweg bij OSAS-patiënten ben je van onschatbare waarde gebleken. Ik schrok 
dan ook toen ik hoorde dat je bijna pensioengerechtigd was. Ondanks dat je me niet zover hebt 
kunnen krijgen om voor de orthodontie te kiezen in plaats van de kaakchirurgie, was je bereid 
om zelfs na je pensioen mee te denken en te helpen en zat je vol met ideeën. Het was aan mij de 
taak om tijdens ons overleg ook mijn onderzoek aan de orde te brengen, want ik moest en zou 
elke week je nieuwe ‘Viewbox’ bevindingen zien en er met je over discussiëren. Jouw visie was 
inspirerend en heeft me geprikkeld om verder te kijken dan mijn neus lang is.
Prof. dr. S.J.H. Reker, beste professor. Ik wil u hartelijk danken voor het beschikbaar stellen van 
uw versie van de Groningse tekst van ‘het Hogeland’ voor dit proefschrift. 
Mevr. L. Kempers, mevr. K. Woldhuis, mevr. N. Jaeger, dhr. H. de Jonge. Beste Lisa, Karin, Nienke 
en Harrie. Op secretarieel en ondersteunend gebied zijn jullie onontbeerlijk geweest de afgelopen 
jaren. Jullie hebben vele processen fantastisch gestroomlijnd. Met jullie was er op de afdeling en 










Alle assistentes die me op de woensdagmiddag op de polikliniek zo kundig hebben geholpen en 
mij veel werk uit handen hebben genomen. Twee van hen wil ik hierbij met naam noemen.
Mevr. I. Copper. Beste Ingrid. In de beginjaren van het onderzoek heb jij je uitzonderlijk ingezet 
op de polikliniek maar ook op secretarieel gebied. De grote stapels vragenlijsten heb jij uiterst 
nauwkeurig gescoord en geen opdracht was je teveel. Met jou waren de woensdagmiddagen 
nooit saai en er is ontzettend veel gelachen samen, ook op onze gezamenlijke onderzoeksoch-
tend op de derde verdieping. Als mijn verstrooidheid zo nu en dan de kop opstak had jij gelukkig 
alles helder gepland en allerlei geheugensteuntjes in je agenda staan. Bedankt voor alles!
Mevr. C. Krul. Beste Chantal. In de eindfase van het onderzoek nam jij de plaats van Ingrid in. 
Zoiets kan natuurlijk lastig zijn, helemaal als de materie ‘afwijkend’ is van wat je gewend bent. 
Van dit alles heb ik eigenlijk niets gemerkt en je pakte alle facetten van het assisteren bij de OSAS-
patiënten heel goed op. Je wilde zelfs nog de laatste vragenlijsten voor je zwangerschapsverlof in 
de database zetten ……en het is gelukt. Bedankt voor al je kundige hulp!
De dames van het secretariaat Klinische Neurofysiologie. Vele PSG-aanvragen hebben jullie moe-
ten plannen voor dit onderzoek. Het was geweldig om te ervaren dat bijna alle patiënten aanslui-
tend op hun bezoek aan de polikliniek gepland konden worden. Ook als er tussendoor nog even 
iets omgezet moest worden stuitte ik zelden op weerstand. Als patiënten niet op kwamen dagen 
waren jullie volhardend om, koste wat het kost, de patiënt alsnog in te kunnen plannen. Het was 
altijd een leuk uitstapje naar de eerste verdieping. Bedankt voor al jullie positieve inzet!
Alle medewerkers van het centrum voor thuisbeademing. Bedankt voor jullie inzet bij alle CPAP 
patiënten.
Dhr. A. Wietsma. Beste Anne. Jij hebt ontzettend veel werk tussendoor gedaan voor alle onder-
zoekspatiënten. Als er reparaties nodig waren aan de MRA’s, dan konden de patiënten altijd bij 
jou terecht. Hierdoor hoefden de patiënten zelden zonder MRA te slapen wat voor hen natuurlijk 
ontzettend prettig was. Ik heb al je werk niet als vanzelfsprekend gezien en wil je bedanken voor 
al je inzet.
De collega onderzoekers op de derde verdieping. Mede door jullie was er altijd een uiterst pret-
tige sfeer op de afdeling. Het was en is nog steeds geweldig om alles met jullie te kunnen delen 
tijdens een kop koffie. Bedankt voor alle steun op welke manier dan ook. 
Alle mede AIOS MKA-chirurgie wil ik bedanken voor de prettige samenwerking en de getoonde 
interesse in het onderzoek. Bedankt dat jullie mij als ‘oudje’ in de groep hebben opgenomen.
Mijn (ex)kamergenoten. Mevrouw Dr. A. Visser. Beste Anita, Moneypenny. Het was een uiterst 
gezellige tijd, ook al was het in de beginfase soms wat druk op de kamer. Je zal me altijd bij blijven 










Mevrouw dr(s). G. Telleman. Beste Gerdien. ‘Twee uitersten op één kamer, als dat maar goed 
komt’, waren mijn eerste gedachten na de herschikking van de kamers op de 3de verdieping. Na 
enkele weken bleken die uitersten wel mee te vallen. Als ik weer eens in mezelf zat te praten 
tijdens het schrijven, de radio weer te hard aan had of verbaal de frustraties uitte achter de PC 
als het niet zo ging zoals ik wilde, dan wist jij dat altijd op een subtiele manier aan mij kenbaar te 
maken. Ik hoop dat we nog een tijd kamergenootjes zullen blijven.
Mevrouw drs. K. Finnema. Lieve ‘Katriensje’. Onze samenwerking begon in 2004 toen ik als 
student-lid bij jou in de opleidingscommissie van de studie tandheelkunde kwam. Toen al had-
den we een ontzettend leuk contact. Dat je ook nog eens de vriendin van die ‘snurkdokter’ bij 
de kaakchirurgie was, bleek handig te zijn toen Aarnoud een opvolger zocht voor het OSAS-
onderzoek. Jij bent misschien wel de cruciale factor geweest dat ik hier toen een start mee heb 
gemaakt. We hebben hele leuke momenten gehad samen, waaronder de trip naar Montreal in 
2006. Onze samenwerking heeft zelfs geresulteerd in jouw co-auteurschap van hoofdstuk 4.2 in 
dit proefschrift. Bedankt voor alles!
Mevrouw drs. S.K.B. Veldhuis. Beste Steffanie. Na je scriptieonderzoek bij mij heb je uiteindelijk 
toch besloten niet door te gaan met het OSAS-onderzoek. Toch heeft jouw scriptieonderzoek 
geresulteerd in een mooie publicatie (hoofdstuk 4.3). Ik wens je alle goeds toe voor de toekomst 
en we zullen elkaar vanuit de NVTS nog regelmatig treffen.
Dr(s). A. van Leeuwen, beste Anne, ‘zeun’. Er zijn van die uiterst zeldzame momenten in het 
leven dat er iemand op je pad komt bij wie je meteen voelt dat er een extra dimensie is waar je 
elkaar vindt. We hebben elkaar de afgelopen jaren in heel veel opzichten gevonden. Ik denk dat 
we kunnen spreken van een echte match. Dat we her en der in het ziekenhuis bekend staan als 
‘Peppi en Kokki’, ‘Pier en Pol’, ‘Jut en Jul’ of ‘de mannetjes van de muppetshow’ zegt al wel ge-
noeg. Het was voor mij dan ook vanzelfsprekend om jou als paranimf te vragen. Nog mooier was 
het dat jij daar eigenlijk al van uit was gegaan. Bedankt dat je mijn paranimf wil zijn.
Drs. M.S. Lingbeek. Beste Steven. Jij hebt me als een ware mentor de afgelopen tijd ingewijd in 
de orale implantologie. Jouw precieze manier van werken, je kritische en artistieke blik werken 
aanstekelijk. Ondanks ons leeftijdsverschil is er een hechte vriendschap ontstaan de afgelopen 
jaren. Ik heb de vele kilometers naar Haaksbergen en terug hier altijd graag voor over gehad. 
Bedankt dat je deze dag mijn paranimf wilt zijn.
Al mijn vrienden en familie die door het onderzoek zonder twijfel te weinig aandacht hebben 
gekregen. Ik hoop dat door de afronding van het proefschrift er weer tijd zal komen om meer 
andere dingen te ondernemen.










Pa, als je ouder wordt en terugkijkt in de tijd dan besef je pas hoe ontzettend waardevol iemand 
voor je kan zijn tijdens je leven. Als ik iemand nodig had om mee te praten dan was een ritje naar 
“Toesternust” en een wandeling samen met jou een verademing. Je stond en staat altijd voor me 
klaar. Heel erg bedankt daarvoor. Ik ben blij dat je weer gelukkig bent met Hennie na mamma 
haar overlijden en wens jullie nog veel liefde en geluk toe voor de toekomst. 
Mijn broers Jan en Hans. Als nakomertje voelde het voor mij als een gemis dat jullie uit huis 
gingen. Ik heb het altijd erg gezellig gevonden samen ondanks dat ik veel jonger was. We zijn 
misschien alle drie heel verschillend maar dat maakt het wellicht juist bijzonder en uitdagend om 
onze band sterk te houden. Laten we ervoor zorgen dat we zo nu en dan samen leuke dingen 
blijven doen.
Lieve mama († 1997), jij hebt veel van mijn bijzondere momenten zoals deze helaas niet meer 
mogen meemaken. Ik weet zeker dat je anders zo trots als een pauw op de eerste rij had gezeten 
tijdens de verdediging van dit proefschrift. Je was de beste moeder die ik me kon wensen. Ik mis 
je nog elke dag. Dit proefschrift draag ik dan ook aan jou op.
Simon, papa’s grote vent. Jij bent het mooiste dat mij is overkomen. Je bent de zonnestraal in 
mijn leven en ik geniet intens van je. Ik zie uit naar de toekomst waarin we nog veel samen zullen 
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